data_2kea_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kea _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.785 0 N-CA-C 112.739 -0.144 . . . . 0.0 112.739 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -119.14 112.49 19.58 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -118.75 117.72 29.67 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.618 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -99.52 113.92 26.61 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 246' ' ' LYS . 2.5 p -77.19 112.73 15.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.401 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -93.56 -25.46 17.55 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.655 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 85.6 m -117.54 117.79 30.39 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -66.72 149.74 50.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.474 0.654 . . . . 0.0 111.637 -177.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.465 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 53.3 t80 -147.29 129.52 15.64 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.647 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 9.7 t -137.78 129.13 16.08 Favored Pre-proline 0 N--CA 1.418 -2.027 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.81 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -91.17 -162.85 0.11 Allowed 'Trans proline' 0 N--CA 1.439 -1.721 0 C-N-CA 122.627 2.218 . . . . 0.0 109.778 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 17.5 m -69.99 128.17 91.88 Favored Pre-proline 0 N--CA 1.431 -1.406 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.94 -32.54 68.32 Favored 'Trans proline' 0 N--CA 1.477 0.529 0 C-N-CA 122.324 2.016 . . . . 0.0 111.897 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -89.55 23.61 2.56 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.098 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -109.77 114.5 28.14 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 16.7 m -70.83 -41.76 71.07 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.01 -74.16 0.05 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.454 ' HA ' ' ND2' ' A' ' 271' ' ' ASN . 8.9 m -49.56 145.98 4.52 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -176.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 53.9 tp -103.1 129.39 49.92 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.262 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -82.44 105.41 13.48 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.465 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 44.0 pt -97.91 132.12 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-O 121.579 0.704 . . . . 0.0 110.545 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.15 108.08 16.16 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.743 -174.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 228' ' ' VAL . 26.0 pttm -38.29 120.24 0.88 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.637 0.732 . . . . 0.0 112.811 178.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 113.55 -6.06 24.56 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.677 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.62 166.03 11.53 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-O 121.087 0.47 . . . . 0.0 111.308 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 48.8 mm -114.95 117.28 55.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.552 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 26.9 mt -99.16 134.9 36.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.361 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . 0.529 ' OD2' ' HB2' ' A' ' 264' ' ' MET . 5.8 p-10 -91.65 145.94 24.18 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 11.4 mt -113.13 134.96 54.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 116.351 -0.386 . . . . 0.0 112.001 -171.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 46.8 mm -111.71 -25.51 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 121.445 0.64 . . . . 0.0 109.868 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 42.4 t -145.77 136.93 24.75 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.777 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.17 133.5 47.61 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.948 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.7 t -147.96 130.64 7.85 Favored Pre-proline 0 C--N 1.307 -1.26 0 CA-C-O 120.882 0.372 . . . . 0.0 110.319 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.3 6.34 4.43 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.386 2.057 . . . . 0.0 111.892 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 25.2 ttt -90.56 -29.13 18.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.42 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -172.85 -145.32 4.96 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 119.925 -1.131 . . . . 0.0 113.121 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -66.95 158.88 29.7 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 122.717 0.407 . . . . 0.0 111.79 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -110.35 154.8 23.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.124 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 7.9 m -92.97 118.96 31.75 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.733 174.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -140.25 -171.0 12.22 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.514 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' MET . . . . . 0.529 ' HB2' ' OD2' ' A' ' 251' ' ' ASP . 64.6 mtt -137.51 142.67 41.46 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.161 0.505 . . . . 0.0 110.603 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 35.1 tp -150.01 127.76 11.71 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 61.26 33.73 18.96 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -175.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 68.72 3.74 4.05 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.203 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -93.28 128.89 39.46 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 9.2 p -89.84 139.16 17.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -174.38 -165.03 30.27 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.302 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.454 ' ND2' ' HA ' ' A' ' 241' ' ' SER . 10.6 p30 -107.34 164.71 11.96 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.742 0.306 . . . . 0.0 110.637 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -169.56 146.89 3.44 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -96.23 121.02 37.56 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.762 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -55.89 -15.46 3.39 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -176.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 41.6 pt -68.44 -16.0 20.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.261 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -98.81 -5.0 31.98 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.282 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 9.1 m -115.46 165.63 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.305 0.574 . . . . 0.0 112.09 -176.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -112.64 131.77 55.48 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.074 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 39.5 t -91.43 104.07 15.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.467 HD11 ' H ' ' A' ' 280' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.318 -0.78 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.183 -176.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.96 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -146.94 127.42 14.08 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -133.88 141.88 47.55 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.981 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -99.3 135.49 40.63 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 245' ' ' LYS . 1.6 p -86.5 129.02 38.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.267 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -115.38 -3.97 12.39 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 120.861 0.363 . . . . 0.0 111.322 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 17.7 m -128.7 124.85 36.69 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -58.15 166.23 1.67 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.397 0.618 . . . . 0.0 112.171 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.43 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 78.0 t80 -168.93 151.17 4.79 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.468 -175.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 86.1 m -151.71 123.45 3.85 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -51.15 142.48 35.5 Favored 'Trans proline' 0 C--O 1.238 0.52 0 C-N-CA 122.604 2.203 . . . . 0.0 111.222 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.4 m -53.75 148.91 17.91 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.215 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -52.58 -20.25 11.85 Favored 'Trans proline' 0 N--CA 1.482 0.832 0 C-N-CA 123.088 2.525 . . . . 0.0 113.456 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -117.69 17.76 14.3 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.141 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -120.26 131.09 54.78 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.2 0.524 . . . . 0.0 111.556 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 20.2 p -120.38 4.9 10.71 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.348 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -90.7 -28.4 18.36 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.588 -176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 14.9 m -73.42 166.12 23.79 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.35 0.595 . . . . 0.0 111.546 -176.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 21.7 tp -101.89 147.82 26.07 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.576 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -98.32 100.33 11.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.796 0.332 . . . . 0.0 110.564 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.43 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 27.3 pt -111.32 150.38 13.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.467 ' O ' HG13 ' A' ' 228' ' ' VAL . 38.7 ttmt -137.69 155.91 48.59 Favored 'General case' 0 C--O 1.213 -0.837 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -62.12 95.83 0.07 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -173.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 145.82 -52.23 0.58 Allowed Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.938 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -38.2 151.99 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 34.6 mm -111.47 125.8 68.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.699 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 4.8 mp -114.56 116.83 53.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 120.459 -0.497 . . . . 0.0 111.478 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -75.44 141.24 43.2 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 173.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 36.0 mt -115.69 123.56 71.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.867 -172.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 12.0 tt -90.67 -17.95 7.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.152 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 48.1 t -155.5 125.48 6.58 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -107.46 86.79 2.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.936 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.65 112.3 33.1 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.362 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.75 35.36 0.29 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.034 2.489 . . . . 0.0 114.079 -175.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 20.3 mmt -112.21 -70.71 0.79 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -156.39 -53.09 0.01 OUTLIER Glycine 0 C--O 1.237 0.304 0 C-N-CA 119.924 -1.131 . . . . 0.0 113.229 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -97.71 118.74 34.92 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.61 0.243 . . . . 0.0 111.017 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.447 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 29.6 m0 -91.03 -179.87 5.57 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 16.9 m -134.04 114.33 13.08 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 269' ' ' VAL . . . -132.41 -168.62 12.07 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.132 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 51.3 ttm -138.66 114.3 9.81 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.912 0.387 . . . . 0.0 110.263 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.504 ' HG ' ' ND2' ' A' ' 266' ' ' ASN . 45.0 tp -135.98 137.04 40.85 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . 0.504 ' ND2' ' HG ' ' A' ' 265' ' ' LEU . 61.5 m-80 60.62 33.83 20.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.198 0.523 . . . . 0.0 110.085 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 20.5 m120 70.8 1.21 3.64 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.114 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -101.82 130.33 48.24 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.665 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 263' ' ' GLY . 3.9 p -95.63 119.45 43.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -151.96 174.23 31.03 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.863 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 9.2 p30 -96.31 136.78 36.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.169 0.509 . . . . 0.0 111.729 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -143.02 152.3 41.76 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.637 178.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -78.56 122.51 25.99 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.39 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -58.64 -22.14 55.9 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.478 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 34.0 pt -54.0 -22.05 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -95.72 3.17 54.1 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 21.3 m -125.24 166.53 20.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.473 0.654 . . . . 0.0 112.572 -177.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -128.3 119.98 26.19 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.144 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 23.2 m -70.38 129.89 34.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.036 0.446 . . . . 0.0 111.345 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.947 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.799 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -133.94 172.79 12.32 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.81 123.12 46.32 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -94.22 124.61 38.35 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 277' ' ' VAL . 7.6 p -79.72 141.92 14.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.463 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -125.3 -7.36 7.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.863 0.364 . . . . 0.0 111.42 -176.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 58.7 m -131.04 127.26 37.9 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -66.46 156.55 34.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.282 0.563 . . . . 0.0 111.719 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.46 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 60.4 t80 -167.35 136.77 2.76 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.973 -176.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' THR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 7.4 t -154.67 136.27 9.27 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.927 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 233' ' ' THR . 1.5 Cg_endo -85.77 -154.06 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.683 2.256 . . . . 0.0 110.017 173.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 45.0 m -68.56 157.15 89.04 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 110.508 -0.182 . . . . 0.0 110.508 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 238' ' ' ASP . 16.7 Cg_endo -58.87 -39.73 78.59 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.466 2.111 . . . . 0.0 112.265 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -76.37 23.69 0.15 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 236' ' ' PRO . 9.2 t70 -94.18 124.1 37.99 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.064 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 4.1 m -123.34 -16.05 6.99 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 120.864 0.364 . . . . 0.0 111.368 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -88.33 -22.4 23.86 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 10.8 m -89.46 -161.76 0.81 Allowed 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.647 -177.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.5 tp -136.54 105.94 6.09 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -78.27 109.32 12.29 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.238 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.46 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 16.3 pt -106.45 154.71 7.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.346 -176.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -123.7 -172.04 2.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.898 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -91.28 87.3 6.43 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.36 0.6 . . . . 0.0 112.509 -176.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 111.74 52.63 0.54 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.729 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -125.12 179.94 4.84 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 48.7 mm -118.58 123.58 71.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.886 0.374 . . . . 0.0 110.821 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 52.2 mt -115.39 126.08 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 121.056 0.455 . . . . 0.0 110.199 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -76.21 161.04 29.12 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 48.2 mt -128.83 122.8 57.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.966 -177.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 36.5 pt -110.89 -28.07 2.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.895 0.379 . . . . 0.0 110.873 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 53.9 t -145.97 122.63 11.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.096 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -92.74 96.18 10.01 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.504 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 32.1 m -71.74 141.34 84.71 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.26 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -65.28 3.99 0.88 Allowed 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.955 2.437 . . . . 0.0 113.001 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 21.6 mmt -121.84 -171.9 2.33 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.629 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -71.96 -29.45 67.01 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.406 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 17.1 ptp -82.47 104.28 12.63 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.079 0.466 . . . . 0.0 111.65 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -97.37 163.09 13.03 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.654 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 2.4 m -112.45 119.3 37.75 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.362 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -154.99 -166.98 16.0 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.019 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -143.74 130.68 20.48 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.219 0.533 . . . . 0.0 111.444 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.507 HD21 ' N ' ' A' ' 266' ' ' ASN . 6.4 tt -113.8 138.55 50.11 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . 0.507 ' N ' HD21 ' A' ' 265' ' ' LEU . 10.7 p30 49.25 33.67 5.4 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.399 0.68 . . . . 0.0 111.082 -175.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.3 m120 71.49 13.43 6.45 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.88 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -102.61 123.22 45.94 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 13.7 p -81.79 134.13 27.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.224 0.535 . . . . 0.0 111.522 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -168.75 -177.07 39.41 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.669 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -97.67 143.26 28.51 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -139.65 145.07 37.99 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.11 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -85.44 118.8 25.19 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.051 0.453 . . . . 0.0 110.747 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . 0.425 ' HA ' HG22 ' A' ' 277' ' ' VAL . 40.3 t80 -52.28 -32.95 39.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.279 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 24.8 pt -54.02 -26.22 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -93.96 -9.84 35.67 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 228' ' ' VAL . 5.6 m -111.83 178.93 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.232 0.539 . . . . 0.0 112.358 -176.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -141.13 140.19 34.08 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.951 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 12.2 t -83.02 118.15 30.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 41.7 pt . . . . . 0 C--N 1.316 -0.867 0 CA-C-O 121.178 0.513 . . . . 0.0 111.493 -177.815 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.843 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -91.49 164.26 13.86 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.883 0.373 . . . . 0.0 110.685 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -140.0 148.46 41.91 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.582 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -92.61 138.93 31.08 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.43 HG23 ' HB ' ' A' ' 244' ' ' ILE . 3.0 p -90.11 129.92 40.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.408 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -111.04 3.89 19.01 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 52.5 m -143.15 133.57 24.79 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.61 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -84.91 94.66 8.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.581 0.705 . . . . 0.0 111.705 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -109.1 104.16 13.3 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 30.7 m -116.97 108.18 44.71 Favored Pre-proline 0 N--CA 1.434 -1.256 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.676 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.18 156.44 25.01 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 123.091 2.528 . . . . 0.0 112.134 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.8 m -62.38 151.72 81.74 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.827 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.18 -25.28 45.45 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.819 2.346 . . . . 0.0 113.029 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -74.73 -3.06 29.27 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.609 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -69.79 151.38 45.83 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.192 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 19.6 p -118.06 98.88 6.54 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 72.8 14.77 4.89 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 171.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 19.0 m -78.17 176.33 9.34 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 172.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 272' ' ' PHE . 22.6 tp -102.55 133.51 47.42 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.246 -0.981 . . . . 0.0 110.967 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -99.91 108.15 20.31 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.438 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.43 ' HB ' HG23 ' A' ' 228' ' ' VAL . 24.0 pt -106.6 159.7 6.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-O 121.059 0.457 . . . . 0.0 111.508 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -128.31 164.34 22.84 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.864 -178.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -77.52 91.58 3.96 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.351 0.596 . . . . 0.0 112.003 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 105.9 82.01 1.5 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.231 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -161.67 174.44 13.29 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 46.6 mm -107.73 125.74 64.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 118.013 0.369 . . . . 0.0 110.42 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 36.3 mt -117.95 118.96 60.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.804 0.335 . . . . 0.0 111.367 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -79.6 151.51 30.58 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 173.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 54.4 mt -129.12 132.53 67.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 118.178 0.445 . . . . 0.0 110.842 -174.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 29.6 pt -116.13 -2.5 10.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.93 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . 0.47 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 49.0 t -157.49 123.77 4.85 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -121.19 142.46 49.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.012 0.434 . . . . 0.0 111.208 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.7 p -124.51 159.13 59.18 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.92 -65.68 0.11 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.051 1.834 . . . . 0.0 111.661 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 58.7 mtm -138.51 115.73 11.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.311 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 156.78 -130.67 2.74 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.197 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -106.58 127.87 53.68 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.85 0.357 . . . . 0.0 111.417 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.512 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 45.0 m0 -92.81 176.75 6.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.478 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 254' ' ' CYS . 20.0 m -126.11 116.26 21.09 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.895 0.379 . . . . 0.0 109.994 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -138.81 -168.39 11.25 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.842 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -135.39 135.55 40.73 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.91 0.386 . . . . 0.0 110.655 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.9 142.85 12.29 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 62.94 34.47 14.1 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.894 0.477 . . . . 0.0 110.767 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 17.6 m120 69.35 16.58 8.32 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.813 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -130.5 140.99 50.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.788 0.327 . . . . 0.0 111.15 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.7 p -102.42 131.78 49.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -164.07 -175.66 35.16 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 119.883 -1.151 . . . . 0.0 112.827 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.512 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 7.6 p30 -101.68 137.23 40.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.85 0.357 . . . . 0.0 111.044 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' PHE . . . . . 0.421 ' HB3' ' HB3' ' A' ' 242' ' ' LEU . 43.9 p90 -136.78 162.56 32.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.73 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -79.5 114.26 18.29 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . 0.476 ' O ' HG22 ' A' ' 277' ' ' VAL . 11.3 p90 -55.59 -31.06 61.9 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -174.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 18.9 pt -54.63 -25.97 15.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -84.59 3.76 35.32 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 274' ' ' PHE . 15.1 m -125.65 161.2 30.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.988 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -129.74 131.16 46.2 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.694 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 7.1 m -79.14 103.77 6.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.627 0.727 . . . . 0.0 110.294 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.428 HD11 ' H ' ' A' ' 280' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.315 -0.918 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.267 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.979 0 N-CA-C 112.331 -0.307 . . . . 0.0 112.331 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -159.28 151.95 21.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.802 0.334 . . . . 0.0 110.571 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -137.18 149.09 47.0 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.638 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -97.72 125.53 42.57 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 246' ' ' LYS . 3.7 p -81.82 111.82 18.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.264 0.554 . . . . 0.0 111.834 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -89.72 -17.6 27.99 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.543 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.401 ' O ' ' HB3' ' A' ' 276' ' ' TYR . 52.1 m -129.59 122.9 30.05 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -77.45 162.04 27.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.854 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -179.94 101.67 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.846 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 9.7 t -103.81 142.23 24.16 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 168.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.82 -70.05 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.735 1.624 . . . . 0.0 110.537 177.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 19.3 m -144.2 156.45 57.84 Favored Pre-proline 0 C--N 1.311 -1.095 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 175.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -58.66 -42.63 52.03 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.203 1.935 . . . . 0.0 111.393 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -92.32 25.45 2.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.649 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -130.09 139.67 50.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.166 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 2.8 m -142.63 25.96 1.79 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.953 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -74.81 -17.73 60.57 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.615 0.721 . . . . 0.0 110.71 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.586 ' HA ' ' OD1' ' A' ' 271' ' ' ASN . 30.2 m -117.25 -167.02 1.24 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.499 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 48.0 tp -99.52 131.09 45.75 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -84.17 96.21 8.88 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 43.0 pt -90.31 140.11 16.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-O 121.233 0.539 . . . . 0.0 110.855 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -135.34 102.94 5.32 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.863 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 228' ' ' VAL . 24.8 pttm -28.53 130.73 0.06 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.832 0.853 . . . . 0.0 113.264 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 97.96 12.53 46.16 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.804 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -124.63 172.71 9.04 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 48.6 mm -115.72 121.96 68.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.458 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 250' ' ' ILE . 4.4 mp -102.05 121.94 53.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.062 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -78.64 151.2 32.42 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 47.5 mt -126.87 131.76 70.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 120.949 0.404 . . . . 0.0 112.029 -173.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 7.7 tt -114.42 -32.6 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.008 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . 0.526 ' HB2' ' HB ' ' A' ' 262' ' ' THR . 19.4 m -133.91 120.29 20.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.024 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.82 89.03 3.19 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.63 ' HB ' ' O ' ' A' ' 260' ' ' MET . 45.1 m -71.7 121.59 84.87 Favored Pre-proline 0 N--CA 1.441 -0.916 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.63 -68.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.263 2.642 . . . . 0.0 113.462 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 14.8 tpt -99.6 106.36 18.33 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.752 0.311 . . . . 0.0 111.524 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 131.49 -125.92 4.56 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.898 -1.144 . . . . 0.0 114.068 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' MET . . . . . 0.63 ' O ' ' HB ' ' A' ' 256' ' ' THR . 20.8 ptt? -107.54 158.21 17.41 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.438 -0.381 . . . . 0.0 111.289 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -105.9 154.86 19.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.09 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' A' ' 254' ' ' CYS . 8.5 m -102.68 114.72 29.2 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 121.169 0.509 . . . . 0.0 110.085 176.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -139.16 -167.92 11.1 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.583 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 22.9 ptp -140.56 134.39 30.5 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.214 0.531 . . . . 0.0 112.152 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.406 HD21 ' H ' ' A' ' 266' ' ' ASN . 0.8 OUTLIER -149.58 139.63 22.05 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.638 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . 0.406 ' H ' HD21 ' A' ' 265' ' ' LEU . 91.1 m-20 63.25 34.1 13.62 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.283 0.563 . . . . 0.0 110.24 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 69.5 12.12 8.15 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.722 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -117.93 133.45 55.91 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.99 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.3 p -91.77 135.48 27.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 174.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -166.77 -158.25 11.11 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.252 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.586 ' OD1' ' HA ' ' A' ' 241' ' ' SER . 20.2 p-10 -110.09 154.77 22.79 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.738 0.304 . . . . 0.0 111.081 -178.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -165.71 154.75 11.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.856 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -88.02 109.29 19.72 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.012 0.434 . . . . 0.0 110.264 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -54.5 -13.59 1.0 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 31.3 pt -65.42 -21.23 28.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.651 0.262 . . . . 0.0 111.665 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 230' ' ' THR . 61.0 m-85 -91.37 -12.97 33.35 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-O 121.003 0.43 . . . . 0.0 111.265 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 15.3 m -107.3 177.62 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.066 0.46 . . . . 0.0 111.363 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -139.73 137.78 35.41 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 20.0 t -86.53 102.4 11.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.085 0.469 . . . . 0.0 110.564 -175.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 44.4 pt . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.097 -179.73 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.626 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 -131.68 149.81 52.36 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 278' ' ' ASP . . . -125.83 132.04 52.3 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -175.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 29.9 ttm-85 -91.94 116.68 29.12 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 175.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 277' ' ' VAL . 9.1 p -76.35 144.21 12.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -177.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -101.22 -32.24 10.62 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.879 -177.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.5 m -130.64 137.49 49.62 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.22 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -60.46 145.92 46.58 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.308 0.575 . . . . 0.0 110.964 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.481 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 63.0 t80 -136.57 112.53 9.63 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.104 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 84.4 m -153.93 98.65 2.6 Favored Pre-proline 0 C--N 1.307 -1.246 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.903 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.2 -69.6 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.124 1.883 . . . . 0.0 110.06 177.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.9 t -143.14 144.69 29.68 Favored Pre-proline 0 N--CA 1.435 -1.182 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.93 -20.65 57.77 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 121.885 1.723 . . . . 0.0 109.773 173.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -94.7 23.31 5.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.303 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -120.32 130.22 54.34 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.692 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 18.2 p -129.61 19.98 5.64 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.119 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -99.65 -21.87 15.66 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.542 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.5 m -102.89 -175.22 2.75 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.863 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 47.0 tp -109.1 117.1 33.29 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? -90.94 113.56 25.82 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.481 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 32.7 pt -130.01 173.32 14.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.189 0.518 . . . . 0.0 110.739 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -120.74 -156.78 0.69 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -105.4 153.93 21.0 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.99 30.69 77.52 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.221 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -100.95 161.43 13.6 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 35.6 mm -116.88 91.69 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 49.3 mt -80.3 132.87 30.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.055 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -83.64 154.89 23.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 175.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 28.3 mt -134.27 133.36 55.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.592 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 12.7 tt -110.03 -23.79 4.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.348 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 48.8 t -148.23 119.44 7.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.263 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -100.54 103.14 14.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.713 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.576 ' HB ' ' O ' ' A' ' 260' ' ' MET . 44.2 m -97.52 102.54 13.17 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.23 33.83 0.25 Allowed 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.2 2.6 . . . . 0.0 113.925 -175.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 48.9 ttm -108.35 -30.44 8.32 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.018 0.437 . . . . 0.0 110.364 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 273' ' ' LYS . . . 168.33 -53.3 0.22 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.85 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' MET . . . . . 0.576 ' O ' ' HB ' ' A' ' 256' ' ' THR . 4.1 mpp? -101.95 135.12 44.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.989 0.423 . . . . 0.0 111.738 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.475 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 38.2 m0 -112.24 149.4 32.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.878 176.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 5.9 m -96.77 114.03 25.64 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -139.48 -175.99 14.53 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.895 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 56.0 ttp -133.07 129.32 37.87 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.082 0.468 . . . . 0.0 111.013 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.508 HD11 ' N ' ' A' ' 266' ' ' ASN . 2.0 tm? -156.26 144.53 19.84 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . 0.508 ' N ' HD11 ' A' ' 265' ' ' LEU . 0.0 OUTLIER 54.56 34.88 22.2 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.417 1.087 . . . . 0.0 112.928 179.176 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 266' ' ' ASN . 7.4 m120 75.06 13.97 3.2 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.069 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -130.48 134.54 47.16 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.416 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.3 p -95.97 132.4 40.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -164.59 -156.31 8.88 Favored Glycine 0 C--N 1.311 -0.848 0 C-N-CA 120.151 -1.024 . . . . 0.0 112.085 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 29.2 p30 -117.01 164.61 14.46 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.047 0.451 . . . . 0.0 111.39 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 260' ' ' MET . 50.3 p90 -170.4 154.56 4.78 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 259' ' ' GLY . 97.5 mttt -85.21 112.16 20.48 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 120.987 0.422 . . . . 0.0 110.101 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . 0.414 ' HA ' HG22 ' A' ' 277' ' ' VAL . 33.5 p90 -58.67 -11.68 3.36 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -176.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 32.7 pt -61.26 -23.92 31.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.638 0.256 . . . . 0.0 111.281 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -89.44 -11.99 41.48 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.363 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 228' ' ' VAL . 10.3 m -113.4 -178.96 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 226' ' ' ALA . 27.3 t70 -141.18 141.09 34.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.546 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 57.2 t -83.8 117.72 29.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.885 0.374 . . . . 0.0 110.852 -176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 37.0 pt . . . . . 0 C--N 1.317 -0.814 0 CA-C-O 121.645 0.736 . . . . 0.0 111.472 -178.421 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.467 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -157.4 151.63 24.83 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 124.18 0.992 . . . . 0.0 108.466 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -144.82 147.03 32.39 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.143 0.497 . . . . 0.0 111.629 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -93.94 125.74 38.74 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.5 p -81.55 137.07 21.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 120.745 0.307 . . . . 0.0 110.483 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -113.4 0.85 14.89 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -175.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 83.1 m -140.15 139.42 35.75 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.621 0.248 . . . . 0.0 111.023 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -77.82 157.97 29.71 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.43 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 68.4 t80 178.52 103.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.047 0.451 . . . . 0.0 112.004 -176.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 5.1 t -136.45 116.49 11.0 Favored Pre-proline 0 N--CA 1.435 -1.213 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.983 172.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -53.99 -45.64 39.49 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.692 2.262 . . . . 0.0 111.282 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 46.4 m -141.73 127.36 10.85 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.26 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.45 -27.91 83.02 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.766 2.311 . . . . 0.0 113.514 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -92.25 -27.07 17.85 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -48.79 162.17 0.11 Allowed 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 2.9 m -143.13 -0.6 1.12 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.768 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -90.06 -48.59 7.1 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.837 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 69.4 m -74.36 -178.16 3.36 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 31.6 tp -107.17 110.97 23.17 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.941 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -86.56 101.56 13.33 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.776 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.43 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 29.6 pt -100.39 149.8 5.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.241 0.543 . . . . 0.0 111.341 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -108.82 162.25 14.36 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.488 -177.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -81.23 86.47 6.21 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.305 0.574 . . . . 0.0 111.217 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 107.48 72.5 0.79 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.62 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -147.94 -174.06 4.46 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 44.1 mm -117.59 124.94 73.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.99 0.424 . . . . 0.0 111.059 -176.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.423 HG22 ' O ' ' A' ' 251' ' ' ASP . 55.0 mt -118.47 126.39 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.279 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . 0.423 ' O ' HG22 ' A' ' 250' ' ' ILE . 26.3 t70 -76.39 167.21 22.26 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 73.2 mt -138.28 107.75 4.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 118.375 0.534 . . . . 0.0 109.924 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 50.9 pt -95.5 -8.31 9.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.117 0.484 . . . . 0.0 110.753 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . 0.477 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 52.7 t -164.31 121.6 1.68 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.312 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.09 -94.87 0.08 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.371 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 30.1 p 49.11 90.59 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 123.299 0.639 . . . . 0.0 112.107 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -63.12 59.85 0.16 Allowed 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.673 2.915 . . . . 0.0 114.23 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 22.2 ptp -91.96 21.57 4.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.299 0.571 . . . . 0.0 109.942 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 105.09 -59.7 0.43 Allowed Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -108.83 122.21 46.69 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.685 0.279 . . . . 0.0 111.107 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.424 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 19.9 m0 -87.62 168.62 12.87 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 175.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 254' ' ' CYS . 6.4 m -117.76 114.07 22.76 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 121.112 0.482 . . . . 0.0 110.092 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -136.63 -169.87 11.81 Favored Glycine 0 N--CA 1.431 -1.663 0 C-N-CA 120.155 -1.022 . . . . 0.0 112.78 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' MET . . . . . 0.414 ' HA ' ' O ' ' A' ' 268' ' ' LYS . 50.8 ttp -134.67 125.0 26.22 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.942 0.401 . . . . 0.0 111.236 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 9.3 tt -135.18 129.78 34.3 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 62.13 38.96 13.39 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.861 0.464 . . . . 0.0 110.944 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 63.9 t30 70.74 2.91 4.34 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.827 0.851 . . . . 0.0 111.994 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 264' ' ' MET . 54.6 tttp -108.64 136.11 48.77 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.86 0.362 . . . . 0.0 111.502 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 6.4 p -89.94 135.38 26.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.915 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -160.27 178.58 36.25 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.256 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 17.8 p30 -108.11 145.31 34.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.903 0.383 . . . . 0.0 111.354 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -152.36 160.59 43.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.6 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -78.04 109.09 11.81 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 176.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . 0.498 ' O ' HG22 ' A' ' 277' ' ' VAL . 54.8 p90 -55.05 -26.41 37.27 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 27.4 pt -59.31 -19.77 16.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -89.54 -7.97 53.76 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 274' ' ' PHE . 15.6 m -109.48 172.28 2.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.064 0.459 . . . . 0.0 111.246 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -133.93 129.48 36.36 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.584 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 6.1 m -76.38 107.3 7.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.391 0.615 . . . . 0.0 111.806 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--N 1.319 -0.723 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.029 -179.833 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.441 ' HA3' ' HB ' ' A' ' 252' ' ' ILE . . . . . . . . 0 N--CA 1.435 -1.421 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 -132.66 112.78 12.31 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.969 0.414 . . . . 0.0 110.636 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.44 ' HB3' HD13 ' A' ' 252' ' ' ILE . . . -132.62 148.48 52.36 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.595 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 45.5 ttt85 -107.23 122.31 46.27 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.6 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.46 133.17 30.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.012 0.434 . . . . 0.0 110.26 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -124.0 -24.24 4.44 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.152 0.501 . . . . 0.0 109.998 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.441 ' HB ' ' HA ' ' A' ' 276' ' ' TYR . 20.4 m -107.65 127.2 53.45 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 176.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -69.41 148.48 49.55 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.994 0.426 . . . . 0.0 110.578 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -145.19 103.91 3.9 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 3.8 t -152.61 114.97 2.83 Favored Pre-proline 0 N--CA 1.425 -1.714 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.611 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -76.07 -156.54 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.402 2.068 . . . . 0.0 109.102 172.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.4 t -64.88 129.93 94.62 Favored Pre-proline 0 C--N 1.316 -0.885 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.09 -20.16 70.63 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.531 2.154 . . . . 0.0 111.595 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -65.69 -37.66 87.08 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.29 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -63.33 133.76 54.65 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 171.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 30.3 m -104.55 -26.58 12.31 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -76.86 -48.31 18.74 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 3.7 m -59.72 131.62 51.46 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.776 0.322 . . . . 0.0 110.425 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 26.0 tp -72.89 107.95 5.57 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.592 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -100.05 108.89 21.18 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.251 0.548 . . . . 0.0 109.587 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 21.2 pt -108.53 178.71 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.663 -175.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -130.69 129.88 43.15 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -60.5 160.77 8.42 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.14 36.0 71.28 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.765 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -135.59 176.02 9.06 Favored 'General case' 0 C--N 1.318 -0.783 0 O-C-N 122.629 -0.336 . . . . 0.0 110.332 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 49.2 mm -108.29 130.68 60.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 34.2 mt -122.85 129.07 75.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 120.664 0.268 . . . . 0.0 110.819 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . 0.405 ' O ' ' HA2' ' A' ' 263' ' ' GLY . 3.4 m-20 -80.0 133.92 36.2 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.441 ' HB ' ' HA3' ' A' ' 224' ' ' GLY . 4.1 mt -99.09 102.44 13.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 48.4 mm -67.69 -60.66 2.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.018 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 57.7 m -121.62 142.86 49.7 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -119.27 97.76 5.82 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.852 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.0 m -84.91 126.08 69.05 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -27.53 -77.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 125.112 3.875 . . . . 0.0 115.539 -175.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 46.4 ttm -31.12 -45.67 0.08 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 144.75 4.84 0.59 Allowed Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 119.793 -1.194 . . . . 0.0 112.731 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 72.5 mtm -78.35 106.02 9.99 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.431 0.634 . . . . 0.0 109.299 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -111.37 140.46 45.93 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.22 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' THR . . . . . 0.402 HG22 HG22 ' A' ' 269' ' ' VAL . 1.3 m -100.3 114.87 28.7 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 269' ' ' VAL . . . -108.96 173.91 17.87 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.952 -176.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 39.5 ttp -129.93 114.51 15.94 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.802 0.334 . . . . 0.0 110.355 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.64 143.62 11.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.328 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 63.5 38.02 10.11 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.965 0.412 . . . . 0.0 110.944 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 14.6 m120 65.07 16.33 10.5 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.48 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -135.59 141.9 45.21 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.824 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 263' ' ' GLY . 4.5 p -101.16 125.03 55.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -149.84 172.41 29.76 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.132 -1.033 . . . . 0.0 112.182 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -88.97 120.12 30.1 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -123.84 -178.82 4.16 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.758 175.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -109.34 143.74 38.45 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.081 0.467 . . . . 0.0 111.348 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -66.98 -14.28 62.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.734 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 36.3 pt -68.98 -21.97 25.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.801 -177.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . 0.441 ' HA ' ' HB ' ' A' ' 230' ' ' THR . 63.2 m-85 -90.04 -3.48 57.94 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.964 0.411 . . . . 0.0 111.186 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 33.8 m -132.16 166.71 28.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.79 140.02 46.67 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.042 174.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 16.3 m -80.79 119.47 30.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.385 0.612 . . . . 0.0 112.449 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 38.3 pt . . . . . 0 C--N 1.321 -0.639 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.927 178.483 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.441 0 N-CA-C 111.619 -0.592 . . . . 0.0 111.619 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -148.23 144.0 27.38 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 120.72 0.295 . . . . 0.0 110.388 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -139.24 126.81 21.76 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.016 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 47.9 ttp180 -75.57 112.56 12.04 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.409 HG21 HD13 ' A' ' 244' ' ' ILE . 6.5 p -73.65 149.11 8.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.809 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -109.63 -21.95 12.18 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.814 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.7 m -127.28 140.98 51.84 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.045 -174.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -74.02 173.86 9.43 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -141.85 123.34 14.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 38.2 m -134.75 97.19 14.23 Favored Pre-proline 0 C--N 1.309 -1.159 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.577 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -97.13 -165.2 0.09 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 123.255 2.637 . . . . 0.0 111.04 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 19.4 m -72.38 140.46 82.26 Favored Pre-proline 0 C--N 1.313 -0.999 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.77 -11.44 9.42 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.236 2.624 . . . . 0.0 114.007 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -113.62 -9.99 13.16 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.84 0.352 . . . . 0.0 110.93 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -58.45 125.93 25.41 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.938 0.399 . . . . 0.0 110.865 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 20.5 p -118.81 28.28 8.39 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.395 0.617 . . . . 0.0 110.144 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -114.38 -18.47 11.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.047 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 12.8 m -114.27 174.33 6.0 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.255 0.55 . . . . 0.0 111.38 -176.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 58.9 tp -115.41 118.64 33.77 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -78.36 88.13 4.38 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.203 0.525 . . . . 0.0 110.326 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 228' ' ' VAL . 16.0 pt -94.91 156.25 3.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.535 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -104.14 172.17 6.94 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.29 147.95 25.3 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 55.82 60.58 8.64 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.155 -177.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 227' ' ' ARG . 1.3 t70 -134.48 -169.83 2.42 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 37.6 mm -130.9 104.29 9.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -176.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 39.0 mt -86.99 129.79 37.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.336 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -85.68 94.37 9.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.11 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 5.9 mt -74.12 120.65 23.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.386 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 18.0 pt -109.75 -21.78 5.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.064 0.459 . . . . 0.0 110.795 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . 0.495 ' HB2' ' HB ' ' A' ' 262' ' ' THR . 56.6 m -146.31 142.01 27.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.756 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.85 171.72 7.87 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.064 0.459 . . . . 0.0 110.732 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 27.7 m -145.31 128.8 8.49 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.72 -42.7 29.9 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.932 2.421 . . . . 0.0 112.275 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 15.2 tpt -145.09 115.57 7.62 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.752 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 137.07 -132.76 6.13 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 119.956 -1.116 . . . . 0.0 113.372 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' MET . . . . . 0.404 ' SD ' ' N ' ' A' ' 260' ' ' MET . 1.5 pmm? -107.17 143.76 34.89 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.048 0.452 . . . . 0.0 111.743 -176.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -102.67 152.24 21.43 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.96 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' A' ' 254' ' ' CYS . 2.8 m -96.82 122.36 39.69 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.84 0.353 . . . . 0.0 110.176 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -154.87 166.07 32.33 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.652 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 23.0 ptp -113.61 146.61 39.46 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.202 0.525 . . . . 0.0 111.223 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.517 HD13 ' N ' ' A' ' 266' ' ' ASN . 1.4 tm? -147.17 142.24 27.1 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . 0.517 ' N ' HD13 ' A' ' 265' ' ' LEU . 11.1 p30 51.18 34.68 11.67 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.624 0.77 . . . . 0.0 111.907 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 15.8 m120 66.89 20.81 10.51 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.462 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -119.46 136.26 54.39 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.0 p -96.13 143.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.028 0.442 . . . . 0.0 111.081 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -175.41 -150.41 7.92 Favored Glycine 0 N--CA 1.438 -1.167 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.803 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -130.96 165.45 23.11 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.946 0.403 . . . . 0.0 110.018 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -154.73 149.58 26.67 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -93.56 113.18 25.24 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . 0.446 ' HA ' HG22 ' A' ' 277' ' ' VAL . 46.1 p90 -51.74 -9.03 0.07 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 45.8 pt -81.04 17.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.117 0.484 . . . . 0.0 109.906 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -137.67 12.54 2.95 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.446 HG22 ' HA ' ' A' ' 274' ' ' PHE . 9.9 m -138.74 178.56 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 121.09 0.471 . . . . 0.0 111.574 -174.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.44 118.13 14.02 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.344 176.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 15.8 m -75.45 104.79 3.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.637 0.732 . . . . 0.0 111.371 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 32.0 pt . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.376 -178.389 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.929 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -136.27 147.84 47.72 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.858 0.361 . . . . 0.0 110.494 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -132.52 147.58 52.36 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.552 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -97.66 116.96 30.89 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.674 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 3.4 p -80.79 113.92 20.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.206 0.527 . . . . 0.0 111.57 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -98.55 -22.81 15.79 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.716 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.451 ' O ' ' HB3' ' A' ' 276' ' ' TYR . 59.6 m -122.45 127.35 49.51 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -75.96 164.09 26.52 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.493 0.663 . . . . 0.0 111.721 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -157.57 134.42 10.01 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.587 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 5.5 t -143.56 131.5 10.97 Favored Pre-proline 0 N--CA 1.433 -1.277 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.115 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.402 ' HB3' ' HB3' ' A' ' 241' ' ' SER . 89.6 Cg_endo -78.02 -176.41 3.23 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.343 2.029 . . . . 0.0 111.082 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 20.7 m -63.66 147.84 95.11 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.943 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -59.65 -12.8 18.95 Favored 'Trans proline' 0 N--CA 1.478 0.602 0 C-N-CA 122.852 2.368 . . . . 0.0 112.33 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -106.55 13.91 27.74 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.42 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -115.04 109.02 17.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.684 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 3.2 m -97.86 9.81 41.76 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.284 0.564 . . . . 0.0 110.403 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -91.47 -68.34 0.8 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.738 -176.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.402 ' HB3' ' HB3' ' A' ' 234' ' ' PRO . 10.7 t -55.78 160.21 2.73 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.345 0.593 . . . . 0.0 112.034 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 23.3 tp -94.78 128.76 41.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.863 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -89.73 97.94 11.48 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.442 ' HA ' ' CD2' ' A' ' 265' ' ' LEU . 40.5 pt -96.83 137.32 24.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.311 0.576 . . . . 0.0 112.349 -175.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -115.31 108.1 16.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.571 -177.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -41.18 136.35 1.62 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 177.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 108.37 -8.59 35.31 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.57 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -109.87 -176.96 3.14 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 120.855 0.359 . . . . 0.0 110.902 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 30.3 mm -121.17 129.46 75.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 35.5 mt -107.7 133.11 53.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.422 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.58 149.66 26.42 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 9.0 mt -129.19 124.87 61.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.817 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 28.3 pt -106.49 -5.78 10.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.217 0.532 . . . . 0.0 110.631 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 40.4 t -155.86 110.4 2.88 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.32 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.14 90.55 5.55 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.584 ' HB ' ' O ' ' A' ' 260' ' ' MET . 20.5 m -89.28 116.82 67.34 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.358 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.02 12.9 0.41 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.034 2.489 . . . . 0.0 113.642 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 51.3 ttm -86.23 -26.95 24.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.744 0.307 . . . . 0.0 110.67 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 144.26 -34.58 1.62 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.446 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' MET . . . . . 0.584 ' O ' ' HB ' ' A' ' 256' ' ' THR . 1.7 pmm? -103.77 138.57 40.21 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.875 0.369 . . . . 0.0 110.826 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.519 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 32.2 m0 -119.37 135.16 54.86 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 44.6 m -90.12 114.34 26.26 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.292 0.568 . . . . 0.0 109.47 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -132.54 -168.92 12.13 Favored Glycine 0 N--CA 1.426 -1.999 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.893 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 28.2 ttt -134.54 120.58 19.84 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.053 0.454 . . . . 0.0 110.773 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.442 ' CD2' ' HA ' ' A' ' 244' ' ' ILE . 39.9 tp -143.82 142.64 30.96 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 7.5 p30 46.76 41.2 9.99 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.374 0.67 . . . . 0.0 112.422 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 66.0 t30 68.28 9.3 7.15 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.943 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -113.88 137.63 51.41 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.793 0.33 . . . . 0.0 110.673 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.7 p -102.32 137.28 30.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -172.35 174.51 45.53 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.116 -179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.519 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 7.9 p30 -110.68 103.11 11.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.609 0.718 . . . . 0.0 112.747 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -94.79 173.83 7.41 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.63 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -95.42 122.51 38.22 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.144 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' PHE . . . . . 0.423 ' HA ' HG22 ' A' ' 277' ' ' VAL . 44.2 p90 -61.4 -9.41 5.42 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 32.8 pt -68.63 -17.7 22.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 120.767 0.318 . . . . 0.0 110.939 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' A' ' 230' ' ' THR . 40.1 m-85 -95.67 -6.74 39.3 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-O 121.091 0.472 . . . . 0.0 110.808 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.423 HG22 ' HA ' ' A' ' 274' ' ' PHE . 4.9 m -122.09 -178.98 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.223 0.535 . . . . 0.0 111.488 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.7 138.93 38.19 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.233 177.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 6.9 p -95.81 121.81 46.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-O 121.112 0.482 . . . . 0.0 110.544 -176.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.507 HD11 ' H ' ' A' ' 280' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.318 -0.762 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.978 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.434 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.87 144.31 82.7 Favored 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 122.579 2.186 . . . . 0.0 111.604 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -83.45 96.39 8.56 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.255 0.55 . . . . 0.0 110.822 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 252' ' ' ILE . 52.6 t -88.71 111.42 21.94 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.784 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -95.05 -173.28 37.47 Favored Glycine 0 C--N 1.31 -0.879 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.739 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -119.14 112.49 19.58 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -118.75 117.72 29.67 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.618 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -99.52 113.92 26.61 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 246' ' ' LYS . 2.5 p -77.19 112.73 15.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.401 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -93.56 -25.46 17.55 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.655 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 85.6 m -117.54 117.79 30.39 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -66.72 149.74 50.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.474 0.654 . . . . 0.0 111.637 -177.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.465 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 53.3 t80 -147.29 129.52 15.64 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.647 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 9.7 t -137.78 129.13 16.08 Favored Pre-proline 0 N--CA 1.418 -2.027 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.81 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -91.17 -162.85 0.11 Allowed 'Trans proline' 0 N--CA 1.439 -1.721 0 C-N-CA 122.627 2.218 . . . . 0.0 109.778 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 17.5 m -69.99 128.17 91.88 Favored Pre-proline 0 N--CA 1.431 -1.406 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.94 -32.54 68.32 Favored 'Trans proline' 0 N--CA 1.477 0.529 0 C-N-CA 122.324 2.016 . . . . 0.0 111.897 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -89.55 23.61 2.56 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.098 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -109.77 114.5 28.14 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 16.7 m -70.83 -41.76 71.07 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.01 -74.16 0.05 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.454 ' HA ' ' ND2' ' A' ' 271' ' ' ASN . 8.9 m -49.56 145.98 4.52 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -176.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 53.9 tp -103.1 129.39 49.92 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.262 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -82.44 105.41 13.48 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.465 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 44.0 pt -97.91 132.12 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-O 121.579 0.704 . . . . 0.0 110.545 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.15 108.08 16.16 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.743 -174.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 228' ' ' VAL . 26.0 pttm -38.29 120.24 0.88 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.637 0.732 . . . . 0.0 112.811 178.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 113.55 -6.06 24.56 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.677 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.62 166.03 11.53 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-O 121.087 0.47 . . . . 0.0 111.308 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 48.8 mm -114.95 117.28 55.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.552 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 26.9 mt -99.16 134.9 36.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.361 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . 0.529 ' OD2' ' HB2' ' A' ' 264' ' ' MET . 5.8 p-10 -91.65 145.94 24.18 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 223' ' ' CYS . 11.4 mt -113.13 134.96 54.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 116.351 -0.386 . . . . 0.0 112.001 -171.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 46.8 mm -111.71 -25.51 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 121.445 0.64 . . . . 0.0 109.868 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 42.4 t -145.77 136.93 24.75 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.777 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.17 133.5 47.61 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.948 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.7 t -147.96 130.64 7.85 Favored Pre-proline 0 C--N 1.307 -1.26 0 CA-C-O 120.882 0.372 . . . . 0.0 110.319 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.3 6.34 4.43 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.386 2.057 . . . . 0.0 111.892 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 25.2 ttt -90.56 -29.13 18.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.42 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -172.85 -145.32 4.96 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 119.925 -1.131 . . . . 0.0 113.121 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -66.95 158.88 29.7 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 122.717 0.407 . . . . 0.0 111.79 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -110.35 154.8 23.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.124 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 7.9 m -92.97 118.96 31.75 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.733 174.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -140.25 -171.0 12.22 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.514 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' MET . . . . . 0.529 ' HB2' ' OD2' ' A' ' 251' ' ' ASP . 64.6 mtt -137.51 142.67 41.46 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.161 0.505 . . . . 0.0 110.603 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 35.1 tp -150.01 127.76 11.71 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 61.26 33.73 18.96 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -175.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 68.72 3.74 4.05 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.203 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -93.28 128.89 39.46 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 9.2 p -89.84 139.16 17.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -174.38 -165.03 30.27 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.302 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.454 ' ND2' ' HA ' ' A' ' 241' ' ' SER . 10.6 p30 -107.34 164.71 11.96 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.742 0.306 . . . . 0.0 110.637 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -169.56 146.89 3.44 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -96.23 121.02 37.56 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.762 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -55.89 -15.46 3.39 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -176.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 41.6 pt -68.44 -16.0 20.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.261 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -98.81 -5.0 31.98 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.282 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 9.1 m -115.46 165.63 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.305 0.574 . . . . 0.0 112.09 -176.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -112.64 131.77 55.48 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.074 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 39.5 t -91.43 104.07 15.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.467 HD11 ' H ' ' A' ' 280' ' ' ILE . 0.2 OUTLIER -125.91 176.17 6.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.183 -176.512 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 11.2 t -114.34 -4.36 13.0 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.827 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--O 1.25 1.094 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.125 -179.667 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.138 0 N-CA-C 111.839 -0.504 . . . . 0.0 111.839 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -77.8 -10.85 16.89 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.997 2.464 . . . . 0.0 113.458 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -85.64 -175.47 5.65 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 73.1 m 73.86 22.7 2.41 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.985 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -100.09 22.38 40.43 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.665 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -146.94 127.42 14.08 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -133.88 141.88 47.55 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.981 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -99.3 135.49 40.63 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 245' ' ' LYS . 1.6 p -86.5 129.02 38.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.267 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -115.38 -3.97 12.39 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 120.861 0.363 . . . . 0.0 111.322 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 17.7 m -128.7 124.85 36.69 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -58.15 166.23 1.67 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.397 0.618 . . . . 0.0 112.171 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.43 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 78.0 t80 -168.93 151.17 4.79 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.468 -175.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 86.1 m -151.71 123.45 3.85 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -51.15 142.48 35.5 Favored 'Trans proline' 0 C--O 1.238 0.52 0 C-N-CA 122.604 2.203 . . . . 0.0 111.222 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.4 m -53.75 148.91 17.91 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.215 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -52.58 -20.25 11.85 Favored 'Trans proline' 0 N--CA 1.482 0.832 0 C-N-CA 123.088 2.525 . . . . 0.0 113.456 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -117.69 17.76 14.3 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.141 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -120.26 131.09 54.78 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.2 0.524 . . . . 0.0 111.556 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 20.2 p -120.38 4.9 10.71 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.348 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -90.7 -28.4 18.36 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.588 -176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 14.9 m -73.42 166.12 23.79 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.35 0.595 . . . . 0.0 111.546 -176.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 21.7 tp -101.89 147.82 26.07 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.576 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -98.32 100.33 11.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.796 0.332 . . . . 0.0 110.564 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.43 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 27.3 pt -111.32 150.38 13.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.467 ' O ' HG13 ' A' ' 228' ' ' VAL . 38.7 ttmt -137.69 155.91 48.59 Favored 'General case' 0 C--O 1.213 -0.837 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -62.12 95.83 0.07 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -173.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 145.82 -52.23 0.58 Allowed Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.938 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -38.2 151.99 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 34.6 mm -111.47 125.8 68.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.699 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 4.8 mp -114.56 116.83 53.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 120.459 -0.497 . . . . 0.0 111.478 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -75.44 141.24 43.2 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 173.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 36.0 mt -115.69 123.56 71.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.867 -172.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 12.0 tt -90.67 -17.95 7.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.152 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 48.1 t -155.5 125.48 6.58 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -107.46 86.79 2.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.936 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.65 112.3 33.1 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.362 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.75 35.36 0.29 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.034 2.489 . . . . 0.0 114.079 -175.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 20.3 mmt -112.21 -70.71 0.79 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -156.39 -53.09 0.01 OUTLIER Glycine 0 C--O 1.237 0.304 0 C-N-CA 119.924 -1.131 . . . . 0.0 113.229 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -97.71 118.74 34.92 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.61 0.243 . . . . 0.0 111.017 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.447 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 29.6 m0 -91.03 -179.87 5.57 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 16.9 m -134.04 114.33 13.08 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 269' ' ' VAL . . . -132.41 -168.62 12.07 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.132 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 51.3 ttm -138.66 114.3 9.81 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.912 0.387 . . . . 0.0 110.263 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.504 ' HG ' ' ND2' ' A' ' 266' ' ' ASN . 45.0 tp -135.98 137.04 40.85 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . 0.504 ' ND2' ' HG ' ' A' ' 265' ' ' LEU . 61.5 m-80 60.62 33.83 20.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.198 0.523 . . . . 0.0 110.085 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 20.5 m120 70.8 1.21 3.64 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.114 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -101.82 130.33 48.24 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.665 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 263' ' ' GLY . 3.9 p -95.63 119.45 43.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -151.96 174.23 31.03 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.863 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 9.2 p30 -96.31 136.78 36.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.169 0.509 . . . . 0.0 111.729 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -143.02 152.3 41.76 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.637 178.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -78.56 122.51 25.99 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.39 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -58.64 -22.14 55.9 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.478 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 34.0 pt -54.0 -22.05 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -95.72 3.17 54.1 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 21.3 m -125.24 166.53 20.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.473 0.654 . . . . 0.0 112.572 -177.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -128.3 119.98 26.19 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.144 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 23.2 m -70.38 129.89 34.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.036 0.446 . . . . 0.0 111.345 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.93 179.68 3.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.947 -178.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 15.9 p -116.21 -46.67 2.79 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.303 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 . . . . . 0 C--O 1.254 1.298 0 CA-C-O 118.716 -0.659 . . . . 0.0 110.356 -179.414 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.359 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -74.63 162.0 38.65 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.828 2.352 . . . . 0.0 111.586 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -77.35 129.97 36.52 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.922 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 60.1 m -87.77 80.29 7.93 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.113 0.483 . . . . 0.0 111.433 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -109.29 -80.98 1.24 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.751 -0.737 . . . . 0.0 111.375 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -133.94 172.79 12.32 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.81 123.12 46.32 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -94.22 124.61 38.35 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 277' ' ' VAL . 7.6 p -79.72 141.92 14.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.463 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -125.3 -7.36 7.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.863 0.364 . . . . 0.0 111.42 -176.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 58.7 m -131.04 127.26 37.9 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -66.46 156.55 34.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.282 0.563 . . . . 0.0 111.719 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.46 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 60.4 t80 -167.35 136.77 2.76 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.973 -176.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 7.4 t -154.67 136.27 9.27 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.927 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 233' ' ' THR . 1.5 Cg_endo -85.77 -154.06 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.683 2.256 . . . . 0.0 110.017 173.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 45.0 m -68.56 157.15 89.04 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 110.508 -0.182 . . . . 0.0 110.508 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 238' ' ' ASP . 16.7 Cg_endo -58.87 -39.73 78.59 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.466 2.111 . . . . 0.0 112.265 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -76.37 23.69 0.15 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 236' ' ' PRO . 9.2 t70 -94.18 124.1 37.99 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.064 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 4.1 m -123.34 -16.05 6.99 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 120.864 0.364 . . . . 0.0 111.368 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -88.33 -22.4 23.86 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 10.8 m -89.46 -161.76 0.81 Allowed 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.647 -177.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.5 tp -136.54 105.94 6.09 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -78.27 109.32 12.29 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.238 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.46 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 16.3 pt -106.45 154.71 7.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.346 -176.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -123.7 -172.04 2.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.898 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -91.28 87.3 6.43 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.36 0.6 . . . . 0.0 112.509 -176.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 111.74 52.63 0.54 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.729 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -125.12 179.94 4.84 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 48.7 mm -118.58 123.58 71.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.886 0.374 . . . . 0.0 110.821 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 52.2 mt -115.39 126.08 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 121.056 0.455 . . . . 0.0 110.199 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -76.21 161.04 29.12 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 48.2 mt -128.83 122.8 57.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.966 -177.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 36.5 pt -110.89 -28.07 2.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.895 0.379 . . . . 0.0 110.873 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 53.9 t -145.97 122.63 11.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.096 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -92.74 96.18 10.01 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.504 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 32.1 m -71.74 141.34 84.71 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.26 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -65.28 3.99 0.88 Allowed 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.955 2.437 . . . . 0.0 113.001 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 21.6 mmt -121.84 -171.9 2.33 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.629 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -71.96 -29.45 67.01 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.406 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 17.1 ptp -82.47 104.28 12.63 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.079 0.466 . . . . 0.0 111.65 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -97.37 163.09 13.03 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.654 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 2.4 m -112.45 119.3 37.75 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.362 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -154.99 -166.98 16.0 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.019 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -143.74 130.68 20.48 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.219 0.533 . . . . 0.0 111.444 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.507 HD21 ' N ' ' A' ' 266' ' ' ASN . 6.4 tt -113.8 138.55 50.11 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . 0.507 ' N ' HD21 ' A' ' 265' ' ' LEU . 10.7 p30 49.25 33.67 5.4 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.399 0.68 . . . . 0.0 111.082 -175.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.3 m120 71.49 13.43 6.45 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.88 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -102.61 123.22 45.94 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 13.7 p -81.79 134.13 27.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.224 0.535 . . . . 0.0 111.522 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -168.75 -177.07 39.41 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.669 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -97.67 143.26 28.51 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -139.65 145.07 37.99 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.11 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -85.44 118.8 25.19 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.051 0.453 . . . . 0.0 110.747 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . 0.425 ' HA ' HG22 ' A' ' 277' ' ' VAL . 40.3 t80 -52.28 -32.95 39.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.279 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 24.8 pt -54.02 -26.22 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -93.96 -9.84 35.67 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 228' ' ' VAL . 5.6 m -111.83 178.93 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.232 0.539 . . . . 0.0 112.358 -176.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -141.13 140.19 34.08 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.951 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 12.2 t -83.02 118.15 30.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 41.7 pt -119.43 166.95 13.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.178 0.513 . . . . 0.0 111.493 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 31.3 t -93.1 144.56 25.15 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.2 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 C--N 1.31 -1.119 0 CA-C-O 118.327 -0.844 . . . . 0.0 109.673 178.388 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.95 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -76.44 -20.68 13.9 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.329 2.019 . . . . 0.0 112.705 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -120.51 161.71 20.81 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.891 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 75.6 m -75.98 -39.05 56.72 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.102 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 87.91 -78.04 1.83 Allowed Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.525 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -91.49 164.26 13.86 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.883 0.373 . . . . 0.0 110.685 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -140.0 148.46 41.91 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.582 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -92.61 138.93 31.08 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.43 HG23 ' HB ' ' A' ' 244' ' ' ILE . 3.0 p -90.11 129.92 40.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.408 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -111.04 3.89 19.01 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 52.5 m -143.15 133.57 24.79 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.61 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -84.91 94.66 8.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.581 0.705 . . . . 0.0 111.705 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -109.1 104.16 13.3 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 30.7 m -116.97 108.18 44.71 Favored Pre-proline 0 N--CA 1.434 -1.256 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.676 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.18 156.44 25.01 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 123.091 2.528 . . . . 0.0 112.134 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.8 m -62.38 151.72 81.74 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.827 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.18 -25.28 45.45 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.819 2.346 . . . . 0.0 113.029 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -74.73 -3.06 29.27 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.609 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -69.79 151.38 45.83 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.192 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 19.6 p -118.06 98.88 6.54 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 72.8 14.77 4.89 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 171.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 19.0 m -78.17 176.33 9.34 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 172.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 272' ' ' PHE . 22.6 tp -102.55 133.51 47.42 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.246 -0.981 . . . . 0.0 110.967 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -99.91 108.15 20.31 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.438 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.43 ' HB ' HG23 ' A' ' 228' ' ' VAL . 24.0 pt -106.6 159.7 6.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-O 121.059 0.457 . . . . 0.0 111.508 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -128.31 164.34 22.84 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.864 -178.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -77.52 91.58 3.96 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.351 0.596 . . . . 0.0 112.003 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 105.9 82.01 1.5 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.231 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -161.67 174.44 13.29 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 46.6 mm -107.73 125.74 64.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 118.013 0.369 . . . . 0.0 110.42 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 36.3 mt -117.95 118.96 60.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.804 0.335 . . . . 0.0 111.367 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -79.6 151.51 30.58 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 173.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 54.4 mt -129.12 132.53 67.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 118.178 0.445 . . . . 0.0 110.842 -174.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 29.6 pt -116.13 -2.5 10.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.93 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . 0.47 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 49.0 t -157.49 123.77 4.85 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -121.19 142.46 49.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.012 0.434 . . . . 0.0 111.208 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.7 p -124.51 159.13 59.18 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.92 -65.68 0.11 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.051 1.834 . . . . 0.0 111.661 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 58.7 mtm -138.51 115.73 11.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.311 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 156.78 -130.67 2.74 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.197 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -106.58 127.87 53.68 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.85 0.357 . . . . 0.0 111.417 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.512 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 45.0 m0 -92.81 176.75 6.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.478 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 254' ' ' CYS . 20.0 m -126.11 116.26 21.09 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.895 0.379 . . . . 0.0 109.994 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -138.81 -168.39 11.25 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.842 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -135.39 135.55 40.73 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.91 0.386 . . . . 0.0 110.655 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.9 142.85 12.29 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 62.94 34.47 14.1 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.894 0.477 . . . . 0.0 110.767 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 17.6 m120 69.35 16.58 8.32 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.813 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -130.5 140.99 50.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.788 0.327 . . . . 0.0 111.15 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.7 p -102.42 131.78 49.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -164.07 -175.66 35.16 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 119.883 -1.151 . . . . 0.0 112.827 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.512 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 7.6 p30 -101.68 137.23 40.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.85 0.357 . . . . 0.0 111.044 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' PHE . . . . . 0.421 ' HB3' ' HB3' ' A' ' 242' ' ' LEU . 43.9 p90 -136.78 162.56 32.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.73 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -79.5 114.26 18.29 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . 0.476 ' O ' HG22 ' A' ' 277' ' ' VAL . 11.3 p90 -55.59 -31.06 61.9 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -174.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 18.9 pt -54.63 -25.97 15.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -84.59 3.76 35.32 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 274' ' ' PHE . 15.1 m -125.65 161.2 30.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.988 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -129.74 131.16 46.2 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.694 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 7.1 m -79.14 103.77 6.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.627 0.727 . . . . 0.0 110.294 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.428 HD11 ' H ' ' A' ' 280' ' ' ILE . 0.2 OUTLIER -67.96 148.26 11.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.267 -178.148 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 33.8 m 63.88 28.93 14.66 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.672 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 . . . . . 0 C--O 1.242 0.683 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.406 179.166 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.363 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.97 155.11 66.05 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.499 2.133 . . . . 0.0 111.792 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -140.35 149.16 42.36 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.998 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 47.0 t -104.22 94.96 5.65 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 160.24 57.17 0.01 OUTLIER Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.331 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.541 ' O ' ' HB2' ' A' ' 281' ' ' SER . 28.3 ptt180 -159.28 151.95 21.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.802 0.334 . . . . 0.0 110.571 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -137.18 149.09 47.0 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.638 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -97.72 125.53 42.57 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 246' ' ' LYS . 3.7 p -81.82 111.82 18.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.264 0.554 . . . . 0.0 111.834 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -89.72 -17.6 27.99 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.543 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.401 ' O ' ' HB3' ' A' ' 276' ' ' TYR . 52.1 m -129.59 122.9 30.05 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -77.45 162.04 27.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.854 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -179.94 101.67 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.846 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 9.7 t -103.81 142.23 24.16 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 168.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.82 -70.05 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.735 1.624 . . . . 0.0 110.537 177.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 19.3 m -144.2 156.45 57.84 Favored Pre-proline 0 C--N 1.311 -1.095 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 175.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -58.66 -42.63 52.03 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.203 1.935 . . . . 0.0 111.393 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -92.32 25.45 2.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.649 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -130.09 139.67 50.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.166 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 2.8 m -142.63 25.96 1.79 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.953 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -74.81 -17.73 60.57 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.615 0.721 . . . . 0.0 110.71 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.586 ' HA ' ' OD1' ' A' ' 271' ' ' ASN . 30.2 m -117.25 -167.02 1.24 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.499 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 48.0 tp -99.52 131.09 45.75 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -84.17 96.21 8.88 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 43.0 pt -90.31 140.11 16.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-O 121.233 0.539 . . . . 0.0 110.855 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -135.34 102.94 5.32 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.863 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 228' ' ' VAL . 24.8 pttm -28.53 130.73 0.06 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.832 0.853 . . . . 0.0 113.264 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 97.96 12.53 46.16 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.804 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -124.63 172.71 9.04 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 48.6 mm -115.72 121.96 68.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.458 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 250' ' ' ILE . 4.4 mp -102.05 121.94 53.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.062 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -78.64 151.2 32.42 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 47.5 mt -126.87 131.76 70.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 120.949 0.404 . . . . 0.0 112.029 -173.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 7.7 tt -114.42 -32.6 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.008 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . 0.526 ' HB2' ' HB ' ' A' ' 262' ' ' THR . 19.4 m -133.91 120.29 20.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.024 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.82 89.03 3.19 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.63 ' HB ' ' O ' ' A' ' 260' ' ' MET . 45.1 m -71.7 121.59 84.87 Favored Pre-proline 0 N--CA 1.441 -0.916 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.63 -68.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.263 2.642 . . . . 0.0 113.462 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 14.8 tpt -99.6 106.36 18.33 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.752 0.311 . . . . 0.0 111.524 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 131.49 -125.92 4.56 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.898 -1.144 . . . . 0.0 114.068 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' MET . . . . . 0.63 ' O ' ' HB ' ' A' ' 256' ' ' THR . 20.8 ptt? -107.54 158.21 17.41 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.438 -0.381 . . . . 0.0 111.289 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -105.9 154.86 19.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.09 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' A' ' 254' ' ' CYS . 8.5 m -102.68 114.72 29.2 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 121.169 0.509 . . . . 0.0 110.085 176.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -139.16 -167.92 11.1 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.583 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 22.9 ptp -140.56 134.39 30.5 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.214 0.531 . . . . 0.0 112.152 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.406 HD21 ' H ' ' A' ' 266' ' ' ASN . 0.8 OUTLIER -149.58 139.63 22.05 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.638 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . 0.406 ' H ' HD21 ' A' ' 265' ' ' LEU . 91.1 m-20 63.25 34.1 13.62 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.283 0.563 . . . . 0.0 110.24 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 69.5 12.12 8.15 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.722 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -117.93 133.45 55.91 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.99 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.3 p -91.77 135.48 27.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 174.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -166.77 -158.25 11.11 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.252 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.586 ' OD1' ' HA ' ' A' ' 241' ' ' SER . 20.2 p-10 -110.09 154.77 22.79 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.738 0.304 . . . . 0.0 111.081 -178.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -165.71 154.75 11.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.856 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -88.02 109.29 19.72 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.012 0.434 . . . . 0.0 110.264 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -54.5 -13.59 1.0 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 31.3 pt -65.42 -21.23 28.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.651 0.262 . . . . 0.0 111.665 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 230' ' ' THR . 61.0 m-85 -91.37 -12.97 33.35 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-O 121.003 0.43 . . . . 0.0 111.265 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 15.3 m -107.3 177.62 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.066 0.46 . . . . 0.0 111.363 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -139.73 137.78 35.41 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 20.0 t -86.53 102.4 11.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.085 0.469 . . . . 0.0 110.564 -175.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 44.4 pt -105.35 8.09 9.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.097 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' SER . . . . . 0.541 ' HB2' ' O ' ' A' ' 225' ' ' ARG . 2.2 t -83.08 6.84 17.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.058 -176.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.207 -179.334 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.422 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.34 154.83 27.5 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.1 2.533 . . . . 0.0 112.051 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -88.98 124.83 34.63 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.156 0.503 . . . . 0.0 111.287 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 5.1 p -83.08 -17.16 44.12 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.492 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 109.98 122.41 4.46 Favored Glycine 0 N--CA 1.432 -1.626 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.471 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 -131.68 149.81 52.36 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 278' ' ' ASP . . . -125.83 132.04 52.3 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -175.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 29.9 ttm-85 -91.94 116.68 29.12 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 175.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 277' ' ' VAL . 9.1 p -76.35 144.21 12.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -177.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -101.22 -32.24 10.62 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.879 -177.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.5 m -130.64 137.49 49.62 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.22 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -60.46 145.92 46.58 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.308 0.575 . . . . 0.0 110.964 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.481 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 63.0 t80 -136.57 112.53 9.63 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.104 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 84.4 m -153.93 98.65 2.6 Favored Pre-proline 0 C--N 1.307 -1.246 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.903 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.2 -69.6 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.124 1.883 . . . . 0.0 110.06 177.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.9 t -143.14 144.69 29.68 Favored Pre-proline 0 N--CA 1.435 -1.182 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.93 -20.65 57.77 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 121.885 1.723 . . . . 0.0 109.773 173.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -94.7 23.31 5.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.303 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -120.32 130.22 54.34 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.692 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 18.2 p -129.61 19.98 5.64 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.119 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -99.65 -21.87 15.66 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.542 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.5 m -102.89 -175.22 2.75 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.863 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 47.0 tp -109.1 117.1 33.29 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? -90.94 113.56 25.82 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.481 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 32.7 pt -130.01 173.32 14.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.189 0.518 . . . . 0.0 110.739 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -120.74 -156.78 0.69 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -105.4 153.93 21.0 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.99 30.69 77.52 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.221 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -100.95 161.43 13.6 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 35.6 mm -116.88 91.69 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 49.3 mt -80.3 132.87 30.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.055 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -83.64 154.89 23.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 175.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 28.3 mt -134.27 133.36 55.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.592 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 12.7 tt -110.03 -23.79 4.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.348 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 48.8 t -148.23 119.44 7.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.263 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -100.54 103.14 14.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.713 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.576 ' HB ' ' O ' ' A' ' 260' ' ' MET . 44.2 m -97.52 102.54 13.17 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.23 33.83 0.25 Allowed 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.2 2.6 . . . . 0.0 113.925 -175.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 48.9 ttm -108.35 -30.44 8.32 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.018 0.437 . . . . 0.0 110.364 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 273' ' ' LYS . . . 168.33 -53.3 0.22 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.85 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' MET . . . . . 0.576 ' O ' ' HB ' ' A' ' 256' ' ' THR . 4.1 mpp? -101.95 135.12 44.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.989 0.423 . . . . 0.0 111.738 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.475 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 38.2 m0 -112.24 149.4 32.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.878 176.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 5.9 m -96.77 114.03 25.64 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -139.48 -175.99 14.53 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.895 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 56.0 ttp -133.07 129.32 37.87 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.082 0.468 . . . . 0.0 111.013 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.508 HD11 ' N ' ' A' ' 266' ' ' ASN . 2.0 tm? -156.26 144.53 19.84 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . 0.508 ' N ' HD11 ' A' ' 265' ' ' LEU . 0.0 OUTLIER 54.56 34.88 22.2 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.417 1.087 . . . . 0.0 112.928 179.176 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 266' ' ' ASN . 7.4 m120 75.06 13.97 3.2 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.069 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -130.48 134.54 47.16 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.416 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.3 p -95.97 132.4 40.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -164.59 -156.31 8.88 Favored Glycine 0 C--N 1.311 -0.848 0 C-N-CA 120.151 -1.024 . . . . 0.0 112.085 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 29.2 p30 -117.01 164.61 14.46 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.047 0.451 . . . . 0.0 111.39 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 260' ' ' MET . 50.3 p90 -170.4 154.56 4.78 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 259' ' ' GLY . 97.5 mttt -85.21 112.16 20.48 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 120.987 0.422 . . . . 0.0 110.101 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . 0.414 ' HA ' HG22 ' A' ' 277' ' ' VAL . 33.5 p90 -58.67 -11.68 3.36 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -176.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 32.7 pt -61.26 -23.92 31.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.638 0.256 . . . . 0.0 111.281 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -89.44 -11.99 41.48 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.363 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 228' ' ' VAL . 10.3 m -113.4 -178.96 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 226' ' ' ALA . 27.3 t70 -141.18 141.09 34.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.546 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 57.2 t -83.8 117.72 29.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.885 0.374 . . . . 0.0 110.852 -176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 37.0 pt -134.29 177.57 6.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.645 0.736 . . . . 0.0 111.472 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 24.6 m -142.05 7.12 1.8 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.596 174.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 C--O 1.249 1.072 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.375 -179.908 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 N-CA-C 111.724 -0.551 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.7 21.64 0.63 Allowed 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.302 2.668 . . . . 0.0 113.741 -176.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -87.2 96.72 10.42 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 85.9 m -80.21 46.07 0.79 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.644 -175.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -94.89 36.12 3.94 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 175.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -157.4 151.63 24.83 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 124.18 0.992 . . . . 0.0 108.466 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -144.82 147.03 32.39 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.143 0.497 . . . . 0.0 111.629 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -93.94 125.74 38.74 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.5 p -81.55 137.07 21.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 120.745 0.307 . . . . 0.0 110.483 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -113.4 0.85 14.89 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -175.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 83.1 m -140.15 139.42 35.75 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.621 0.248 . . . . 0.0 111.023 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -77.82 157.97 29.71 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.43 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 68.4 t80 178.52 103.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.047 0.451 . . . . 0.0 112.004 -176.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 5.1 t -136.45 116.49 11.0 Favored Pre-proline 0 N--CA 1.435 -1.213 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.983 172.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -53.99 -45.64 39.49 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.692 2.262 . . . . 0.0 111.282 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 46.4 m -141.73 127.36 10.85 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.26 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.45 -27.91 83.02 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.766 2.311 . . . . 0.0 113.514 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -92.25 -27.07 17.85 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -48.79 162.17 0.11 Allowed 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 2.9 m -143.13 -0.6 1.12 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.768 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -90.06 -48.59 7.1 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.837 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 69.4 m -74.36 -178.16 3.36 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 31.6 tp -107.17 110.97 23.17 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.941 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -86.56 101.56 13.33 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.776 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.43 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 29.6 pt -100.39 149.8 5.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.241 0.543 . . . . 0.0 111.341 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -108.82 162.25 14.36 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.488 -177.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -81.23 86.47 6.21 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.305 0.574 . . . . 0.0 111.217 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 107.48 72.5 0.79 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.62 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -147.94 -174.06 4.46 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 44.1 mm -117.59 124.94 73.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.99 0.424 . . . . 0.0 111.059 -176.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.423 HG22 ' O ' ' A' ' 251' ' ' ASP . 55.0 mt -118.47 126.39 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.279 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . 0.423 ' O ' HG22 ' A' ' 250' ' ' ILE . 26.3 t70 -76.39 167.21 22.26 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 73.2 mt -138.28 107.75 4.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 118.375 0.534 . . . . 0.0 109.924 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 50.9 pt -95.5 -8.31 9.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.117 0.484 . . . . 0.0 110.753 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . 0.477 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 52.7 t -164.31 121.6 1.68 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.312 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.09 -94.87 0.08 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.371 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 30.1 p 49.11 90.59 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 123.299 0.639 . . . . 0.0 112.107 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -63.12 59.85 0.16 Allowed 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.673 2.915 . . . . 0.0 114.23 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 22.2 ptp -91.96 21.57 4.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.299 0.571 . . . . 0.0 109.942 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 105.09 -59.7 0.43 Allowed Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -108.83 122.21 46.69 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.685 0.279 . . . . 0.0 111.107 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.424 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 19.9 m0 -87.62 168.62 12.87 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 175.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 254' ' ' CYS . 6.4 m -117.76 114.07 22.76 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 121.112 0.482 . . . . 0.0 110.092 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -136.63 -169.87 11.81 Favored Glycine 0 N--CA 1.431 -1.663 0 C-N-CA 120.155 -1.022 . . . . 0.0 112.78 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' MET . . . . . 0.414 ' HA ' ' O ' ' A' ' 268' ' ' LYS . 50.8 ttp -134.67 125.0 26.22 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.942 0.401 . . . . 0.0 111.236 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 9.3 tt -135.18 129.78 34.3 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 62.13 38.96 13.39 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.861 0.464 . . . . 0.0 110.944 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 63.9 t30 70.74 2.91 4.34 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.827 0.851 . . . . 0.0 111.994 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 264' ' ' MET . 54.6 tttp -108.64 136.11 48.77 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.86 0.362 . . . . 0.0 111.502 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 6.4 p -89.94 135.38 26.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.915 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -160.27 178.58 36.25 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.256 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 17.8 p30 -108.11 145.31 34.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.903 0.383 . . . . 0.0 111.354 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -152.36 160.59 43.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.6 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -78.04 109.09 11.81 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 176.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . 0.498 ' O ' HG22 ' A' ' 277' ' ' VAL . 54.8 p90 -55.05 -26.41 37.27 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 27.4 pt -59.31 -19.77 16.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -89.54 -7.97 53.76 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 274' ' ' PHE . 15.6 m -109.48 172.28 2.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.064 0.459 . . . . 0.0 111.246 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -133.93 129.48 36.36 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.584 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 6.1 m -76.38 107.3 7.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.391 0.615 . . . . 0.0 111.806 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 2.8 pp -138.02 169.89 17.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.029 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 33.3 m -155.03 145.4 22.04 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.048 0.452 . . . . 0.0 111.843 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 . . . . . 0 C--O 1.249 1.048 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.715 178.37 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.329 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -78.36 161.9 28.4 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.591 2.194 . . . . 0.0 112.165 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -100.03 165.04 11.72 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.989 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 65.9 m -62.57 -36.99 84.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.241 0.543 . . . . 0.0 109.812 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.441 ' HA3' ' HB ' ' A' ' 252' ' ' ILE . . . 161.69 125.81 0.79 Allowed Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.82 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 -132.66 112.78 12.31 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.969 0.414 . . . . 0.0 110.636 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.44 ' HB3' HD13 ' A' ' 252' ' ' ILE . . . -132.62 148.48 52.36 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.595 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 45.5 ttt85 -107.23 122.31 46.27 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.6 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.46 133.17 30.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.012 0.434 . . . . 0.0 110.26 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -124.0 -24.24 4.44 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.152 0.501 . . . . 0.0 109.998 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.441 ' HB ' ' HA ' ' A' ' 276' ' ' TYR . 20.4 m -107.65 127.2 53.45 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 176.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -69.41 148.48 49.55 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.994 0.426 . . . . 0.0 110.578 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -145.19 103.91 3.9 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 3.8 t -152.61 114.97 2.83 Favored Pre-proline 0 N--CA 1.425 -1.714 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.611 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -76.07 -156.54 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.402 2.068 . . . . 0.0 109.102 172.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.4 t -64.88 129.93 94.62 Favored Pre-proline 0 C--N 1.316 -0.885 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.09 -20.16 70.63 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.531 2.154 . . . . 0.0 111.595 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -65.69 -37.66 87.08 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.29 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -63.33 133.76 54.65 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 171.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 30.3 m -104.55 -26.58 12.31 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -76.86 -48.31 18.74 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 3.7 m -59.72 131.62 51.46 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.776 0.322 . . . . 0.0 110.425 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 26.0 tp -72.89 107.95 5.57 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.592 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -100.05 108.89 21.18 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.251 0.548 . . . . 0.0 109.587 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 21.2 pt -108.53 178.71 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.663 -175.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -130.69 129.88 43.15 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -60.5 160.77 8.42 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.14 36.0 71.28 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.765 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -135.59 176.02 9.06 Favored 'General case' 0 C--N 1.318 -0.783 0 O-C-N 122.629 -0.336 . . . . 0.0 110.332 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 49.2 mm -108.29 130.68 60.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 34.2 mt -122.85 129.07 75.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 120.664 0.268 . . . . 0.0 110.819 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . 0.405 ' O ' ' HA2' ' A' ' 263' ' ' GLY . 3.4 m-20 -80.0 133.92 36.2 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.441 ' HB ' ' HA3' ' A' ' 224' ' ' GLY . 4.1 mt -99.09 102.44 13.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 48.4 mm -67.69 -60.66 2.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.018 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 57.7 m -121.62 142.86 49.7 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -119.27 97.76 5.82 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.852 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.0 m -84.91 126.08 69.05 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -27.53 -77.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 125.112 3.875 . . . . 0.0 115.539 -175.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 46.4 ttm -31.12 -45.67 0.08 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 144.75 4.84 0.59 Allowed Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 119.793 -1.194 . . . . 0.0 112.731 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 72.5 mtm -78.35 106.02 9.99 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.431 0.634 . . . . 0.0 109.299 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -111.37 140.46 45.93 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.22 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' THR . . . . . 0.402 HG22 HG22 ' A' ' 269' ' ' VAL . 1.3 m -100.3 114.87 28.7 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 269' ' ' VAL . . . -108.96 173.91 17.87 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.952 -176.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 39.5 ttp -129.93 114.51 15.94 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.802 0.334 . . . . 0.0 110.355 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.64 143.62 11.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.328 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 63.5 38.02 10.11 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.965 0.412 . . . . 0.0 110.944 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 14.6 m120 65.07 16.33 10.5 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.48 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -135.59 141.9 45.21 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.824 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 263' ' ' GLY . 4.5 p -101.16 125.03 55.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -149.84 172.41 29.76 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.132 -1.033 . . . . 0.0 112.182 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -88.97 120.12 30.1 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -123.84 -178.82 4.16 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.758 175.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -109.34 143.74 38.45 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.081 0.467 . . . . 0.0 111.348 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -66.98 -14.28 62.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.734 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 36.3 pt -68.98 -21.97 25.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.801 -177.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . 0.441 ' HA ' ' HB ' ' A' ' 230' ' ' THR . 63.2 m-85 -90.04 -3.48 57.94 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.964 0.411 . . . . 0.0 111.186 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 33.8 m -132.16 166.71 28.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.79 140.02 46.67 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.042 174.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 16.3 m -80.79 119.47 30.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.385 0.612 . . . . 0.0 112.449 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 38.3 pt -95.92 -8.6 9.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.927 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 3.7 p -68.73 148.38 50.45 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.459 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.679 -0.677 . . . . 0.0 110.339 -178.455 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.869 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -71.64 -171.01 0.58 Allowed 'Trans proline' 0 C--O 1.239 0.54 0 C-N-CA 122.847 2.364 . . . . 0.0 111.731 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -74.32 109.44 7.8 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.096 0.474 . . . . 0.0 110.532 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 79.5 m -85.91 98.46 10.81 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.774 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -94.52 136.12 12.82 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.619 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -148.23 144.0 27.38 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 120.72 0.295 . . . . 0.0 110.388 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -139.24 126.81 21.76 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.016 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 47.9 ttp180 -75.57 112.56 12.04 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.409 HG21 HD13 ' A' ' 244' ' ' ILE . 6.5 p -73.65 149.11 8.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.809 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -109.63 -21.95 12.18 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.814 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.7 m -127.28 140.98 51.84 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.045 -174.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -74.02 173.86 9.43 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -141.85 123.34 14.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 38.2 m -134.75 97.19 14.23 Favored Pre-proline 0 C--N 1.309 -1.159 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.577 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -97.13 -165.2 0.09 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 123.255 2.637 . . . . 0.0 111.04 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 19.4 m -72.38 140.46 82.26 Favored Pre-proline 0 C--N 1.313 -0.999 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.77 -11.44 9.42 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.236 2.624 . . . . 0.0 114.007 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -113.62 -9.99 13.16 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.84 0.352 . . . . 0.0 110.93 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -58.45 125.93 25.41 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.938 0.399 . . . . 0.0 110.865 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 20.5 p -118.81 28.28 8.39 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.395 0.617 . . . . 0.0 110.144 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -114.38 -18.47 11.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.047 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 12.8 m -114.27 174.33 6.0 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.255 0.55 . . . . 0.0 111.38 -176.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 58.9 tp -115.41 118.64 33.77 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -78.36 88.13 4.38 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.203 0.525 . . . . 0.0 110.326 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 228' ' ' VAL . 16.0 pt -94.91 156.25 3.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.535 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -104.14 172.17 6.94 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.29 147.95 25.3 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 55.82 60.58 8.64 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.155 -177.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 227' ' ' ARG . 1.3 t70 -134.48 -169.83 2.42 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 37.6 mm -130.9 104.29 9.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -176.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 39.0 mt -86.99 129.79 37.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.336 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -85.68 94.37 9.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.11 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 5.9 mt -74.12 120.65 23.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.386 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 18.0 pt -109.75 -21.78 5.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.064 0.459 . . . . 0.0 110.795 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . 0.495 ' HB2' ' HB ' ' A' ' 262' ' ' THR . 56.6 m -146.31 142.01 27.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.756 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.85 171.72 7.87 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.064 0.459 . . . . 0.0 110.732 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 27.7 m -145.31 128.8 8.49 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.72 -42.7 29.9 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.932 2.421 . . . . 0.0 112.275 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 15.2 tpt -145.09 115.57 7.62 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.752 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 137.07 -132.76 6.13 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 119.956 -1.116 . . . . 0.0 113.372 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' MET . . . . . 0.404 ' SD ' ' N ' ' A' ' 260' ' ' MET . 1.5 pmm? -107.17 143.76 34.89 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.048 0.452 . . . . 0.0 111.743 -176.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -102.67 152.24 21.43 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.96 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' A' ' 254' ' ' CYS . 2.8 m -96.82 122.36 39.69 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.84 0.353 . . . . 0.0 110.176 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -154.87 166.07 32.33 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.652 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 23.0 ptp -113.61 146.61 39.46 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.202 0.525 . . . . 0.0 111.223 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.517 HD13 ' N ' ' A' ' 266' ' ' ASN . 1.4 tm? -147.17 142.24 27.1 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . 0.517 ' N ' HD13 ' A' ' 265' ' ' LEU . 11.1 p30 51.18 34.68 11.67 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.624 0.77 . . . . 0.0 111.907 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 15.8 m120 66.89 20.81 10.51 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.462 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -119.46 136.26 54.39 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.0 p -96.13 143.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.028 0.442 . . . . 0.0 111.081 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -175.41 -150.41 7.92 Favored Glycine 0 N--CA 1.438 -1.167 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.803 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -130.96 165.45 23.11 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.946 0.403 . . . . 0.0 110.018 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -154.73 149.58 26.67 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -93.56 113.18 25.24 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . 0.446 ' HA ' HG22 ' A' ' 277' ' ' VAL . 46.1 p90 -51.74 -9.03 0.07 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 45.8 pt -81.04 17.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.117 0.484 . . . . 0.0 109.906 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -137.67 12.54 2.95 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.446 HG22 ' HA ' ' A' ' 274' ' ' PHE . 9.9 m -138.74 178.56 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 121.09 0.471 . . . . 0.0 111.574 -174.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.44 118.13 14.02 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.344 176.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 15.8 m -75.45 104.79 3.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.637 0.732 . . . . 0.0 111.371 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 32.0 pt -81.69 2.17 2.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.376 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 11.3 m -66.86 -43.11 84.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.86 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.581 -0.723 . . . . 0.0 109.952 -179.746 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.307 0 N-CA-C 112.437 -0.265 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.57 -21.91 39.02 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.999 2.466 . . . . 0.0 112.854 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -84.41 -39.84 18.52 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.126 0.488 . . . . 0.0 109.767 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 29.7 m -64.59 -44.74 89.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.403 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 119.55 141.12 6.36 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -136.27 147.84 47.72 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.858 0.361 . . . . 0.0 110.494 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -132.52 147.58 52.36 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.552 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -97.66 116.96 30.89 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.674 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 3.4 p -80.79 113.92 20.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.206 0.527 . . . . 0.0 111.57 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -98.55 -22.81 15.79 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.716 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.451 ' O ' ' HB3' ' A' ' 276' ' ' TYR . 59.6 m -122.45 127.35 49.51 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -75.96 164.09 26.52 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.493 0.663 . . . . 0.0 111.721 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -157.57 134.42 10.01 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.587 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 5.5 t -143.56 131.5 10.97 Favored Pre-proline 0 N--CA 1.433 -1.277 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.115 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.402 ' HB3' ' HB3' ' A' ' 241' ' ' SER . 89.6 Cg_endo -78.02 -176.41 3.23 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.343 2.029 . . . . 0.0 111.082 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 20.7 m -63.66 147.84 95.11 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.943 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -59.65 -12.8 18.95 Favored 'Trans proline' 0 N--CA 1.478 0.602 0 C-N-CA 122.852 2.368 . . . . 0.0 112.33 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -106.55 13.91 27.74 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.42 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -115.04 109.02 17.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.684 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 3.2 m -97.86 9.81 41.76 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.284 0.564 . . . . 0.0 110.403 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -91.47 -68.34 0.8 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.738 -176.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.402 ' HB3' ' HB3' ' A' ' 234' ' ' PRO . 10.7 t -55.78 160.21 2.73 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.345 0.593 . . . . 0.0 112.034 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 23.3 tp -94.78 128.76 41.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.863 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -89.73 97.94 11.48 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.442 ' HA ' ' CD2' ' A' ' 265' ' ' LEU . 40.5 pt -96.83 137.32 24.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.311 0.576 . . . . 0.0 112.349 -175.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -115.31 108.1 16.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.571 -177.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -41.18 136.35 1.62 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 177.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 108.37 -8.59 35.31 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.57 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -109.87 -176.96 3.14 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 120.855 0.359 . . . . 0.0 110.902 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 30.3 mm -121.17 129.46 75.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 35.5 mt -107.7 133.11 53.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.422 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.58 149.66 26.42 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 9.0 mt -129.19 124.87 61.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.817 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 28.3 pt -106.49 -5.78 10.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.217 0.532 . . . . 0.0 110.631 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 40.4 t -155.86 110.4 2.88 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.32 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.14 90.55 5.55 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.584 ' HB ' ' O ' ' A' ' 260' ' ' MET . 20.5 m -89.28 116.82 67.34 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.358 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.02 12.9 0.41 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.034 2.489 . . . . 0.0 113.642 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 51.3 ttm -86.23 -26.95 24.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.744 0.307 . . . . 0.0 110.67 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 144.26 -34.58 1.62 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.446 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' MET . . . . . 0.584 ' O ' ' HB ' ' A' ' 256' ' ' THR . 1.7 pmm? -103.77 138.57 40.21 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.875 0.369 . . . . 0.0 110.826 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.519 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 32.2 m0 -119.37 135.16 54.86 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 44.6 m -90.12 114.34 26.26 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.292 0.568 . . . . 0.0 109.47 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -132.54 -168.92 12.13 Favored Glycine 0 N--CA 1.426 -1.999 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.893 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 28.2 ttt -134.54 120.58 19.84 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.053 0.454 . . . . 0.0 110.773 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.442 ' CD2' ' HA ' ' A' ' 244' ' ' ILE . 39.9 tp -143.82 142.64 30.96 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 7.5 p30 46.76 41.2 9.99 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.374 0.67 . . . . 0.0 112.422 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 66.0 t30 68.28 9.3 7.15 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.943 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -113.88 137.63 51.41 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.793 0.33 . . . . 0.0 110.673 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.7 p -102.32 137.28 30.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -172.35 174.51 45.53 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.116 -179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.519 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 7.9 p30 -110.68 103.11 11.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.609 0.718 . . . . 0.0 112.747 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -94.79 173.83 7.41 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.63 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -95.42 122.51 38.22 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.144 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' PHE . . . . . 0.423 ' HA ' HG22 ' A' ' 277' ' ' VAL . 44.2 p90 -61.4 -9.41 5.42 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 32.8 pt -68.63 -17.7 22.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 120.767 0.318 . . . . 0.0 110.939 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' A' ' 230' ' ' THR . 40.1 m-85 -95.67 -6.74 39.3 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-O 121.091 0.472 . . . . 0.0 110.808 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.423 HG22 ' HA ' ' A' ' 274' ' ' PHE . 4.9 m -122.09 -178.98 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.223 0.535 . . . . 0.0 111.488 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.7 138.93 38.19 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.233 177.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 6.9 p -95.81 121.81 46.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-O 121.112 0.482 . . . . 0.0 110.544 -176.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.507 HD11 ' H ' ' A' ' 280' ' ' ILE . 0.2 OUTLIER -102.82 -5.63 9.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.978 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 20.6 m -84.62 104.98 15.08 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.009 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.623 -0.703 . . . . 0.0 109.624 179.549 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.785 0 N-CA-C 112.739 -0.144 . . . . 0.0 112.739 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -119.14 112.49 19.58 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -118.75 117.72 29.67 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.618 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -99.52 113.92 26.61 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 246' ' ' LYS . 2.5 p -77.19 112.73 15.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.401 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -93.56 -25.46 17.55 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.655 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.401 ' O ' ' HB3' ' A' ' 276' ' ' TYR . 85.6 m -117.54 117.79 30.39 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -66.72 149.74 50.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.474 0.654 . . . . 0.0 111.637 -177.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.478 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 53.3 t80 -147.29 129.52 15.64 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.647 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 9.7 t -137.78 129.13 16.08 Favored Pre-proline 0 N--CA 1.418 -2.027 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.81 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -91.17 -162.85 0.11 Allowed 'Trans proline' 0 N--CA 1.439 -1.721 0 C-N-CA 122.627 2.218 . . . . 0.0 109.778 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 17.5 m -69.99 128.17 91.88 Favored Pre-proline 0 N--CA 1.431 -1.406 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.94 -32.54 68.32 Favored 'Trans proline' 0 N--CA 1.477 0.529 0 C-N-CA 122.324 2.016 . . . . 0.0 111.897 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -89.55 23.61 2.56 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.098 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -109.77 114.5 28.14 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 16.7 m -70.83 -41.76 71.07 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.01 -74.16 0.05 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 8.9 m -49.56 145.98 4.52 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -176.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 53.9 tp -103.1 129.39 49.92 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.262 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.429 ' C ' ' HD3' ' A' ' 243' ' ' LYS . 1.4 tmtp? -82.44 105.41 13.48 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.478 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 44.0 pt -97.91 132.12 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-O 121.579 0.704 . . . . 0.0 110.545 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.15 108.08 16.16 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.743 -174.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 228' ' ' VAL . 26.0 pttm -38.29 120.24 0.88 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.637 0.732 . . . . 0.0 112.811 178.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 113.55 -6.06 24.56 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.677 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.62 166.03 11.53 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-O 121.087 0.47 . . . . 0.0 111.308 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 48.8 mm -114.95 117.28 55.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.552 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 26.9 mt -99.16 134.9 36.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.361 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' ASP . . . . . 0.536 ' OD2' ' HB2' ' A' ' 264' ' ' MET . 5.8 p-10 -91.65 145.94 24.18 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.406 HG21 ' HG3' ' A' ' 255' ' ' LYS . 11.4 mt -113.13 134.96 54.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 116.351 -0.386 . . . . 0.0 112.001 -171.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 46.8 mm -111.71 -25.51 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 121.445 0.64 . . . . 0.0 109.868 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 42.4 t -145.77 136.93 24.75 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.777 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.406 ' HG3' HG21 ' A' ' 252' ' ' ILE . 0.0 OUTLIER -129.17 133.5 47.61 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.948 178.631 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.7 t -147.96 130.64 7.85 Favored Pre-proline 0 C--N 1.307 -1.26 0 CA-C-O 120.882 0.372 . . . . 0.0 110.319 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.3 6.34 4.43 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.386 2.057 . . . . 0.0 111.892 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 25.2 ttt -90.56 -29.13 18.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.42 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -172.85 -145.32 4.96 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 119.925 -1.131 . . . . 0.0 113.121 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -66.95 158.88 29.7 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 122.717 0.407 . . . . 0.0 111.79 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -110.35 154.8 23.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.124 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 7.9 m -92.97 118.96 31.75 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.733 174.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -140.25 -171.0 12.22 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.514 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' MET . . . . . 0.536 ' HB2' ' OD2' ' A' ' 251' ' ' ASP . 64.6 mtt -137.51 142.67 41.46 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.161 0.505 . . . . 0.0 110.603 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 35.1 tp -150.01 127.76 11.71 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 11.8 m120 61.26 33.73 18.96 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -175.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 68.72 3.74 4.05 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.203 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -93.28 128.89 39.46 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 9.2 p -89.84 139.16 17.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -174.38 -165.03 30.27 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.302 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -107.34 164.71 11.96 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.742 0.306 . . . . 0.0 110.637 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -169.56 146.89 3.44 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -96.23 121.02 37.56 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.762 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.425 ' HA ' HG22 ' A' ' 277' ' ' VAL . 42.0 p90 -55.89 -15.46 3.39 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 41.6 pt -68.44 -16.0 20.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.261 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 230' ' ' THR . 27.2 m-85 -98.81 -5.0 31.98 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.282 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' A' ' 274' ' ' PHE . 9.1 m -115.46 165.63 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.305 0.574 . . . . 0.0 112.09 -176.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -112.64 131.77 55.48 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.074 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 39.5 t -91.43 104.07 15.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.603 HD13 ' H ' ' A' ' 280' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.318 -0.78 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.183 -176.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.96 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.434 ' HG2' ' HA ' ' A' ' 251' ' ' ASP . 97.4 mtt180 -146.94 127.42 14.08 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -133.88 141.88 47.55 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.981 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.408 ' HG3' HD13 ' A' ' 249' ' ' ILE . 67.7 ttt180 -99.3 135.49 40.63 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 245' ' ' LYS . 1.6 p -86.5 129.02 38.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.267 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -115.38 -3.97 12.39 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 120.861 0.363 . . . . 0.0 111.322 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 17.7 m -128.7 124.85 36.69 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -58.15 166.23 1.67 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.397 0.618 . . . . 0.0 112.171 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.448 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 78.0 t80 -168.93 151.17 4.79 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.468 -175.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 86.1 m -151.71 123.45 3.85 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -51.15 142.48 35.5 Favored 'Trans proline' 0 C--O 1.238 0.52 0 C-N-CA 122.604 2.203 . . . . 0.0 111.222 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.4 m -53.75 148.91 17.91 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.215 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -52.58 -20.25 11.85 Favored 'Trans proline' 0 N--CA 1.482 0.832 0 C-N-CA 123.088 2.525 . . . . 0.0 113.456 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -117.69 17.76 14.3 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.141 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -120.26 131.09 54.78 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.2 0.524 . . . . 0.0 111.556 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 20.2 p -120.38 4.9 10.71 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.348 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -90.7 -28.4 18.36 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.588 -176.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 14.9 m -73.42 166.12 23.79 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.35 0.595 . . . . 0.0 111.546 -176.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 21.7 tp -101.89 147.82 26.07 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.576 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -98.32 100.33 11.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.796 0.332 . . . . 0.0 110.564 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.448 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 27.3 pt -111.32 150.38 13.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.502 ' O ' HG13 ' A' ' 228' ' ' VAL . 38.7 ttmt -137.69 155.91 48.59 Favored 'General case' 0 C--O 1.213 -0.837 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -62.12 95.83 0.07 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -173.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 145.82 -52.23 0.58 Allowed Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.938 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -38.2 151.99 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.408 HD13 ' HG3' ' A' ' 227' ' ' ARG . 34.6 mm -111.47 125.8 68.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.699 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 4.8 mp -114.56 116.83 53.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 120.459 -0.497 . . . . 0.0 111.478 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' ASP . . . . . 0.434 ' HA ' ' HG2' ' A' ' 225' ' ' ARG . 29.4 t70 -75.44 141.24 43.2 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 173.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 36.0 mt -115.69 123.56 71.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.867 -172.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 12.0 tt -90.67 -17.95 7.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.152 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 48.1 t -155.5 125.48 6.58 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -107.46 86.79 2.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.936 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.65 112.3 33.1 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.362 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.75 35.36 0.29 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.034 2.489 . . . . 0.0 114.079 -175.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 20.3 mmt -112.21 -70.71 0.79 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -156.39 -53.09 0.01 OUTLIER Glycine 0 C--O 1.237 0.304 0 C-N-CA 119.924 -1.131 . . . . 0.0 113.229 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -97.71 118.74 34.92 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.61 0.243 . . . . 0.0 111.017 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.454 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 29.6 m0 -91.03 -179.87 5.57 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 16.9 m -134.04 114.33 13.08 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 269' ' ' VAL . . . -132.41 -168.62 12.07 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.132 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 51.3 ttm -138.66 114.3 9.81 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.912 0.387 . . . . 0.0 110.263 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 45.0 tp -135.98 137.04 40.85 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 27.3 m120 60.62 33.83 20.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.198 0.523 . . . . 0.0 110.085 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 20.5 m120 70.8 1.21 3.64 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.114 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -101.82 130.33 48.24 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.665 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 263' ' ' GLY . 3.9 p -95.63 119.45 43.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -151.96 174.23 31.03 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.863 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 9.2 p30 -96.31 136.78 36.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.169 0.509 . . . . 0.0 111.729 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -143.02 152.3 41.76 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.637 178.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.402 ' HB3' HG12 ' A' ' 275' ' ' ILE . 98.5 mttt -78.56 122.51 25.99 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.39 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -58.64 -22.14 55.9 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.478 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.402 HG12 ' HB3' ' A' ' 273' ' ' LYS . 34.0 pt -54.0 -22.05 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -95.72 3.17 54.1 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.412 HG12 ' HB ' ' A' ' 228' ' ' VAL . 21.3 m -125.24 166.53 20.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.473 0.654 . . . . 0.0 112.572 -177.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -128.3 119.98 26.19 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.144 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 23.2 m -70.38 129.89 34.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.036 0.446 . . . . 0.0 111.345 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.509 HD13 ' H ' ' A' ' 280' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.947 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.799 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -133.94 172.79 12.32 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.81 123.12 46.32 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.498 ' HB2' HD13 ' A' ' 280' ' ' ILE . 26.5 ttm180 -94.22 124.61 38.35 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 277' ' ' VAL . 7.6 p -79.72 141.92 14.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.463 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -125.3 -7.36 7.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.863 0.364 . . . . 0.0 111.42 -176.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 58.7 m -131.04 127.26 37.9 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -66.46 156.55 34.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.282 0.563 . . . . 0.0 111.719 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.471 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 60.4 t80 -167.35 136.77 2.76 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.973 -176.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.49 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 7.4 t -154.67 136.27 9.27 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.927 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 233' ' ' THR . 1.5 Cg_endo -85.77 -154.06 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.683 2.256 . . . . 0.0 110.017 173.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 45.0 m -68.56 157.15 89.04 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 110.508 -0.182 . . . . 0.0 110.508 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -58.87 -39.73 78.59 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.466 2.111 . . . . 0.0 112.265 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -76.37 23.69 0.15 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -94.18 124.1 37.99 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.064 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 4.1 m -123.34 -16.05 6.99 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 120.864 0.364 . . . . 0.0 111.368 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -88.33 -22.4 23.86 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 10.8 m -89.46 -161.76 0.81 Allowed 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.647 -177.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.5 tp -136.54 105.94 6.09 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -78.27 109.32 12.29 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.238 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.471 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 16.3 pt -106.45 154.71 7.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.346 -176.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -123.7 -172.04 2.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.898 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -91.28 87.3 6.43 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.36 0.6 . . . . 0.0 112.509 -176.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 111.74 52.63 0.54 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.729 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -125.12 179.94 4.84 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 48.7 mm -118.58 123.58 71.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.886 0.374 . . . . 0.0 110.821 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 52.2 mt -115.39 126.08 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 121.056 0.455 . . . . 0.0 110.199 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' ASP . . . . . 0.515 ' HB3' ' HG2' ' A' ' 264' ' ' MET . 32.9 t70 -76.21 161.04 29.12 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 48.2 mt -128.83 122.8 57.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.966 -177.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 36.5 pt -110.89 -28.07 2.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.895 0.379 . . . . 0.0 110.873 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 53.9 t -145.97 122.63 11.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.096 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -92.74 96.18 10.01 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.504 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 32.1 m -71.74 141.34 84.71 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.26 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 256' ' ' THR . 26.0 Cg_exo -65.28 3.99 0.88 Allowed 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.955 2.437 . . . . 0.0 113.001 178.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 21.6 mmt -121.84 -171.9 2.33 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.629 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -71.96 -29.45 67.01 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.406 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 17.1 ptp -82.47 104.28 12.63 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.079 0.466 . . . . 0.0 111.65 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -97.37 163.09 13.03 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.654 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 2.4 m -112.45 119.3 37.75 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.362 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -154.99 -166.98 16.0 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.019 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' MET . . . . . 0.515 ' HG2' ' HB3' ' A' ' 251' ' ' ASP . 20.3 ptt? -143.74 130.68 20.48 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.219 0.533 . . . . 0.0 111.444 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 266' ' ' ASN . 6.4 tt -113.8 138.55 50.11 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' ASN . . . . . 0.504 ' N ' HD23 ' A' ' 265' ' ' LEU . 1.9 p-10 49.25 33.67 5.4 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.399 0.68 . . . . 0.0 111.082 -175.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.3 m120 71.49 13.43 6.45 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.88 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -102.61 123.22 45.94 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 13.7 p -81.79 134.13 27.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.224 0.535 . . . . 0.0 111.522 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -168.75 -177.07 39.41 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.669 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -97.67 143.26 28.51 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -139.65 145.07 37.99 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.11 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -85.44 118.8 25.19 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.051 0.453 . . . . 0.0 110.747 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.5 ' HA ' HG22 ' A' ' 277' ' ' VAL . 40.3 t80 -52.28 -32.95 39.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.279 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 24.8 pt -54.02 -26.22 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -93.96 -9.84 35.67 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.5 HG22 ' HA ' ' A' ' 274' ' ' PHE . 5.6 m -111.83 178.93 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.232 0.539 . . . . 0.0 112.358 -176.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -141.13 140.19 34.08 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.951 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 12.2 t -83.02 118.15 30.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.498 HD13 ' HB2' ' A' ' 227' ' ' ARG . 41.7 pt . . . . . 0 C--N 1.316 -0.867 0 CA-C-O 121.178 0.513 . . . . 0.0 111.493 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.843 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -91.49 164.26 13.86 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.883 0.373 . . . . 0.0 110.685 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -140.0 148.46 41.91 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.582 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -92.61 138.93 31.08 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.477 HG21 ' HB ' ' A' ' 244' ' ' ILE . 3.0 p -90.11 129.92 40.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.408 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -111.04 3.89 19.01 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 52.5 m -143.15 133.57 24.79 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.61 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -84.91 94.66 8.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.581 0.705 . . . . 0.0 111.705 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.443 ' H ' HG13 ' A' ' 244' ' ' ILE . 89.0 t80 -109.1 104.16 13.3 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.406 HG23 ' HB3' ' A' ' 243' ' ' LYS . 30.7 m -116.97 108.18 44.71 Favored Pre-proline 0 N--CA 1.434 -1.256 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.676 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.18 156.44 25.01 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 123.091 2.528 . . . . 0.0 112.134 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.8 m -62.38 151.72 81.74 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.827 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.18 -25.28 45.45 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.819 2.346 . . . . 0.0 113.029 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -74.73 -3.06 29.27 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.609 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -69.79 151.38 45.83 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.192 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 19.6 p -118.06 98.88 6.54 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 72.8 14.77 4.89 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 171.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 19.0 m -78.17 176.33 9.34 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 172.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 272' ' ' PHE . 22.6 tp -102.55 133.51 47.42 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.246 -0.981 . . . . 0.0 110.967 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.406 ' HB3' HG23 ' A' ' 233' ' ' THR . 88.9 mttt -99.91 108.15 20.31 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.438 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.477 ' HB ' HG21 ' A' ' 228' ' ' VAL . 24.0 pt -106.6 159.7 6.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-O 121.059 0.457 . . . . 0.0 111.508 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -128.31 164.34 22.84 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.864 -178.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -77.52 91.58 3.96 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.351 0.596 . . . . 0.0 112.003 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 105.9 82.01 1.5 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.231 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -161.67 174.44 13.29 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 46.6 mm -107.73 125.74 64.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 118.013 0.369 . . . . 0.0 110.42 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 36.3 mt -117.95 118.96 60.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.804 0.335 . . . . 0.0 111.367 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -79.6 151.51 30.58 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 173.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 54.4 mt -129.12 132.53 67.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 118.178 0.445 . . . . 0.0 110.842 -174.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 29.6 pt -116.13 -2.5 10.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.93 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.502 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 49.0 t -157.49 123.77 4.85 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -121.19 142.46 49.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.012 0.434 . . . . 0.0 111.208 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.7 p -124.51 159.13 59.18 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.92 -65.68 0.11 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.051 1.834 . . . . 0.0 111.661 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 58.7 mtm -138.51 115.73 11.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.311 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 156.78 -130.67 2.74 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.197 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -106.58 127.87 53.68 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.85 0.357 . . . . 0.0 111.417 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.529 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 45.0 m0 -92.81 176.75 6.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.478 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 254' ' ' CYS . 20.0 m -126.11 116.26 21.09 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.895 0.379 . . . . 0.0 109.994 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -138.81 -168.39 11.25 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.842 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -135.39 135.55 40.73 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.91 0.386 . . . . 0.0 110.655 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.9 142.85 12.29 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 62.94 34.47 14.1 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.894 0.477 . . . . 0.0 110.767 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 17.6 m120 69.35 16.58 8.32 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.813 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -130.5 140.99 50.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.788 0.327 . . . . 0.0 111.15 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.7 p -102.42 131.78 49.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -164.07 -175.66 35.16 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 119.883 -1.151 . . . . 0.0 112.827 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.529 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 7.6 p30 -101.68 137.23 40.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.85 0.357 . . . . 0.0 111.044 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' PHE . . . . . 0.445 ' HB3' ' HB3' ' A' ' 242' ' ' LEU . 43.9 p90 -136.78 162.56 32.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.73 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.447 ' HG3' HG12 ' A' ' 275' ' ' ILE . 22.2 tptm -79.5 114.26 18.29 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.493 ' O ' HG22 ' A' ' 277' ' ' VAL . 11.3 p90 -55.59 -31.06 61.9 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -174.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.447 HG12 ' HG3' ' A' ' 273' ' ' LYS . 18.9 pt -54.63 -25.97 15.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' TYR . . . . . 0.445 ' CD2' ' HB3' ' A' ' 273' ' ' LYS . 54.3 m-85 -84.59 3.76 35.32 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 274' ' ' PHE . 15.1 m -125.65 161.2 30.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.988 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -129.74 131.16 46.2 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.694 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 7.1 m -79.14 103.77 6.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.627 0.727 . . . . 0.0 110.294 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.562 HD13 ' H ' ' A' ' 280' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.315 -0.918 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.267 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.979 0 N-CA-C 112.331 -0.307 . . . . 0.0 112.331 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -159.28 151.95 21.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.802 0.334 . . . . 0.0 110.571 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -137.18 149.09 47.0 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.638 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -97.72 125.53 42.57 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 246' ' ' LYS . 3.7 p -81.82 111.82 18.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.264 0.554 . . . . 0.0 111.834 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -89.72 -17.6 27.99 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.543 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 276' ' ' TYR . 52.1 m -129.59 122.9 30.05 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -77.45 162.04 27.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.854 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -179.94 101.67 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.846 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 9.7 t -103.81 142.23 24.16 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 168.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.82 -70.05 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.735 1.624 . . . . 0.0 110.537 177.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 238' ' ' ASP . 19.3 m -144.2 156.45 57.84 Favored Pre-proline 0 C--N 1.311 -1.095 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 175.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -58.66 -42.63 52.03 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.203 1.935 . . . . 0.0 111.393 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -92.32 25.45 2.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.649 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.454 ' HB2' ' HB2' ' A' ' 235' ' ' SER . 14.6 t70 -130.09 139.67 50.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.166 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 2.8 m -142.63 25.96 1.79 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.953 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -74.81 -17.73 60.57 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.615 0.721 . . . . 0.0 110.71 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.608 ' HA ' ' OD1' ' A' ' 271' ' ' ASN . 30.2 m -117.25 -167.02 1.24 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.499 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 48.0 tp -99.52 131.09 45.75 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -84.17 96.21 8.88 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.433 ' HA ' HD13 ' A' ' 265' ' ' LEU . 43.0 pt -90.31 140.11 16.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-O 121.233 0.539 . . . . 0.0 110.855 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -135.34 102.94 5.32 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.863 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 228' ' ' VAL . 24.8 pttm -28.53 130.73 0.06 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.832 0.853 . . . . 0.0 113.264 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 97.96 12.53 46.16 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.804 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -124.63 172.71 9.04 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 48.6 mm -115.72 121.96 68.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.458 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 250' ' ' ILE . 4.4 mp -102.05 121.94 53.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.062 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' ASP . . . . . 0.499 ' HB3' ' CG ' ' A' ' 264' ' ' MET . 14.7 t70 -78.64 151.2 32.42 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 47.5 mt -126.87 131.76 70.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 120.949 0.404 . . . . 0.0 112.029 -173.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 7.7 tt -114.42 -32.6 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.008 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.532 ' HB2' ' HB ' ' A' ' 262' ' ' THR . 19.4 m -133.91 120.29 20.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.024 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.42 ' N ' ' HD3' ' A' ' 255' ' ' LYS . 0.0 OUTLIER -103.82 89.03 3.19 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.335 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.63 ' HB ' ' O ' ' A' ' 260' ' ' MET . 45.1 m -71.7 121.59 84.87 Favored Pre-proline 0 N--CA 1.441 -0.916 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.63 -68.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.263 2.642 . . . . 0.0 113.462 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 14.8 tpt -99.6 106.36 18.33 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.752 0.311 . . . . 0.0 111.524 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 131.49 -125.92 4.56 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.898 -1.144 . . . . 0.0 114.068 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' MET . . . . . 0.63 ' O ' ' HB ' ' A' ' 256' ' ' THR . 20.8 ptt? -107.54 158.21 17.41 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.438 -0.381 . . . . 0.0 111.289 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -105.9 154.86 19.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.09 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 254' ' ' CYS . 8.5 m -102.68 114.72 29.2 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 121.169 0.509 . . . . 0.0 110.085 176.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -139.16 -167.92 11.1 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.583 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' MET . . . . . 0.499 ' CG ' ' HB3' ' A' ' 251' ' ' ASP . 22.9 ptp -140.56 134.39 30.5 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.214 0.531 . . . . 0.0 112.152 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 244' ' ' ILE . 0.8 OUTLIER -149.58 139.63 22.05 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.638 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 266' ' ' ASN . . . . . 0.427 ' H ' HD23 ' A' ' 265' ' ' LEU . 91.1 m-20 63.25 34.1 13.62 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.283 0.563 . . . . 0.0 110.24 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 69.5 12.12 8.15 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.722 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -117.93 133.45 55.91 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.99 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.3 p -91.77 135.48 27.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 174.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -166.77 -158.25 11.11 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.252 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.608 ' OD1' ' HA ' ' A' ' 241' ' ' SER . 20.2 p-10 -110.09 154.77 22.79 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.738 0.304 . . . . 0.0 111.081 -178.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -165.71 154.75 11.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.856 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.415 ' HB3' HG12 ' A' ' 275' ' ' ILE . 68.2 mttm -88.02 109.29 19.72 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.012 0.434 . . . . 0.0 110.264 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -54.5 -13.59 1.0 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.415 HG12 ' HB3' ' A' ' 273' ' ' LYS . 31.3 pt -65.42 -21.23 28.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.651 0.262 . . . . 0.0 111.665 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' TYR . . . . . 0.412 ' HB3' ' O ' ' A' ' 230' ' ' THR . 61.0 m-85 -91.37 -12.97 33.35 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-O 121.003 0.43 . . . . 0.0 111.265 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 15.3 m -107.3 177.62 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.066 0.46 . . . . 0.0 111.363 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -139.73 137.78 35.41 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 20.0 t -86.53 102.4 11.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.085 0.469 . . . . 0.0 110.564 -175.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 44.4 pt . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.097 -179.73 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.626 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 -131.68 149.81 52.36 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 278' ' ' ASP . . . -125.83 132.04 52.3 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -175.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.565 ' HE ' HD13 ' A' ' 280' ' ' ILE . 29.9 ttm-85 -91.94 116.68 29.12 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 175.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 277' ' ' VAL . 9.1 p -76.35 144.21 12.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -177.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.497 ' NE2' ' HB2' ' A' ' 278' ' ' ASP . 98.9 m-70 -101.22 -32.24 10.62 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.879 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.5 m -130.64 137.49 49.62 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.22 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -60.46 145.92 46.58 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.308 0.575 . . . . 0.0 110.964 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.499 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 63.0 t80 -136.57 112.53 9.63 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.104 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 84.4 m -153.93 98.65 2.6 Favored Pre-proline 0 C--N 1.307 -1.246 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.903 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.2 -69.6 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.124 1.883 . . . . 0.0 110.06 177.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.9 t -143.14 144.69 29.68 Favored Pre-proline 0 N--CA 1.435 -1.182 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.93 -20.65 57.77 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 121.885 1.723 . . . . 0.0 109.773 173.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -94.7 23.31 5.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.303 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -120.32 130.22 54.34 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.692 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 18.2 p -129.61 19.98 5.64 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.119 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -99.65 -21.87 15.66 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.542 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.5 m -102.89 -175.22 2.75 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.863 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 47.0 tp -109.1 117.1 33.29 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? -90.94 113.56 25.82 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.499 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 32.7 pt -130.01 173.32 14.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.189 0.518 . . . . 0.0 110.739 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -120.74 -156.78 0.69 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -105.4 153.93 21.0 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.99 30.69 77.52 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.221 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.424 ' H ' ' CG1' ' A' ' 228' ' ' VAL . 11.3 m-20 -100.95 161.43 13.6 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 177.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 35.6 mm -116.88 91.69 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 49.3 mt -80.3 132.87 30.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.055 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -83.64 154.89 23.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 175.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.467 HG21 ' HG3' ' A' ' 255' ' ' LYS . 28.3 mt -134.27 133.36 55.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.592 -176.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 12.7 tt -110.03 -23.79 4.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.348 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.404 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 48.8 t -148.23 119.44 7.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.263 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.467 ' HG3' HG21 ' A' ' 252' ' ' ILE . 3.9 mppt? -100.54 103.14 14.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.713 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.585 ' HB ' ' O ' ' A' ' 260' ' ' MET . 44.2 m -97.52 102.54 13.17 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.23 33.83 0.25 Allowed 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.2 2.6 . . . . 0.0 113.925 -175.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 48.9 ttm -108.35 -30.44 8.32 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.018 0.437 . . . . 0.0 110.364 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 273' ' ' LYS . . . 168.33 -53.3 0.22 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.85 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' MET . . . . . 0.585 ' O ' ' HB ' ' A' ' 256' ' ' THR . 4.1 mpp? -101.95 135.12 44.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.989 0.423 . . . . 0.0 111.738 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.486 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 38.2 m0 -112.24 149.4 32.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.878 176.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 254' ' ' CYS . 5.9 m -96.77 114.03 25.64 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -139.48 -175.99 14.53 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.895 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 56.0 ttp -133.07 129.32 37.87 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.082 0.468 . . . . 0.0 111.013 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.536 HD13 ' N ' ' A' ' 266' ' ' ASN . 2.0 tm? -156.26 144.53 19.84 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' ASN . . . . . 0.536 ' N ' HD13 ' A' ' 265' ' ' LEU . 0.0 OUTLIER 54.56 34.88 22.2 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.417 1.087 . . . . 0.0 112.928 179.176 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 266' ' ' ASN . 7.4 m120 75.06 13.97 3.2 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.069 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -130.48 134.54 47.16 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.416 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.3 p -95.97 132.4 40.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -164.59 -156.31 8.88 Favored Glycine 0 C--N 1.311 -0.848 0 C-N-CA 120.151 -1.024 . . . . 0.0 112.085 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 29.2 p30 -117.01 164.61 14.46 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.047 0.451 . . . . 0.0 111.39 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 260' ' ' MET . 50.3 p90 -170.4 154.56 4.78 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 259' ' ' GLY . 97.5 mttt -85.21 112.16 20.48 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 120.987 0.422 . . . . 0.0 110.101 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.464 ' HA ' HG22 ' A' ' 277' ' ' VAL . 33.5 p90 -58.67 -11.68 3.36 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -176.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 32.7 pt -61.26 -23.92 31.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.638 0.256 . . . . 0.0 111.281 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -89.44 -11.99 41.48 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.363 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 274' ' ' PHE . 10.3 m -113.4 -178.96 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.497 ' HB2' ' NE2' ' A' ' 229' ' ' HIS . 27.3 t70 -141.18 141.09 34.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.546 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 57.2 t -83.8 117.72 29.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.885 0.374 . . . . 0.0 110.852 -176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.565 HD13 ' HE ' ' A' ' 227' ' ' ARG . 37.0 pt . . . . . 0 C--N 1.317 -0.814 0 CA-C-O 121.645 0.736 . . . . 0.0 111.472 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.467 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -157.4 151.63 24.83 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 124.18 0.992 . . . . 0.0 108.466 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -144.82 147.03 32.39 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.143 0.497 . . . . 0.0 111.629 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -93.94 125.74 38.74 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.5 p -81.55 137.07 21.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 120.745 0.307 . . . . 0.0 110.483 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -113.4 0.85 14.89 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -175.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 83.1 m -140.15 139.42 35.75 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.621 0.248 . . . . 0.0 111.023 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -77.82 157.97 29.71 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.443 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 68.4 t80 178.52 103.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.047 0.451 . . . . 0.0 112.004 -176.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.449 ' OG1' ' HG2' ' A' ' 243' ' ' LYS . 5.1 t -136.45 116.49 11.0 Favored Pre-proline 0 N--CA 1.435 -1.213 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.983 172.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -53.99 -45.64 39.49 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.692 2.262 . . . . 0.0 111.282 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 238' ' ' ASP . 46.4 m -141.73 127.36 10.85 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.26 176.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.45 -27.91 83.02 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.766 2.311 . . . . 0.0 113.514 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -92.25 -27.07 17.85 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.542 ' HB2' ' HB2' ' A' ' 235' ' ' SER . 25.7 t70 -48.79 162.17 0.11 Allowed 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 2.9 m -143.13 -0.6 1.12 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.768 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -90.06 -48.59 7.1 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.837 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 69.4 m -74.36 -178.16 3.36 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 31.6 tp -107.17 110.97 23.17 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.941 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.449 ' HG2' ' OG1' ' A' ' 233' ' ' THR . 43.7 mtmt -86.56 101.56 13.33 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.776 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.443 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 29.6 pt -100.39 149.8 5.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.241 0.543 . . . . 0.0 111.341 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -108.82 162.25 14.36 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.488 -177.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -81.23 86.47 6.21 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.305 0.574 . . . . 0.0 111.217 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 107.48 72.5 0.79 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.62 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -147.94 -174.06 4.46 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 44.1 mm -117.59 124.94 73.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.99 0.424 . . . . 0.0 111.059 -176.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.481 HG12 HD12 ' A' ' 265' ' ' LEU . 55.0 mt -118.47 126.39 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.279 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' ASP . . . . . 0.464 ' HB3' ' HB3' ' A' ' 264' ' ' MET . 26.3 t70 -76.39 167.21 22.26 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 73.2 mt -138.28 107.75 4.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 118.375 0.534 . . . . 0.0 109.924 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 50.9 pt -95.5 -8.31 9.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.117 0.484 . . . . 0.0 110.753 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.5 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 52.7 t -164.31 121.6 1.68 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.312 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.442 ' N ' ' HD3' ' A' ' 255' ' ' LYS . 0.1 OUTLIER -86.09 -94.87 0.08 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.371 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 30.1 p 49.11 90.59 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 123.299 0.639 . . . . 0.0 112.107 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -63.12 59.85 0.16 Allowed 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.673 2.915 . . . . 0.0 114.23 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 22.2 ptp -91.96 21.57 4.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.299 0.571 . . . . 0.0 109.942 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 105.09 -59.7 0.43 Allowed Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' MET . . . . . 0.423 ' HB3' ' HB2' ' A' ' 271' ' ' ASN . 3.8 mpp? -108.83 122.21 46.69 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.685 0.279 . . . . 0.0 111.107 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.442 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 19.9 m0 -87.62 168.62 12.87 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 175.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 254' ' ' CYS . 6.4 m -117.76 114.07 22.76 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 121.112 0.482 . . . . 0.0 110.092 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -136.63 -169.87 11.81 Favored Glycine 0 N--CA 1.431 -1.663 0 C-N-CA 120.155 -1.022 . . . . 0.0 112.78 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' MET . . . . . 0.464 ' HB3' ' HB3' ' A' ' 251' ' ' ASP . 50.8 ttp -134.67 125.0 26.22 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.942 0.401 . . . . 0.0 111.236 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.481 HD12 HG12 ' A' ' 250' ' ' ILE . 9.3 tt -135.18 129.78 34.3 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 62.13 38.96 13.39 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.861 0.464 . . . . 0.0 110.944 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 63.9 t30 70.74 2.91 4.34 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.827 0.851 . . . . 0.0 111.994 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 264' ' ' MET . 54.6 tttp -108.64 136.11 48.77 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.86 0.362 . . . . 0.0 111.502 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 6.4 p -89.94 135.38 26.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.915 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -160.27 178.58 36.25 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.256 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 17.8 p30 -108.11 145.31 34.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.903 0.383 . . . . 0.0 111.354 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -152.36 160.59 43.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.6 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.42 ' HE3' ' SD ' ' A' ' 260' ' ' MET . 9.1 mptt -78.04 109.09 11.81 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 176.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.508 ' O ' HG22 ' A' ' 277' ' ' VAL . 54.8 p90 -55.05 -26.41 37.27 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 27.4 pt -59.31 -19.77 16.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -89.54 -7.97 53.76 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 274' ' ' PHE . 15.6 m -109.48 172.28 2.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.064 0.459 . . . . 0.0 111.246 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -133.93 129.48 36.36 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.584 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 6.1 m -76.38 107.3 7.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.391 0.615 . . . . 0.0 111.806 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--N 1.319 -0.723 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.029 -179.833 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.482 ' HA3' ' HB ' ' A' ' 252' ' ' ILE . . . . . . . . 0 N--CA 1.435 -1.421 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 -132.66 112.78 12.31 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.969 0.414 . . . . 0.0 110.636 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.498 ' HB2' HD11 ' A' ' 252' ' ' ILE . . . -132.62 148.48 52.36 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.595 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 45.5 ttt85 -107.23 122.31 46.27 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.6 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.46 133.17 30.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.012 0.434 . . . . 0.0 110.26 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -124.0 -24.24 4.44 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.152 0.501 . . . . 0.0 109.998 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.452 ' HB ' ' HA ' ' A' ' 276' ' ' TYR . 20.4 m -107.65 127.2 53.45 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 176.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -69.41 148.48 49.55 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.994 0.426 . . . . 0.0 110.578 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -145.19 103.91 3.9 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 3.8 t -152.61 114.97 2.83 Favored Pre-proline 0 N--CA 1.425 -1.714 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.611 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 233' ' ' THR . 6.8 Cg_exo -76.07 -156.54 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.402 2.068 . . . . 0.0 109.102 172.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.4 t -64.88 129.93 94.62 Favored Pre-proline 0 C--N 1.316 -0.885 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.09 -20.16 70.63 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.531 2.154 . . . . 0.0 111.595 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -65.69 -37.66 87.08 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.29 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -63.33 133.76 54.65 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 171.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.448 ' O ' ' HE2' ' A' ' 268' ' ' LYS . 30.3 m -104.55 -26.58 12.31 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -76.86 -48.31 18.74 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 3.7 m -59.72 131.62 51.46 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.776 0.322 . . . . 0.0 110.425 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 26.0 tp -72.89 107.95 5.57 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.592 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -100.05 108.89 21.18 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.251 0.548 . . . . 0.0 109.587 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 21.2 pt -108.53 178.71 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.663 -175.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -130.69 129.88 43.15 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -60.5 160.77 8.42 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.14 36.0 71.28 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.765 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -135.59 176.02 9.06 Favored 'General case' 0 C--N 1.318 -0.783 0 O-C-N 122.629 -0.336 . . . . 0.0 110.332 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 49.2 mm -108.29 130.68 60.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 34.2 mt -122.85 129.07 75.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 120.664 0.268 . . . . 0.0 110.819 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' ASP . . . . . 0.415 ' O ' ' HA2' ' A' ' 263' ' ' GLY . 3.4 m-20 -80.0 133.92 36.2 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 226' ' ' ALA . 4.1 mt -99.09 102.44 13.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 48.4 mm -67.69 -60.66 2.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.018 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.401 ' C ' ' HD3' ' A' ' 255' ' ' LYS . 57.7 m -121.62 142.86 49.7 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.401 ' HD3' ' C ' ' A' ' 254' ' ' CYS . 3.2 mppt? -119.27 97.76 5.82 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.852 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.0 m -84.91 126.08 69.05 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -27.53 -77.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 125.112 3.875 . . . . 0.0 115.539 -175.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 46.4 ttm -31.12 -45.67 0.08 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 144.75 4.84 0.59 Allowed Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 119.793 -1.194 . . . . 0.0 112.731 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 72.5 mtm -78.35 106.02 9.99 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.431 0.634 . . . . 0.0 109.299 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -111.37 140.46 45.93 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.22 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' THR . . . . . 0.486 HG22 HG22 ' A' ' 269' ' ' VAL . 1.3 m -100.3 114.87 28.7 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 269' ' ' VAL . . . -108.96 173.91 17.87 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.952 -176.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 39.5 ttp -129.93 114.51 15.94 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.802 0.334 . . . . 0.0 110.355 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.64 143.62 11.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.328 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 63.5 38.02 10.11 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.965 0.412 . . . . 0.0 110.944 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 14.6 m120 65.07 16.33 10.5 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.48 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.448 ' HE2' ' O ' ' A' ' 239' ' ' THR . 63.3 tttp -135.59 141.9 45.21 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.824 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 263' ' ' GLY . 4.5 p -101.16 125.03 55.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -149.84 172.41 29.76 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.132 -1.033 . . . . 0.0 112.182 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -88.97 120.12 30.1 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -123.84 -178.82 4.16 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.758 175.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -109.34 143.74 38.45 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.081 0.467 . . . . 0.0 111.348 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -66.98 -14.28 62.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.734 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 36.3 pt -68.98 -21.97 25.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.801 -177.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' TYR . . . . . 0.452 ' HA ' ' HB ' ' A' ' 230' ' ' THR . 63.2 m-85 -90.04 -3.48 57.94 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.964 0.411 . . . . 0.0 111.186 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 33.8 m -132.16 166.71 28.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.79 140.02 46.67 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.042 174.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 16.3 m -80.79 119.47 30.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.385 0.612 . . . . 0.0 112.449 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 38.3 pt . . . . . 0 C--N 1.321 -0.639 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.927 178.483 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.441 0 N-CA-C 111.619 -0.592 . . . . 0.0 111.619 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -148.23 144.0 27.38 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 120.72 0.295 . . . . 0.0 110.388 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.484 ' HB2' HD11 ' A' ' 252' ' ' ILE . . . -139.24 126.81 21.76 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.016 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 47.9 ttp180 -75.57 112.56 12.04 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.503 HG21 HD12 ' A' ' 244' ' ' ILE . 6.5 p -73.65 149.11 8.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.809 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -109.63 -21.95 12.18 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.814 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.7 m -127.28 140.98 51.84 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.045 -174.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -74.02 173.86 9.43 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.426 ' HB2' HG12 ' A' ' 244' ' ' ILE . 16.6 t80 -141.85 123.34 14.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 38.2 m -134.75 97.19 14.23 Favored Pre-proline 0 C--N 1.309 -1.159 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.577 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -97.13 -165.2 0.09 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 123.255 2.637 . . . . 0.0 111.04 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 19.4 m -72.38 140.46 82.26 Favored Pre-proline 0 C--N 1.313 -0.999 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.77 -11.44 9.42 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.236 2.624 . . . . 0.0 114.007 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -113.62 -9.99 13.16 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.84 0.352 . . . . 0.0 110.93 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -58.45 125.93 25.41 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.938 0.399 . . . . 0.0 110.865 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 20.5 p -118.81 28.28 8.39 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.395 0.617 . . . . 0.0 110.144 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -114.38 -18.47 11.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.047 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 12.8 m -114.27 174.33 6.0 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.255 0.55 . . . . 0.0 111.38 -176.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 58.9 tp -115.41 118.64 33.77 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -78.36 88.13 4.38 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.203 0.525 . . . . 0.0 110.326 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.503 HD12 HG21 ' A' ' 228' ' ' VAL . 16.0 pt -94.91 156.25 3.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.535 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -104.14 172.17 6.94 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.471 ' O ' ' HD2' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -87.29 147.95 25.3 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 55.82 60.58 8.64 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.155 -177.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 227' ' ' ARG . 1.3 t70 -134.48 -169.83 2.42 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 37.6 mm -130.9 104.29 9.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -176.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 39.0 mt -86.99 129.79 37.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.336 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' ASP . . . . . 0.475 ' HB3' ' HG2' ' A' ' 264' ' ' MET . 13.7 t70 -85.68 94.37 9.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.11 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.484 HD11 ' HB2' ' A' ' 226' ' ' ALA . 5.9 mt -74.12 120.65 23.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.386 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 18.0 pt -109.75 -21.78 5.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.064 0.459 . . . . 0.0 110.795 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.504 ' HB2' ' HB ' ' A' ' 262' ' ' THR . 56.6 m -146.31 142.01 27.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.756 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.85 171.72 7.87 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.064 0.459 . . . . 0.0 110.732 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 27.7 m -145.31 128.8 8.49 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.72 -42.7 29.9 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.932 2.421 . . . . 0.0 112.275 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 15.2 tpt -145.09 115.57 7.62 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.752 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 137.07 -132.76 6.13 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 119.956 -1.116 . . . . 0.0 113.372 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -107.17 143.76 34.89 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.048 0.452 . . . . 0.0 111.743 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -102.67 152.24 21.43 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.96 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' THR . . . . . 0.504 ' HB ' ' HB2' ' A' ' 254' ' ' CYS . 2.8 m -96.82 122.36 39.69 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.84 0.353 . . . . 0.0 110.176 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -154.87 166.07 32.33 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.652 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' MET . . . . . 0.475 ' HG2' ' HB3' ' A' ' 251' ' ' ASP . 23.0 ptp -113.61 146.61 39.46 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.202 0.525 . . . . 0.0 111.223 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.501 HD13 ' N ' ' A' ' 266' ' ' ASN . 1.4 tm? -147.17 142.24 27.1 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' ASN . . . . . 0.501 ' N ' HD13 ' A' ' 265' ' ' LEU . 2.0 p-10 51.18 34.68 11.67 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.624 0.77 . . . . 0.0 111.907 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 66.89 20.81 10.51 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.462 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -119.46 136.26 54.39 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.0 p -96.13 143.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.028 0.442 . . . . 0.0 111.081 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -175.41 -150.41 7.92 Favored Glycine 0 N--CA 1.438 -1.167 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.803 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -130.96 165.45 23.11 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.946 0.403 . . . . 0.0 110.018 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -154.73 149.58 26.67 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.458 ' HB3' HG12 ' A' ' 275' ' ' ILE . 13.5 mptt -93.56 113.18 25.24 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.575 ' HA ' HG22 ' A' ' 277' ' ' VAL . 46.1 p90 -51.74 -9.03 0.07 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.458 HG12 ' HB3' ' A' ' 273' ' ' LYS . 45.8 pt -81.04 17.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.117 0.484 . . . . 0.0 109.906 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -137.67 12.54 2.95 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.575 HG22 ' HA ' ' A' ' 274' ' ' PHE . 9.9 m -138.74 178.56 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 121.09 0.471 . . . . 0.0 111.574 -174.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.44 118.13 14.02 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.344 176.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 15.8 m -75.45 104.79 3.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.637 0.732 . . . . 0.0 111.371 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 32.0 pt . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.376 -178.389 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.929 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -136.27 147.84 47.72 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.858 0.361 . . . . 0.0 110.494 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -132.52 147.58 52.36 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.552 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -97.66 116.96 30.89 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.674 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.41 ' HA ' HG12 ' A' ' 277' ' ' VAL . 3.4 p -80.79 113.92 20.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.206 0.527 . . . . 0.0 111.57 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -98.55 -22.81 15.79 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.716 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' A' ' 276' ' ' TYR . 59.6 m -122.45 127.35 49.51 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.512 ' HB3' ' HG3' ' A' ' 246' ' ' LYS . 5.1 p-10 -75.96 164.09 26.52 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.493 0.663 . . . . 0.0 111.721 -176.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -157.57 134.42 10.01 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.587 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 5.5 t -143.56 131.5 10.97 Favored Pre-proline 0 N--CA 1.433 -1.277 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.115 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.446 ' HB3' ' HB3' ' A' ' 241' ' ' SER . 89.6 Cg_endo -78.02 -176.41 3.23 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.343 2.029 . . . . 0.0 111.082 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 20.7 m -63.66 147.84 95.11 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.943 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -59.65 -12.8 18.95 Favored 'Trans proline' 0 N--CA 1.478 0.602 0 C-N-CA 122.852 2.368 . . . . 0.0 112.33 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -106.55 13.91 27.74 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.42 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -115.04 109.02 17.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.684 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 3.2 m -97.86 9.81 41.76 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.284 0.564 . . . . 0.0 110.403 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -91.47 -68.34 0.8 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.738 -176.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 234' ' ' PRO . 10.7 t -55.78 160.21 2.73 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.345 0.593 . . . . 0.0 112.034 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 23.3 tp -94.78 128.76 41.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.863 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -89.73 97.94 11.48 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.444 ' HA ' ' CD2' ' A' ' 265' ' ' LEU . 40.5 pt -96.83 137.32 24.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.311 0.576 . . . . 0.0 112.349 -175.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -115.31 108.1 16.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.571 -177.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.602 ' O ' ' HD2' ' A' ' 246' ' ' LYS . 0.1 OUTLIER -41.18 136.35 1.62 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 177.67 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 108.37 -8.59 35.31 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.57 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -109.87 -176.96 3.14 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 120.855 0.359 . . . . 0.0 110.902 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 30.3 mm -121.17 129.46 75.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 35.5 mt -107.7 133.11 53.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.422 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.58 149.66 26.42 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 9.0 mt -129.19 124.87 61.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.817 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 28.3 pt -106.49 -5.78 10.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.217 0.532 . . . . 0.0 110.631 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.414 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 40.4 t -155.86 110.4 2.88 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.32 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.423 ' N ' ' HD3' ' A' ' 255' ' ' LYS . 0.1 OUTLIER -96.14 90.55 5.55 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.668 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.589 ' HB ' ' O ' ' A' ' 260' ' ' MET . 20.5 m -89.28 116.82 67.34 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.358 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.02 12.9 0.41 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.034 2.489 . . . . 0.0 113.642 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 51.3 ttm -86.23 -26.95 24.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.744 0.307 . . . . 0.0 110.67 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 144.26 -34.58 1.62 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.446 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' MET . . . . . 0.589 ' O ' ' HB ' ' A' ' 256' ' ' THR . 1.7 pmm? -103.77 138.57 40.21 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.875 0.369 . . . . 0.0 110.826 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.526 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 32.2 m0 -119.37 135.16 54.86 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 254' ' ' CYS . 44.6 m -90.12 114.34 26.26 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.292 0.568 . . . . 0.0 109.47 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -132.54 -168.92 12.13 Favored Glycine 0 N--CA 1.426 -1.999 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.893 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 28.2 ttt -134.54 120.58 19.84 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.053 0.454 . . . . 0.0 110.773 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.444 ' CD2' ' HA ' ' A' ' 244' ' ' ILE . 39.9 tp -143.82 142.64 30.96 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 46.76 41.2 9.99 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.374 0.67 . . . . 0.0 112.422 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 66.0 t30 68.28 9.3 7.15 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.943 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -113.88 137.63 51.41 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.793 0.33 . . . . 0.0 110.673 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.7 p -102.32 137.28 30.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -172.35 174.51 45.53 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.116 -179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.526 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 7.9 p30 -110.68 103.11 11.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.609 0.718 . . . . 0.0 112.747 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -94.79 173.83 7.41 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.63 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.455 ' HB2' ' CE2' ' A' ' 276' ' ' TYR . 99.0 mttt -95.42 122.51 38.22 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.144 177.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' PHE . . . . . 0.462 ' HA ' HG22 ' A' ' 277' ' ' VAL . 44.2 p90 -61.4 -9.41 5.42 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.413 HG12 ' HB3' ' A' ' 273' ' ' LYS . 32.8 pt -68.63 -17.7 22.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 120.767 0.318 . . . . 0.0 110.939 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' A' ' 230' ' ' THR . 40.1 m-85 -95.67 -6.74 39.3 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-O 121.091 0.472 . . . . 0.0 110.808 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 274' ' ' PHE . 4.9 m -122.09 -178.98 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.223 0.535 . . . . 0.0 111.488 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.7 138.93 38.19 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.233 177.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 6.9 p -95.81 121.81 46.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-O 121.112 0.482 . . . . 0.0 110.544 -176.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.564 HD13 ' H ' ' A' ' 280' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.318 -0.762 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.978 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.434 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.87 144.31 82.7 Favored 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 122.579 2.186 . . . . 0.0 111.604 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -83.45 96.39 8.56 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.255 0.55 . . . . 0.0 110.822 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' CYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 252' ' ' ILE . 52.6 t -88.71 111.42 21.94 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.784 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -95.05 -173.28 37.47 Favored Glycine 0 C--N 1.31 -0.879 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.739 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -119.14 112.49 19.58 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -118.75 117.72 29.67 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.618 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -99.52 113.92 26.61 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 246' ' ' LYS . 2.5 p -77.19 112.73 15.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.401 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -93.56 -25.46 17.55 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.655 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.401 ' O ' ' HB3' ' A' ' 276' ' ' TYR . 85.6 m -117.54 117.79 30.39 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -66.72 149.74 50.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.474 0.654 . . . . 0.0 111.637 -177.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.478 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 53.3 t80 -147.29 129.52 15.64 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.647 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 9.7 t -137.78 129.13 16.08 Favored Pre-proline 0 N--CA 1.418 -2.027 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.81 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -91.17 -162.85 0.11 Allowed 'Trans proline' 0 N--CA 1.439 -1.721 0 C-N-CA 122.627 2.218 . . . . 0.0 109.778 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 17.5 m -69.99 128.17 91.88 Favored Pre-proline 0 N--CA 1.431 -1.406 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.94 -32.54 68.32 Favored 'Trans proline' 0 N--CA 1.477 0.529 0 C-N-CA 122.324 2.016 . . . . 0.0 111.897 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -89.55 23.61 2.56 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.098 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -109.77 114.5 28.14 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 16.7 m -70.83 -41.76 71.07 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.01 -74.16 0.05 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 8.9 m -49.56 145.98 4.52 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -176.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 53.9 tp -103.1 129.39 49.92 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.262 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.429 ' C ' ' HD3' ' A' ' 243' ' ' LYS . 1.4 tmtp? -82.44 105.41 13.48 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.478 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 44.0 pt -97.91 132.12 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-O 121.579 0.704 . . . . 0.0 110.545 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.15 108.08 16.16 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.743 -174.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 228' ' ' VAL . 26.0 pttm -38.29 120.24 0.88 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.637 0.732 . . . . 0.0 112.811 178.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 113.55 -6.06 24.56 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.677 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.62 166.03 11.53 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-O 121.087 0.47 . . . . 0.0 111.308 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 48.8 mm -114.95 117.28 55.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.552 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 26.9 mt -99.16 134.9 36.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.361 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ASP . . . . . 0.552 ' HB2' ' SG ' ' A' ' 223' ' ' CYS . 5.8 p-10 -91.65 145.94 24.18 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 223' ' ' CYS . 11.4 mt -113.13 134.96 54.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 116.351 -0.386 . . . . 0.0 112.001 -171.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 46.8 mm -111.71 -25.51 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 121.445 0.64 . . . . 0.0 109.868 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 42.4 t -145.77 136.93 24.75 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.777 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.406 ' HG3' HG21 ' A' ' 252' ' ' ILE . 0.0 OUTLIER -129.17 133.5 47.61 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.948 178.631 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.7 t -147.96 130.64 7.85 Favored Pre-proline 0 C--N 1.307 -1.26 0 CA-C-O 120.882 0.372 . . . . 0.0 110.319 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.3 6.34 4.43 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.386 2.057 . . . . 0.0 111.892 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 25.2 ttt -90.56 -29.13 18.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.42 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -172.85 -145.32 4.96 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 119.925 -1.131 . . . . 0.0 113.121 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -66.95 158.88 29.7 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 122.717 0.407 . . . . 0.0 111.79 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -110.35 154.8 23.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.124 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 7.9 m -92.97 118.96 31.75 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.733 174.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -140.25 -171.0 12.22 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.514 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' MET . . . . . 0.536 ' HB2' ' OD2' ' A' ' 251' ' ' ASP . 64.6 mtt -137.51 142.67 41.46 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.161 0.505 . . . . 0.0 110.603 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 35.1 tp -150.01 127.76 11.71 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 11.8 m120 61.26 33.73 18.96 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -175.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 68.72 3.74 4.05 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.203 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -93.28 128.89 39.46 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 9.2 p -89.84 139.16 17.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -174.38 -165.03 30.27 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.302 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -107.34 164.71 11.96 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.742 0.306 . . . . 0.0 110.637 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -169.56 146.89 3.44 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -96.23 121.02 37.56 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.762 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.425 ' HA ' HG22 ' A' ' 277' ' ' VAL . 42.0 p90 -55.89 -15.46 3.39 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 41.6 pt -68.44 -16.0 20.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.261 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 230' ' ' THR . 27.2 m-85 -98.81 -5.0 31.98 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.282 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' A' ' 274' ' ' PHE . 9.1 m -115.46 165.63 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.305 0.574 . . . . 0.0 112.09 -176.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -112.64 131.77 55.48 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.074 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 39.5 t -91.43 104.07 15.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.603 HD13 ' H ' ' A' ' 280' ' ' ILE . 0.2 OUTLIER -125.91 176.17 6.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.183 -176.512 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 11.2 t -114.34 -4.36 13.0 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.827 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--O 1.25 1.094 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.125 -179.667 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.138 0 N-CA-C 111.839 -0.504 . . . . 0.0 111.839 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -77.8 -10.85 16.89 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.997 2.464 . . . . 0.0 113.458 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -85.64 -175.47 5.65 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 73.1 m 73.86 22.7 2.41 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.985 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -100.09 22.38 40.43 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.665 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.434 ' HG2' ' HA ' ' A' ' 251' ' ' ASP . 97.4 mtt180 -146.94 127.42 14.08 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -133.88 141.88 47.55 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.981 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.408 ' HG3' HD13 ' A' ' 249' ' ' ILE . 67.7 ttt180 -99.3 135.49 40.63 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 245' ' ' LYS . 1.6 p -86.5 129.02 38.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.267 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -115.38 -3.97 12.39 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 120.861 0.363 . . . . 0.0 111.322 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 17.7 m -128.7 124.85 36.69 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -58.15 166.23 1.67 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.397 0.618 . . . . 0.0 112.171 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.448 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 78.0 t80 -168.93 151.17 4.79 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.468 -175.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 86.1 m -151.71 123.45 3.85 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -51.15 142.48 35.5 Favored 'Trans proline' 0 C--O 1.238 0.52 0 C-N-CA 122.604 2.203 . . . . 0.0 111.222 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.4 m -53.75 148.91 17.91 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.215 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -52.58 -20.25 11.85 Favored 'Trans proline' 0 N--CA 1.482 0.832 0 C-N-CA 123.088 2.525 . . . . 0.0 113.456 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -117.69 17.76 14.3 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.141 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -120.26 131.09 54.78 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.2 0.524 . . . . 0.0 111.556 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 20.2 p -120.38 4.9 10.71 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.348 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -90.7 -28.4 18.36 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.588 -176.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 14.9 m -73.42 166.12 23.79 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.35 0.595 . . . . 0.0 111.546 -176.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 21.7 tp -101.89 147.82 26.07 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.576 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -98.32 100.33 11.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.796 0.332 . . . . 0.0 110.564 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.448 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 27.3 pt -111.32 150.38 13.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.502 ' O ' HG13 ' A' ' 228' ' ' VAL . 38.7 ttmt -137.69 155.91 48.59 Favored 'General case' 0 C--O 1.213 -0.837 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -62.12 95.83 0.07 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -173.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 145.82 -52.23 0.58 Allowed Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.938 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -38.2 151.99 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.408 HD13 ' HG3' ' A' ' 227' ' ' ARG . 34.6 mm -111.47 125.8 68.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.699 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 4.8 mp -114.56 116.83 53.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 120.459 -0.497 . . . . 0.0 111.478 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ASP . . . . . 0.434 ' HA ' ' HG2' ' A' ' 225' ' ' ARG . 29.4 t70 -75.44 141.24 43.2 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 173.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 36.0 mt -115.69 123.56 71.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.867 -172.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 12.0 tt -90.67 -17.95 7.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.152 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 48.1 t -155.5 125.48 6.58 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -107.46 86.79 2.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.936 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.65 112.3 33.1 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.362 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.75 35.36 0.29 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.034 2.489 . . . . 0.0 114.079 -175.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 20.3 mmt -112.21 -70.71 0.79 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -156.39 -53.09 0.01 OUTLIER Glycine 0 C--O 1.237 0.304 0 C-N-CA 119.924 -1.131 . . . . 0.0 113.229 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -97.71 118.74 34.92 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.61 0.243 . . . . 0.0 111.017 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.454 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 29.6 m0 -91.03 -179.87 5.57 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 16.9 m -134.04 114.33 13.08 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 269' ' ' VAL . . . -132.41 -168.62 12.07 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.132 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 51.3 ttm -138.66 114.3 9.81 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.912 0.387 . . . . 0.0 110.263 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 45.0 tp -135.98 137.04 40.85 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 27.3 m120 60.62 33.83 20.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.198 0.523 . . . . 0.0 110.085 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 20.5 m120 70.8 1.21 3.64 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.114 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -101.82 130.33 48.24 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.665 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 263' ' ' GLY . 3.9 p -95.63 119.45 43.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -151.96 174.23 31.03 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.863 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 9.2 p30 -96.31 136.78 36.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.169 0.509 . . . . 0.0 111.729 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -143.02 152.3 41.76 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.637 178.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.402 ' HB3' HG12 ' A' ' 275' ' ' ILE . 98.5 mttt -78.56 122.51 25.99 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.39 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -58.64 -22.14 55.9 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.478 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.402 HG12 ' HB3' ' A' ' 273' ' ' LYS . 34.0 pt -54.0 -22.05 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -95.72 3.17 54.1 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.412 HG12 ' HB ' ' A' ' 228' ' ' VAL . 21.3 m -125.24 166.53 20.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.473 0.654 . . . . 0.0 112.572 -177.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -128.3 119.98 26.19 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.144 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 23.2 m -70.38 129.89 34.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.036 0.446 . . . . 0.0 111.345 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.509 HD13 ' H ' ' A' ' 280' ' ' ILE . 0.2 OUTLIER -127.93 179.68 3.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.947 -178.284 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 15.9 p -116.21 -46.67 2.79 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.303 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 . . . . . 0 C--O 1.254 1.298 0 CA-C-O 118.716 -0.659 . . . . 0.0 110.356 -179.414 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.359 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -74.63 162.0 38.65 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.828 2.352 . . . . 0.0 111.586 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -77.35 129.97 36.52 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.922 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 60.1 m -87.77 80.29 7.93 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.113 0.483 . . . . 0.0 111.433 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -109.29 -80.98 1.24 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.751 -0.737 . . . . 0.0 111.375 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -133.94 172.79 12.32 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.81 123.12 46.32 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.498 ' HB2' HD13 ' A' ' 280' ' ' ILE . 26.5 ttm180 -94.22 124.61 38.35 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 277' ' ' VAL . 7.6 p -79.72 141.92 14.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.463 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -125.3 -7.36 7.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.863 0.364 . . . . 0.0 111.42 -176.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 58.7 m -131.04 127.26 37.9 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -66.46 156.55 34.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.282 0.563 . . . . 0.0 111.719 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.471 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 60.4 t80 -167.35 136.77 2.76 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.973 -176.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.49 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 7.4 t -154.67 136.27 9.27 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.927 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 233' ' ' THR . 1.5 Cg_endo -85.77 -154.06 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.683 2.256 . . . . 0.0 110.017 173.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 45.0 m -68.56 157.15 89.04 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 110.508 -0.182 . . . . 0.0 110.508 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -58.87 -39.73 78.59 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.466 2.111 . . . . 0.0 112.265 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -76.37 23.69 0.15 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -94.18 124.1 37.99 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.064 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 4.1 m -123.34 -16.05 6.99 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 120.864 0.364 . . . . 0.0 111.368 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -88.33 -22.4 23.86 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 10.8 m -89.46 -161.76 0.81 Allowed 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.647 -177.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.5 tp -136.54 105.94 6.09 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -78.27 109.32 12.29 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.238 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.471 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 16.3 pt -106.45 154.71 7.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.346 -176.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -123.7 -172.04 2.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.898 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -91.28 87.3 6.43 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.36 0.6 . . . . 0.0 112.509 -176.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 111.74 52.63 0.54 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.729 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -125.12 179.94 4.84 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 48.7 mm -118.58 123.58 71.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.886 0.374 . . . . 0.0 110.821 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 52.2 mt -115.39 126.08 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 121.056 0.455 . . . . 0.0 110.199 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ASP . . . . . 0.515 ' HB3' ' HG2' ' A' ' 264' ' ' MET . 32.9 t70 -76.21 161.04 29.12 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 48.2 mt -128.83 122.8 57.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.966 -177.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 36.5 pt -110.89 -28.07 2.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.895 0.379 . . . . 0.0 110.873 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 53.9 t -145.97 122.63 11.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.096 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -92.74 96.18 10.01 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.504 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 32.1 m -71.74 141.34 84.71 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.26 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 256' ' ' THR . 26.0 Cg_exo -65.28 3.99 0.88 Allowed 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.955 2.437 . . . . 0.0 113.001 178.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 21.6 mmt -121.84 -171.9 2.33 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.629 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -71.96 -29.45 67.01 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.406 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 17.1 ptp -82.47 104.28 12.63 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.079 0.466 . . . . 0.0 111.65 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -97.37 163.09 13.03 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.654 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 2.4 m -112.45 119.3 37.75 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.362 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -154.99 -166.98 16.0 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.019 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' MET . . . . . 0.515 ' HG2' ' HB3' ' A' ' 251' ' ' ASP . 20.3 ptt? -143.74 130.68 20.48 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.219 0.533 . . . . 0.0 111.444 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 266' ' ' ASN . 6.4 tt -113.8 138.55 50.11 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ASN . . . . . 0.504 ' N ' HD23 ' A' ' 265' ' ' LEU . 1.9 p-10 49.25 33.67 5.4 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.399 0.68 . . . . 0.0 111.082 -175.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.3 m120 71.49 13.43 6.45 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.88 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -102.61 123.22 45.94 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 13.7 p -81.79 134.13 27.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.224 0.535 . . . . 0.0 111.522 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -168.75 -177.07 39.41 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.669 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -97.67 143.26 28.51 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -139.65 145.07 37.99 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.11 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -85.44 118.8 25.19 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.051 0.453 . . . . 0.0 110.747 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.5 ' HA ' HG22 ' A' ' 277' ' ' VAL . 40.3 t80 -52.28 -32.95 39.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.279 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 24.8 pt -54.02 -26.22 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -93.96 -9.84 35.67 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.5 HG22 ' HA ' ' A' ' 274' ' ' PHE . 5.6 m -111.83 178.93 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.232 0.539 . . . . 0.0 112.358 -176.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -141.13 140.19 34.08 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.951 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 12.2 t -83.02 118.15 30.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.498 HD13 ' HB2' ' A' ' 227' ' ' ARG . 41.7 pt -119.43 166.95 13.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.178 0.513 . . . . 0.0 111.493 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 31.3 t -93.1 144.56 25.15 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.2 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 C--N 1.31 -1.119 0 CA-C-O 118.327 -0.844 . . . . 0.0 109.673 178.388 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.95 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -76.44 -20.68 13.9 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.329 2.019 . . . . 0.0 112.705 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -120.51 161.71 20.81 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.891 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 75.6 m -75.98 -39.05 56.72 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.102 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 87.91 -78.04 1.83 Allowed Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.525 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -91.49 164.26 13.86 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.883 0.373 . . . . 0.0 110.685 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -140.0 148.46 41.91 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.582 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -92.61 138.93 31.08 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.477 HG21 ' HB ' ' A' ' 244' ' ' ILE . 3.0 p -90.11 129.92 40.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.408 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -111.04 3.89 19.01 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 52.5 m -143.15 133.57 24.79 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.61 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -84.91 94.66 8.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.581 0.705 . . . . 0.0 111.705 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.443 ' H ' HG13 ' A' ' 244' ' ' ILE . 89.0 t80 -109.1 104.16 13.3 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.406 HG23 ' HB3' ' A' ' 243' ' ' LYS . 30.7 m -116.97 108.18 44.71 Favored Pre-proline 0 N--CA 1.434 -1.256 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.676 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.18 156.44 25.01 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 123.091 2.528 . . . . 0.0 112.134 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.8 m -62.38 151.72 81.74 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.827 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.18 -25.28 45.45 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.819 2.346 . . . . 0.0 113.029 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -74.73 -3.06 29.27 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.609 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -69.79 151.38 45.83 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.192 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 19.6 p -118.06 98.88 6.54 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 72.8 14.77 4.89 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 171.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 19.0 m -78.17 176.33 9.34 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 172.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 272' ' ' PHE . 22.6 tp -102.55 133.51 47.42 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.246 -0.981 . . . . 0.0 110.967 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.406 ' HB3' HG23 ' A' ' 233' ' ' THR . 88.9 mttt -99.91 108.15 20.31 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.438 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.477 ' HB ' HG21 ' A' ' 228' ' ' VAL . 24.0 pt -106.6 159.7 6.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-O 121.059 0.457 . . . . 0.0 111.508 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -128.31 164.34 22.84 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.864 -178.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -77.52 91.58 3.96 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.351 0.596 . . . . 0.0 112.003 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 105.9 82.01 1.5 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.231 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -161.67 174.44 13.29 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 46.6 mm -107.73 125.74 64.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 118.013 0.369 . . . . 0.0 110.42 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 36.3 mt -117.95 118.96 60.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.804 0.335 . . . . 0.0 111.367 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -79.6 151.51 30.58 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 173.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 54.4 mt -129.12 132.53 67.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 118.178 0.445 . . . . 0.0 110.842 -174.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 29.6 pt -116.13 -2.5 10.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.93 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.502 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 49.0 t -157.49 123.77 4.85 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -121.19 142.46 49.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.012 0.434 . . . . 0.0 111.208 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.7 p -124.51 159.13 59.18 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.92 -65.68 0.11 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.051 1.834 . . . . 0.0 111.661 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 58.7 mtm -138.51 115.73 11.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.311 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 156.78 -130.67 2.74 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.197 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -106.58 127.87 53.68 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.85 0.357 . . . . 0.0 111.417 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.529 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 45.0 m0 -92.81 176.75 6.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.478 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 254' ' ' CYS . 20.0 m -126.11 116.26 21.09 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.895 0.379 . . . . 0.0 109.994 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -138.81 -168.39 11.25 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.842 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -135.39 135.55 40.73 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.91 0.386 . . . . 0.0 110.655 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.9 142.85 12.29 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 62.94 34.47 14.1 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.894 0.477 . . . . 0.0 110.767 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 17.6 m120 69.35 16.58 8.32 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.813 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -130.5 140.99 50.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.788 0.327 . . . . 0.0 111.15 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.7 p -102.42 131.78 49.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -164.07 -175.66 35.16 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 119.883 -1.151 . . . . 0.0 112.827 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.529 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 7.6 p30 -101.68 137.23 40.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.85 0.357 . . . . 0.0 111.044 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' PHE . . . . . 0.445 ' HB3' ' HB3' ' A' ' 242' ' ' LEU . 43.9 p90 -136.78 162.56 32.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.73 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.447 ' HG3' HG12 ' A' ' 275' ' ' ILE . 22.2 tptm -79.5 114.26 18.29 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.493 ' O ' HG22 ' A' ' 277' ' ' VAL . 11.3 p90 -55.59 -31.06 61.9 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -174.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.447 HG12 ' HG3' ' A' ' 273' ' ' LYS . 18.9 pt -54.63 -25.97 15.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' TYR . . . . . 0.445 ' CD2' ' HB3' ' A' ' 273' ' ' LYS . 54.3 m-85 -84.59 3.76 35.32 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 274' ' ' PHE . 15.1 m -125.65 161.2 30.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.988 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -129.74 131.16 46.2 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.694 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 7.1 m -79.14 103.77 6.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.627 0.727 . . . . 0.0 110.294 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.562 HD13 ' H ' ' A' ' 280' ' ' ILE . 0.2 OUTLIER -67.96 148.26 11.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.267 -178.148 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 33.8 m 63.88 28.93 14.66 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.672 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 . . . . . 0 C--O 1.242 0.683 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.406 179.166 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.363 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.97 155.11 66.05 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.499 2.133 . . . . 0.0 111.792 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -140.35 149.16 42.36 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.998 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 47.0 t -104.22 94.96 5.65 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 160.24 57.17 0.01 OUTLIER Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.331 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.554 ' O ' ' HB2' ' A' ' 281' ' ' SER . 28.3 ptt180 -159.28 151.95 21.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.802 0.334 . . . . 0.0 110.571 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -137.18 149.09 47.0 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.638 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -97.72 125.53 42.57 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 246' ' ' LYS . 3.7 p -81.82 111.82 18.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.264 0.554 . . . . 0.0 111.834 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -89.72 -17.6 27.99 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.543 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 276' ' ' TYR . 52.1 m -129.59 122.9 30.05 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -77.45 162.04 27.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.854 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -179.94 101.67 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.846 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 9.7 t -103.81 142.23 24.16 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 168.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.82 -70.05 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.735 1.624 . . . . 0.0 110.537 177.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 238' ' ' ASP . 19.3 m -144.2 156.45 57.84 Favored Pre-proline 0 C--N 1.311 -1.095 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 175.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -58.66 -42.63 52.03 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.203 1.935 . . . . 0.0 111.393 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -92.32 25.45 2.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.649 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.454 ' HB2' ' HB2' ' A' ' 235' ' ' SER . 14.6 t70 -130.09 139.67 50.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.166 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 2.8 m -142.63 25.96 1.79 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.953 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -74.81 -17.73 60.57 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.615 0.721 . . . . 0.0 110.71 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.608 ' HA ' ' OD1' ' A' ' 271' ' ' ASN . 30.2 m -117.25 -167.02 1.24 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.499 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 48.0 tp -99.52 131.09 45.75 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -84.17 96.21 8.88 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.433 ' HA ' HD13 ' A' ' 265' ' ' LEU . 43.0 pt -90.31 140.11 16.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-O 121.233 0.539 . . . . 0.0 110.855 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -135.34 102.94 5.32 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.863 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 228' ' ' VAL . 24.8 pttm -28.53 130.73 0.06 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.832 0.853 . . . . 0.0 113.264 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 97.96 12.53 46.16 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.804 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -124.63 172.71 9.04 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 48.6 mm -115.72 121.96 68.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.458 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 250' ' ' ILE . 4.4 mp -102.05 121.94 53.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.062 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ASP . . . . . 0.499 ' HB3' ' CG ' ' A' ' 264' ' ' MET . 14.7 t70 -78.64 151.2 32.42 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 47.5 mt -126.87 131.76 70.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 120.949 0.404 . . . . 0.0 112.029 -173.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 7.7 tt -114.42 -32.6 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.008 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.532 ' HB2' ' HB ' ' A' ' 262' ' ' THR . 19.4 m -133.91 120.29 20.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.024 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.42 ' N ' ' HD3' ' A' ' 255' ' ' LYS . 0.0 OUTLIER -103.82 89.03 3.19 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.335 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.63 ' HB ' ' O ' ' A' ' 260' ' ' MET . 45.1 m -71.7 121.59 84.87 Favored Pre-proline 0 N--CA 1.441 -0.916 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.63 -68.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.263 2.642 . . . . 0.0 113.462 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 14.8 tpt -99.6 106.36 18.33 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.752 0.311 . . . . 0.0 111.524 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 131.49 -125.92 4.56 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.898 -1.144 . . . . 0.0 114.068 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' MET . . . . . 0.63 ' O ' ' HB ' ' A' ' 256' ' ' THR . 20.8 ptt? -107.54 158.21 17.41 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.438 -0.381 . . . . 0.0 111.289 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -105.9 154.86 19.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.09 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 254' ' ' CYS . 8.5 m -102.68 114.72 29.2 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 121.169 0.509 . . . . 0.0 110.085 176.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -139.16 -167.92 11.1 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.583 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' MET . . . . . 0.499 ' CG ' ' HB3' ' A' ' 251' ' ' ASP . 22.9 ptp -140.56 134.39 30.5 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.214 0.531 . . . . 0.0 112.152 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 244' ' ' ILE . 0.8 OUTLIER -149.58 139.63 22.05 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.638 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ASN . . . . . 0.427 ' H ' HD23 ' A' ' 265' ' ' LEU . 91.1 m-20 63.25 34.1 13.62 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.283 0.563 . . . . 0.0 110.24 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 69.5 12.12 8.15 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.722 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -117.93 133.45 55.91 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.99 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.3 p -91.77 135.48 27.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 174.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -166.77 -158.25 11.11 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.252 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.608 ' OD1' ' HA ' ' A' ' 241' ' ' SER . 20.2 p-10 -110.09 154.77 22.79 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.738 0.304 . . . . 0.0 111.081 -178.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -165.71 154.75 11.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.856 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.415 ' HB3' HG12 ' A' ' 275' ' ' ILE . 68.2 mttm -88.02 109.29 19.72 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.012 0.434 . . . . 0.0 110.264 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -54.5 -13.59 1.0 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.415 HG12 ' HB3' ' A' ' 273' ' ' LYS . 31.3 pt -65.42 -21.23 28.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.651 0.262 . . . . 0.0 111.665 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' TYR . . . . . 0.412 ' HB3' ' O ' ' A' ' 230' ' ' THR . 61.0 m-85 -91.37 -12.97 33.35 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-O 121.003 0.43 . . . . 0.0 111.265 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 15.3 m -107.3 177.62 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.066 0.46 . . . . 0.0 111.363 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -139.73 137.78 35.41 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 20.0 t -86.53 102.4 11.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.085 0.469 . . . . 0.0 110.564 -175.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 44.4 pt -105.35 8.09 9.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.097 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.554 ' HB2' ' O ' ' A' ' 225' ' ' ARG . 2.2 t -83.08 6.84 17.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.058 -176.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.207 -179.334 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.422 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.34 154.83 27.5 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.1 2.533 . . . . 0.0 112.051 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -88.98 124.83 34.63 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.156 0.503 . . . . 0.0 111.287 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 5.1 p -83.08 -17.16 44.12 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.492 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 109.98 122.41 4.46 Favored Glycine 0 N--CA 1.432 -1.626 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.471 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 -131.68 149.81 52.36 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 278' ' ' ASP . . . -125.83 132.04 52.3 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -175.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.565 ' HE ' HD13 ' A' ' 280' ' ' ILE . 29.9 ttm-85 -91.94 116.68 29.12 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 175.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 277' ' ' VAL . 9.1 p -76.35 144.21 12.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -177.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.497 ' NE2' ' HB2' ' A' ' 278' ' ' ASP . 98.9 m-70 -101.22 -32.24 10.62 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.879 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.5 m -130.64 137.49 49.62 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.22 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -60.46 145.92 46.58 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.308 0.575 . . . . 0.0 110.964 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.499 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 63.0 t80 -136.57 112.53 9.63 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.104 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 84.4 m -153.93 98.65 2.6 Favored Pre-proline 0 C--N 1.307 -1.246 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.903 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.2 -69.6 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.124 1.883 . . . . 0.0 110.06 177.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.9 t -143.14 144.69 29.68 Favored Pre-proline 0 N--CA 1.435 -1.182 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.93 -20.65 57.77 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 121.885 1.723 . . . . 0.0 109.773 173.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -94.7 23.31 5.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.303 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -120.32 130.22 54.34 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.692 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 18.2 p -129.61 19.98 5.64 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.119 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -99.65 -21.87 15.66 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.542 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.5 m -102.89 -175.22 2.75 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.863 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 47.0 tp -109.1 117.1 33.29 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? -90.94 113.56 25.82 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.499 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 32.7 pt -130.01 173.32 14.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.189 0.518 . . . . 0.0 110.739 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -120.74 -156.78 0.69 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -105.4 153.93 21.0 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.99 30.69 77.52 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.221 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.424 ' H ' ' CG1' ' A' ' 228' ' ' VAL . 11.3 m-20 -100.95 161.43 13.6 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 177.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 35.6 mm -116.88 91.69 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 49.3 mt -80.3 132.87 30.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.055 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -83.64 154.89 23.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 175.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.467 HG21 ' HG3' ' A' ' 255' ' ' LYS . 28.3 mt -134.27 133.36 55.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.592 -176.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 12.7 tt -110.03 -23.79 4.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.348 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.404 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 48.8 t -148.23 119.44 7.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.263 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.467 ' HG3' HG21 ' A' ' 252' ' ' ILE . 3.9 mppt? -100.54 103.14 14.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.713 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.585 ' HB ' ' O ' ' A' ' 260' ' ' MET . 44.2 m -97.52 102.54 13.17 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.23 33.83 0.25 Allowed 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.2 2.6 . . . . 0.0 113.925 -175.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 48.9 ttm -108.35 -30.44 8.32 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.018 0.437 . . . . 0.0 110.364 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 273' ' ' LYS . . . 168.33 -53.3 0.22 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.85 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' MET . . . . . 0.585 ' O ' ' HB ' ' A' ' 256' ' ' THR . 4.1 mpp? -101.95 135.12 44.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.989 0.423 . . . . 0.0 111.738 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.486 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 38.2 m0 -112.24 149.4 32.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.878 176.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 254' ' ' CYS . 5.9 m -96.77 114.03 25.64 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -139.48 -175.99 14.53 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.895 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 56.0 ttp -133.07 129.32 37.87 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.082 0.468 . . . . 0.0 111.013 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.536 HD13 ' N ' ' A' ' 266' ' ' ASN . 2.0 tm? -156.26 144.53 19.84 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ASN . . . . . 0.536 ' N ' HD13 ' A' ' 265' ' ' LEU . 0.0 OUTLIER 54.56 34.88 22.2 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.417 1.087 . . . . 0.0 112.928 179.176 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 266' ' ' ASN . 7.4 m120 75.06 13.97 3.2 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.069 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -130.48 134.54 47.16 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.416 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.3 p -95.97 132.4 40.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -164.59 -156.31 8.88 Favored Glycine 0 C--N 1.311 -0.848 0 C-N-CA 120.151 -1.024 . . . . 0.0 112.085 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 29.2 p30 -117.01 164.61 14.46 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.047 0.451 . . . . 0.0 111.39 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 260' ' ' MET . 50.3 p90 -170.4 154.56 4.78 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 259' ' ' GLY . 97.5 mttt -85.21 112.16 20.48 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 120.987 0.422 . . . . 0.0 110.101 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.464 ' HA ' HG22 ' A' ' 277' ' ' VAL . 33.5 p90 -58.67 -11.68 3.36 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -176.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 32.7 pt -61.26 -23.92 31.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.638 0.256 . . . . 0.0 111.281 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -89.44 -11.99 41.48 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.363 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 274' ' ' PHE . 10.3 m -113.4 -178.96 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.497 ' HB2' ' NE2' ' A' ' 229' ' ' HIS . 27.3 t70 -141.18 141.09 34.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.546 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 57.2 t -83.8 117.72 29.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.885 0.374 . . . . 0.0 110.852 -176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.565 HD13 ' HE ' ' A' ' 227' ' ' ARG . 37.0 pt -134.29 177.57 6.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.645 0.736 . . . . 0.0 111.472 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 24.6 m -142.05 7.12 1.8 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.596 174.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 C--O 1.249 1.072 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.375 -179.908 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 N-CA-C 111.724 -0.551 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.7 21.64 0.63 Allowed 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.302 2.668 . . . . 0.0 113.741 -176.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -87.2 96.72 10.42 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 85.9 m -80.21 46.07 0.79 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.644 -175.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -94.89 36.12 3.94 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 175.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -157.4 151.63 24.83 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 124.18 0.992 . . . . 0.0 108.466 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -144.82 147.03 32.39 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.143 0.497 . . . . 0.0 111.629 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -93.94 125.74 38.74 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.5 p -81.55 137.07 21.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 120.745 0.307 . . . . 0.0 110.483 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -113.4 0.85 14.89 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -175.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 83.1 m -140.15 139.42 35.75 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.621 0.248 . . . . 0.0 111.023 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -77.82 157.97 29.71 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.443 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 68.4 t80 178.52 103.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.047 0.451 . . . . 0.0 112.004 -176.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.449 ' OG1' ' HG2' ' A' ' 243' ' ' LYS . 5.1 t -136.45 116.49 11.0 Favored Pre-proline 0 N--CA 1.435 -1.213 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.983 172.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -53.99 -45.64 39.49 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.692 2.262 . . . . 0.0 111.282 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 238' ' ' ASP . 46.4 m -141.73 127.36 10.85 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.26 176.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.45 -27.91 83.02 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.766 2.311 . . . . 0.0 113.514 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -92.25 -27.07 17.85 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.542 ' HB2' ' HB2' ' A' ' 235' ' ' SER . 25.7 t70 -48.79 162.17 0.11 Allowed 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 2.9 m -143.13 -0.6 1.12 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.768 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -90.06 -48.59 7.1 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.837 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 69.4 m -74.36 -178.16 3.36 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 31.6 tp -107.17 110.97 23.17 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.941 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.449 ' HG2' ' OG1' ' A' ' 233' ' ' THR . 43.7 mtmt -86.56 101.56 13.33 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.776 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.443 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 29.6 pt -100.39 149.8 5.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.241 0.543 . . . . 0.0 111.341 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -108.82 162.25 14.36 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.488 -177.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -81.23 86.47 6.21 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.305 0.574 . . . . 0.0 111.217 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 107.48 72.5 0.79 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.62 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -147.94 -174.06 4.46 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 44.1 mm -117.59 124.94 73.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.99 0.424 . . . . 0.0 111.059 -176.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.481 HG12 HD12 ' A' ' 265' ' ' LEU . 55.0 mt -118.47 126.39 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.279 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ASP . . . . . 0.464 ' HB3' ' HB3' ' A' ' 264' ' ' MET . 26.3 t70 -76.39 167.21 22.26 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 73.2 mt -138.28 107.75 4.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 118.375 0.534 . . . . 0.0 109.924 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 50.9 pt -95.5 -8.31 9.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.117 0.484 . . . . 0.0 110.753 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.5 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 52.7 t -164.31 121.6 1.68 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.312 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.442 ' N ' ' HD3' ' A' ' 255' ' ' LYS . 0.1 OUTLIER -86.09 -94.87 0.08 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.371 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 30.1 p 49.11 90.59 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 123.299 0.639 . . . . 0.0 112.107 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -63.12 59.85 0.16 Allowed 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.673 2.915 . . . . 0.0 114.23 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 22.2 ptp -91.96 21.57 4.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.299 0.571 . . . . 0.0 109.942 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 105.09 -59.7 0.43 Allowed Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' MET . . . . . 0.423 ' HB3' ' HB2' ' A' ' 271' ' ' ASN . 3.8 mpp? -108.83 122.21 46.69 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.685 0.279 . . . . 0.0 111.107 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.442 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 19.9 m0 -87.62 168.62 12.87 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 175.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 254' ' ' CYS . 6.4 m -117.76 114.07 22.76 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 121.112 0.482 . . . . 0.0 110.092 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -136.63 -169.87 11.81 Favored Glycine 0 N--CA 1.431 -1.663 0 C-N-CA 120.155 -1.022 . . . . 0.0 112.78 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' MET . . . . . 0.464 ' HB3' ' HB3' ' A' ' 251' ' ' ASP . 50.8 ttp -134.67 125.0 26.22 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.942 0.401 . . . . 0.0 111.236 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.481 HD12 HG12 ' A' ' 250' ' ' ILE . 9.3 tt -135.18 129.78 34.3 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 62.13 38.96 13.39 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.861 0.464 . . . . 0.0 110.944 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 63.9 t30 70.74 2.91 4.34 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.827 0.851 . . . . 0.0 111.994 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 264' ' ' MET . 54.6 tttp -108.64 136.11 48.77 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.86 0.362 . . . . 0.0 111.502 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 6.4 p -89.94 135.38 26.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.915 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -160.27 178.58 36.25 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.256 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 17.8 p30 -108.11 145.31 34.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.903 0.383 . . . . 0.0 111.354 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -152.36 160.59 43.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.6 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.42 ' HE3' ' SD ' ' A' ' 260' ' ' MET . 9.1 mptt -78.04 109.09 11.81 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 176.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.508 ' O ' HG22 ' A' ' 277' ' ' VAL . 54.8 p90 -55.05 -26.41 37.27 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 27.4 pt -59.31 -19.77 16.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -89.54 -7.97 53.76 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 274' ' ' PHE . 15.6 m -109.48 172.28 2.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.064 0.459 . . . . 0.0 111.246 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -133.93 129.48 36.36 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.584 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 6.1 m -76.38 107.3 7.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.391 0.615 . . . . 0.0 111.806 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 2.8 pp -138.02 169.89 17.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.029 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 33.3 m -155.03 145.4 22.04 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.048 0.452 . . . . 0.0 111.843 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 . . . . . 0 C--O 1.249 1.048 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.715 178.37 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.329 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -78.36 161.9 28.4 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.591 2.194 . . . . 0.0 112.165 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -100.03 165.04 11.72 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.989 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 65.9 m -62.57 -36.99 84.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.241 0.543 . . . . 0.0 109.812 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.482 ' HA3' ' HB ' ' A' ' 252' ' ' ILE . . . 161.69 125.81 0.79 Allowed Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.82 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 -132.66 112.78 12.31 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.969 0.414 . . . . 0.0 110.636 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.498 ' HB2' HD11 ' A' ' 252' ' ' ILE . . . -132.62 148.48 52.36 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.595 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 45.5 ttt85 -107.23 122.31 46.27 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.6 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.46 133.17 30.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.012 0.434 . . . . 0.0 110.26 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -124.0 -24.24 4.44 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.152 0.501 . . . . 0.0 109.998 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.452 ' HB ' ' HA ' ' A' ' 276' ' ' TYR . 20.4 m -107.65 127.2 53.45 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 176.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -69.41 148.48 49.55 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.994 0.426 . . . . 0.0 110.578 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -145.19 103.91 3.9 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 3.8 t -152.61 114.97 2.83 Favored Pre-proline 0 N--CA 1.425 -1.714 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.611 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 233' ' ' THR . 6.8 Cg_exo -76.07 -156.54 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.402 2.068 . . . . 0.0 109.102 172.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.4 t -64.88 129.93 94.62 Favored Pre-proline 0 C--N 1.316 -0.885 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.09 -20.16 70.63 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.531 2.154 . . . . 0.0 111.595 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -65.69 -37.66 87.08 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.29 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -63.33 133.76 54.65 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 171.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.448 ' O ' ' HE2' ' A' ' 268' ' ' LYS . 30.3 m -104.55 -26.58 12.31 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -76.86 -48.31 18.74 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 3.7 m -59.72 131.62 51.46 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.776 0.322 . . . . 0.0 110.425 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 26.0 tp -72.89 107.95 5.57 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.592 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -100.05 108.89 21.18 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.251 0.548 . . . . 0.0 109.587 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 21.2 pt -108.53 178.71 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.663 -175.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -130.69 129.88 43.15 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -60.5 160.77 8.42 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.14 36.0 71.28 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.765 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -135.59 176.02 9.06 Favored 'General case' 0 C--N 1.318 -0.783 0 O-C-N 122.629 -0.336 . . . . 0.0 110.332 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 49.2 mm -108.29 130.68 60.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 34.2 mt -122.85 129.07 75.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 120.664 0.268 . . . . 0.0 110.819 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ASP . . . . . 0.415 ' O ' ' HA2' ' A' ' 263' ' ' GLY . 3.4 m-20 -80.0 133.92 36.2 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 226' ' ' ALA . 4.1 mt -99.09 102.44 13.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 48.4 mm -67.69 -60.66 2.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.018 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.401 ' C ' ' HD3' ' A' ' 255' ' ' LYS . 57.7 m -121.62 142.86 49.7 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.401 ' HD3' ' C ' ' A' ' 254' ' ' CYS . 3.2 mppt? -119.27 97.76 5.82 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.852 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.0 m -84.91 126.08 69.05 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -27.53 -77.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 125.112 3.875 . . . . 0.0 115.539 -175.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 46.4 ttm -31.12 -45.67 0.08 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 144.75 4.84 0.59 Allowed Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 119.793 -1.194 . . . . 0.0 112.731 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 72.5 mtm -78.35 106.02 9.99 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.431 0.634 . . . . 0.0 109.299 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -111.37 140.46 45.93 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.22 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' THR . . . . . 0.486 HG22 HG22 ' A' ' 269' ' ' VAL . 1.3 m -100.3 114.87 28.7 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 269' ' ' VAL . . . -108.96 173.91 17.87 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.952 -176.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 39.5 ttp -129.93 114.51 15.94 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.802 0.334 . . . . 0.0 110.355 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.64 143.62 11.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.328 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 63.5 38.02 10.11 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.965 0.412 . . . . 0.0 110.944 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 14.6 m120 65.07 16.33 10.5 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.48 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.448 ' HE2' ' O ' ' A' ' 239' ' ' THR . 63.3 tttp -135.59 141.9 45.21 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.824 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 263' ' ' GLY . 4.5 p -101.16 125.03 55.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -149.84 172.41 29.76 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.132 -1.033 . . . . 0.0 112.182 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -88.97 120.12 30.1 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -123.84 -178.82 4.16 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.758 175.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -109.34 143.74 38.45 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.081 0.467 . . . . 0.0 111.348 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -66.98 -14.28 62.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.734 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 36.3 pt -68.98 -21.97 25.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.801 -177.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' TYR . . . . . 0.452 ' HA ' ' HB ' ' A' ' 230' ' ' THR . 63.2 m-85 -90.04 -3.48 57.94 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.964 0.411 . . . . 0.0 111.186 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 33.8 m -132.16 166.71 28.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.79 140.02 46.67 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.042 174.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 16.3 m -80.79 119.47 30.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.385 0.612 . . . . 0.0 112.449 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 38.3 pt -95.92 -8.6 9.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.927 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 3.7 p -68.73 148.38 50.45 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.459 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.679 -0.677 . . . . 0.0 110.339 -178.455 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.869 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -71.64 -171.01 0.58 Allowed 'Trans proline' 0 C--O 1.239 0.54 0 C-N-CA 122.847 2.364 . . . . 0.0 111.731 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -74.32 109.44 7.8 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.096 0.474 . . . . 0.0 110.532 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 79.5 m -85.91 98.46 10.81 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.774 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -94.52 136.12 12.82 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.619 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -148.23 144.0 27.38 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 120.72 0.295 . . . . 0.0 110.388 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.484 ' HB2' HD11 ' A' ' 252' ' ' ILE . . . -139.24 126.81 21.76 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.016 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 47.9 ttp180 -75.57 112.56 12.04 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.503 HG21 HD12 ' A' ' 244' ' ' ILE . 6.5 p -73.65 149.11 8.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.809 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -109.63 -21.95 12.18 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.814 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.7 m -127.28 140.98 51.84 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.045 -174.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -74.02 173.86 9.43 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.426 ' HB2' HG12 ' A' ' 244' ' ' ILE . 16.6 t80 -141.85 123.34 14.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 38.2 m -134.75 97.19 14.23 Favored Pre-proline 0 C--N 1.309 -1.159 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.577 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -97.13 -165.2 0.09 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 123.255 2.637 . . . . 0.0 111.04 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 19.4 m -72.38 140.46 82.26 Favored Pre-proline 0 C--N 1.313 -0.999 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.77 -11.44 9.42 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.236 2.624 . . . . 0.0 114.007 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -113.62 -9.99 13.16 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.84 0.352 . . . . 0.0 110.93 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -58.45 125.93 25.41 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.938 0.399 . . . . 0.0 110.865 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 20.5 p -118.81 28.28 8.39 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.395 0.617 . . . . 0.0 110.144 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -114.38 -18.47 11.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.047 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 12.8 m -114.27 174.33 6.0 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.255 0.55 . . . . 0.0 111.38 -176.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 58.9 tp -115.41 118.64 33.77 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -78.36 88.13 4.38 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.203 0.525 . . . . 0.0 110.326 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.503 HD12 HG21 ' A' ' 228' ' ' VAL . 16.0 pt -94.91 156.25 3.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.535 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -104.14 172.17 6.94 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.471 ' O ' ' HD2' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -87.29 147.95 25.3 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 55.82 60.58 8.64 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.155 -177.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 227' ' ' ARG . 1.3 t70 -134.48 -169.83 2.42 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 37.6 mm -130.9 104.29 9.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -176.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 39.0 mt -86.99 129.79 37.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.336 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ASP . . . . . 0.475 ' HB3' ' HG2' ' A' ' 264' ' ' MET . 13.7 t70 -85.68 94.37 9.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.11 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.484 HD11 ' HB2' ' A' ' 226' ' ' ALA . 5.9 mt -74.12 120.65 23.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.386 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 18.0 pt -109.75 -21.78 5.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.064 0.459 . . . . 0.0 110.795 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.504 ' HB2' ' HB ' ' A' ' 262' ' ' THR . 56.6 m -146.31 142.01 27.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.756 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.85 171.72 7.87 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.064 0.459 . . . . 0.0 110.732 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 27.7 m -145.31 128.8 8.49 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.72 -42.7 29.9 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.932 2.421 . . . . 0.0 112.275 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 15.2 tpt -145.09 115.57 7.62 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.752 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 137.07 -132.76 6.13 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 119.956 -1.116 . . . . 0.0 113.372 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -107.17 143.76 34.89 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.048 0.452 . . . . 0.0 111.743 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -102.67 152.24 21.43 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.96 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' THR . . . . . 0.504 ' HB ' ' HB2' ' A' ' 254' ' ' CYS . 2.8 m -96.82 122.36 39.69 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.84 0.353 . . . . 0.0 110.176 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -154.87 166.07 32.33 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.652 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' MET . . . . . 0.475 ' HG2' ' HB3' ' A' ' 251' ' ' ASP . 23.0 ptp -113.61 146.61 39.46 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.202 0.525 . . . . 0.0 111.223 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.501 HD13 ' N ' ' A' ' 266' ' ' ASN . 1.4 tm? -147.17 142.24 27.1 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ASN . . . . . 0.501 ' N ' HD13 ' A' ' 265' ' ' LEU . 2.0 p-10 51.18 34.68 11.67 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.624 0.77 . . . . 0.0 111.907 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 66.89 20.81 10.51 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.462 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -119.46 136.26 54.39 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.0 p -96.13 143.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.028 0.442 . . . . 0.0 111.081 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -175.41 -150.41 7.92 Favored Glycine 0 N--CA 1.438 -1.167 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.803 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -130.96 165.45 23.11 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.946 0.403 . . . . 0.0 110.018 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -154.73 149.58 26.67 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.458 ' HB3' HG12 ' A' ' 275' ' ' ILE . 13.5 mptt -93.56 113.18 25.24 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.575 ' HA ' HG22 ' A' ' 277' ' ' VAL . 46.1 p90 -51.74 -9.03 0.07 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.458 HG12 ' HB3' ' A' ' 273' ' ' LYS . 45.8 pt -81.04 17.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.117 0.484 . . . . 0.0 109.906 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -137.67 12.54 2.95 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.575 HG22 ' HA ' ' A' ' 274' ' ' PHE . 9.9 m -138.74 178.56 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 121.09 0.471 . . . . 0.0 111.574 -174.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.44 118.13 14.02 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.344 176.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 15.8 m -75.45 104.79 3.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.637 0.732 . . . . 0.0 111.371 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 32.0 pt -81.69 2.17 2.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.376 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 11.3 m -66.86 -43.11 84.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.86 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.581 -0.723 . . . . 0.0 109.952 -179.746 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.418 ' N ' ' HG ' ' A' ' 223' ' ' CYS . . . . . . . . 0 N--CA 1.476 1.307 0 N-CA-C 112.437 -0.265 . . . . 0.0 112.437 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.57 -21.91 39.02 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.999 2.466 . . . . 0.0 112.854 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -84.41 -39.84 18.52 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.126 0.488 . . . . 0.0 109.767 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' CYS . . . . . 0.418 ' HG ' ' N ' ' A' ' 220' ' ' GLY . 29.7 m -64.59 -44.74 89.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.403 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 119.55 141.12 6.36 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -136.27 147.84 47.72 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.858 0.361 . . . . 0.0 110.494 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -132.52 147.58 52.36 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.552 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -97.66 116.96 30.89 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.674 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.41 ' HA ' HG12 ' A' ' 277' ' ' VAL . 3.4 p -80.79 113.92 20.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.206 0.527 . . . . 0.0 111.57 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -98.55 -22.81 15.79 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.716 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' A' ' 276' ' ' TYR . 59.6 m -122.45 127.35 49.51 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.512 ' HB3' ' HG3' ' A' ' 246' ' ' LYS . 5.1 p-10 -75.96 164.09 26.52 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.493 0.663 . . . . 0.0 111.721 -176.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -157.57 134.42 10.01 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.587 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 5.5 t -143.56 131.5 10.97 Favored Pre-proline 0 N--CA 1.433 -1.277 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.115 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.446 ' HB3' ' HB3' ' A' ' 241' ' ' SER . 89.6 Cg_endo -78.02 -176.41 3.23 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.343 2.029 . . . . 0.0 111.082 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 20.7 m -63.66 147.84 95.11 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.943 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -59.65 -12.8 18.95 Favored 'Trans proline' 0 N--CA 1.478 0.602 0 C-N-CA 122.852 2.368 . . . . 0.0 112.33 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -106.55 13.91 27.74 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.42 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -115.04 109.02 17.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.684 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 3.2 m -97.86 9.81 41.76 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.284 0.564 . . . . 0.0 110.403 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -91.47 -68.34 0.8 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.738 -176.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 234' ' ' PRO . 10.7 t -55.78 160.21 2.73 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.345 0.593 . . . . 0.0 112.034 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 23.3 tp -94.78 128.76 41.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.863 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -89.73 97.94 11.48 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.444 ' HA ' ' CD2' ' A' ' 265' ' ' LEU . 40.5 pt -96.83 137.32 24.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.311 0.576 . . . . 0.0 112.349 -175.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -115.31 108.1 16.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.571 -177.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.602 ' O ' ' HD2' ' A' ' 246' ' ' LYS . 0.1 OUTLIER -41.18 136.35 1.62 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 177.67 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 108.37 -8.59 35.31 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.57 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -109.87 -176.96 3.14 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 120.855 0.359 . . . . 0.0 110.902 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 30.3 mm -121.17 129.46 75.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 35.5 mt -107.7 133.11 53.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.422 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.58 149.66 26.42 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 9.0 mt -129.19 124.87 61.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.817 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 28.3 pt -106.49 -5.78 10.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.217 0.532 . . . . 0.0 110.631 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.414 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 40.4 t -155.86 110.4 2.88 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.32 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.423 ' N ' ' HD3' ' A' ' 255' ' ' LYS . 0.1 OUTLIER -96.14 90.55 5.55 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.668 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.589 ' HB ' ' O ' ' A' ' 260' ' ' MET . 20.5 m -89.28 116.82 67.34 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.358 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.02 12.9 0.41 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.034 2.489 . . . . 0.0 113.642 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 51.3 ttm -86.23 -26.95 24.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.744 0.307 . . . . 0.0 110.67 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 144.26 -34.58 1.62 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.446 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' MET . . . . . 0.589 ' O ' ' HB ' ' A' ' 256' ' ' THR . 1.7 pmm? -103.77 138.57 40.21 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.875 0.369 . . . . 0.0 110.826 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.526 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 32.2 m0 -119.37 135.16 54.86 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 254' ' ' CYS . 44.6 m -90.12 114.34 26.26 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.292 0.568 . . . . 0.0 109.47 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -132.54 -168.92 12.13 Favored Glycine 0 N--CA 1.426 -1.999 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.893 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 28.2 ttt -134.54 120.58 19.84 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.053 0.454 . . . . 0.0 110.773 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.444 ' CD2' ' HA ' ' A' ' 244' ' ' ILE . 39.9 tp -143.82 142.64 30.96 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 46.76 41.2 9.99 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.374 0.67 . . . . 0.0 112.422 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 66.0 t30 68.28 9.3 7.15 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.943 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -113.88 137.63 51.41 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.793 0.33 . . . . 0.0 110.673 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.7 p -102.32 137.28 30.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -172.35 174.51 45.53 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.116 -179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.526 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 7.9 p30 -110.68 103.11 11.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.609 0.718 . . . . 0.0 112.747 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -94.79 173.83 7.41 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.63 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.455 ' HB2' ' CE2' ' A' ' 276' ' ' TYR . 99.0 mttt -95.42 122.51 38.22 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.144 177.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' PHE . . . . . 0.462 ' HA ' HG22 ' A' ' 277' ' ' VAL . 44.2 p90 -61.4 -9.41 5.42 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.413 HG12 ' HB3' ' A' ' 273' ' ' LYS . 32.8 pt -68.63 -17.7 22.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 120.767 0.318 . . . . 0.0 110.939 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' A' ' 230' ' ' THR . 40.1 m-85 -95.67 -6.74 39.3 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-O 121.091 0.472 . . . . 0.0 110.808 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 274' ' ' PHE . 4.9 m -122.09 -178.98 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.223 0.535 . . . . 0.0 111.488 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.7 138.93 38.19 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.233 177.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 6.9 p -95.81 121.81 46.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-O 121.112 0.482 . . . . 0.0 110.544 -176.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.564 HD13 ' H ' ' A' ' 280' ' ' ILE . 0.2 OUTLIER -102.82 -5.63 9.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.978 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 20.6 m -84.62 104.98 15.08 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.009 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.623 -0.703 . . . . 0.0 109.624 179.549 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.785 0 N-CA-C 112.739 -0.144 . . . . 0.0 112.739 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -119.14 112.49 19.58 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -118.75 117.72 29.67 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.618 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -99.52 113.92 26.61 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 246' ' ' LYS . 2.5 p -77.19 112.73 15.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.401 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -93.56 -25.46 17.55 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.655 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.401 ' O ' ' HB3' ' A' ' 276' ' ' TYR . 85.6 m -117.54 117.79 30.39 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -66.72 149.74 50.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.474 0.654 . . . . 0.0 111.637 -177.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.478 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 53.3 t80 -147.29 129.52 15.64 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.647 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 9.7 t -137.78 129.13 16.08 Favored Pre-proline 0 N--CA 1.418 -2.027 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.81 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -91.17 -162.85 0.11 Allowed 'Trans proline' 0 N--CA 1.439 -1.721 0 C-N-CA 122.627 2.218 . . . . 0.0 109.778 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 17.5 m -69.99 128.17 91.88 Favored Pre-proline 0 N--CA 1.431 -1.406 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.94 -32.54 68.32 Favored 'Trans proline' 0 N--CA 1.477 0.529 0 C-N-CA 122.324 2.016 . . . . 0.0 111.897 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -89.55 23.61 2.56 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.098 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -109.77 114.5 28.14 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 16.7 m -70.83 -41.76 71.07 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.01 -74.16 0.05 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.446 ' HA ' ' ND2' ' A' ' 271' ' ' ASN . 8.9 m -49.56 145.98 4.52 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -176.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 53.9 tp -103.1 129.39 49.92 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.262 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.429 ' C ' ' HD3' ' A' ' 243' ' ' LYS . 1.4 tmtp? -82.44 105.41 13.48 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.478 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 44.0 pt -97.91 132.12 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-O 121.579 0.704 . . . . 0.0 110.545 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.15 108.08 16.16 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.743 -174.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 228' ' ' VAL . 26.0 pttm -38.29 120.24 0.88 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.637 0.732 . . . . 0.0 112.811 178.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 113.55 -6.06 24.56 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.677 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.62 166.03 11.53 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-O 121.087 0.47 . . . . 0.0 111.308 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 48.8 mm -114.95 117.28 55.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.552 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 26.9 mt -99.16 134.9 36.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.361 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . 0.536 ' OD2' ' HB2' ' A' ' 264' ' ' MET . 5.8 p-10 -91.65 145.94 24.18 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.406 HG21 ' HG3' ' A' ' 255' ' ' LYS . 11.4 mt -113.13 134.96 54.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 116.351 -0.386 . . . . 0.0 112.001 -171.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 46.8 mm -111.71 -25.51 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 121.445 0.64 . . . . 0.0 109.868 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 42.4 t -145.77 136.93 24.75 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.777 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.406 ' HG3' HG21 ' A' ' 252' ' ' ILE . 0.0 OUTLIER -129.17 133.5 47.61 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.948 178.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.7 t -147.96 130.64 7.85 Favored Pre-proline 0 C--N 1.307 -1.26 0 CA-C-O 120.882 0.372 . . . . 0.0 110.319 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.3 6.34 4.43 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.386 2.057 . . . . 0.0 111.892 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 25.2 ttt -90.56 -29.13 18.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.42 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -172.85 -145.32 4.96 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 119.925 -1.131 . . . . 0.0 113.121 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -66.95 158.88 29.7 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 122.717 0.407 . . . . 0.0 111.79 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -110.35 154.8 23.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.124 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 7.9 m -92.97 118.96 31.75 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.733 174.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -140.25 -171.0 12.22 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.514 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . 0.536 ' HB2' ' OD2' ' A' ' 251' ' ' ASP . 64.6 mtt -137.51 142.67 41.46 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.161 0.505 . . . . 0.0 110.603 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 35.1 tp -150.01 127.76 11.71 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 61.26 33.73 18.96 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -175.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 68.72 3.74 4.05 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.203 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -93.28 128.89 39.46 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 9.2 p -89.84 139.16 17.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -174.38 -165.03 30.27 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.302 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.446 ' ND2' ' HA ' ' A' ' 241' ' ' SER . 10.6 p30 -107.34 164.71 11.96 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.742 0.306 . . . . 0.0 110.637 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -169.56 146.89 3.44 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -96.23 121.02 37.56 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.762 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.425 ' HA ' HG22 ' A' ' 277' ' ' VAL . 42.0 p90 -55.89 -15.46 3.39 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 41.6 pt -68.44 -16.0 20.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.261 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 230' ' ' THR . 27.2 m-85 -98.81 -5.0 31.98 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.282 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' A' ' 274' ' ' PHE . 9.1 m -115.46 165.63 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.305 0.574 . . . . 0.0 112.09 -176.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -112.64 131.77 55.48 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.074 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 39.5 t -91.43 104.07 15.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.603 HD13 ' H ' ' A' ' 280' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.318 -0.78 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.183 -176.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.96 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.434 ' HG2' ' HA ' ' A' ' 251' ' ' ASP . 97.4 mtt180 -146.94 127.42 14.08 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -133.88 141.88 47.55 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.981 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.408 ' HG3' HD13 ' A' ' 249' ' ' ILE . 67.7 ttt180 -99.3 135.49 40.63 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 245' ' ' LYS . 1.6 p -86.5 129.02 38.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.267 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -115.38 -3.97 12.39 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 120.861 0.363 . . . . 0.0 111.322 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 17.7 m -128.7 124.85 36.69 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -58.15 166.23 1.67 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.397 0.618 . . . . 0.0 112.171 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.448 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 78.0 t80 -168.93 151.17 4.79 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.468 -175.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 86.1 m -151.71 123.45 3.85 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -51.15 142.48 35.5 Favored 'Trans proline' 0 C--O 1.238 0.52 0 C-N-CA 122.604 2.203 . . . . 0.0 111.222 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.4 m -53.75 148.91 17.91 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.215 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -52.58 -20.25 11.85 Favored 'Trans proline' 0 N--CA 1.482 0.832 0 C-N-CA 123.088 2.525 . . . . 0.0 113.456 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -117.69 17.76 14.3 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.141 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -120.26 131.09 54.78 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.2 0.524 . . . . 0.0 111.556 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 20.2 p -120.38 4.9 10.71 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.348 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -90.7 -28.4 18.36 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.588 -176.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 14.9 m -73.42 166.12 23.79 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.35 0.595 . . . . 0.0 111.546 -176.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 21.7 tp -101.89 147.82 26.07 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.576 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -98.32 100.33 11.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.796 0.332 . . . . 0.0 110.564 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.448 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 27.3 pt -111.32 150.38 13.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.502 ' O ' HG13 ' A' ' 228' ' ' VAL . 38.7 ttmt -137.69 155.91 48.59 Favored 'General case' 0 C--O 1.213 -0.837 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -62.12 95.83 0.07 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -173.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 145.82 -52.23 0.58 Allowed Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.938 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -38.2 151.99 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.408 HD13 ' HG3' ' A' ' 227' ' ' ARG . 34.6 mm -111.47 125.8 68.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.699 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 4.8 mp -114.56 116.83 53.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 120.459 -0.497 . . . . 0.0 111.478 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . 0.434 ' HA ' ' HG2' ' A' ' 225' ' ' ARG . 29.4 t70 -75.44 141.24 43.2 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 173.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 36.0 mt -115.69 123.56 71.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.867 -172.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 12.0 tt -90.67 -17.95 7.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.152 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 48.1 t -155.5 125.48 6.58 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -107.46 86.79 2.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.936 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.65 112.3 33.1 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.362 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.75 35.36 0.29 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.034 2.489 . . . . 0.0 114.079 -175.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 20.3 mmt -112.21 -70.71 0.79 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -156.39 -53.09 0.01 OUTLIER Glycine 0 C--O 1.237 0.304 0 C-N-CA 119.924 -1.131 . . . . 0.0 113.229 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -97.71 118.74 34.92 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.61 0.243 . . . . 0.0 111.017 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.454 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 29.6 m0 -91.03 -179.87 5.57 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 16.9 m -134.04 114.33 13.08 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 269' ' ' VAL . . . -132.41 -168.62 12.07 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.132 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 51.3 ttm -138.66 114.3 9.81 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.912 0.387 . . . . 0.0 110.263 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.512 ' HG ' ' ND2' ' A' ' 266' ' ' ASN . 45.0 tp -135.98 137.04 40.85 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . 0.512 ' ND2' ' HG ' ' A' ' 265' ' ' LEU . 61.5 m-80 60.62 33.83 20.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.198 0.523 . . . . 0.0 110.085 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 20.5 m120 70.8 1.21 3.64 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.114 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -101.82 130.33 48.24 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.665 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 263' ' ' GLY . 3.9 p -95.63 119.45 43.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -151.96 174.23 31.03 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.863 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 9.2 p30 -96.31 136.78 36.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.169 0.509 . . . . 0.0 111.729 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -143.02 152.3 41.76 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.637 178.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.402 ' HB3' HG12 ' A' ' 275' ' ' ILE . 98.5 mttt -78.56 122.51 25.99 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.39 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -58.64 -22.14 55.9 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.478 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.402 HG12 ' HB3' ' A' ' 273' ' ' LYS . 34.0 pt -54.0 -22.05 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -95.72 3.17 54.1 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.412 HG12 ' HB ' ' A' ' 228' ' ' VAL . 21.3 m -125.24 166.53 20.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.473 0.654 . . . . 0.0 112.572 -177.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -128.3 119.98 26.19 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.144 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 23.2 m -70.38 129.89 34.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.036 0.446 . . . . 0.0 111.345 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.509 HD13 ' H ' ' A' ' 280' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.947 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.799 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -133.94 172.79 12.32 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.81 123.12 46.32 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.498 ' HB2' HD13 ' A' ' 280' ' ' ILE . 26.5 ttm180 -94.22 124.61 38.35 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 277' ' ' VAL . 7.6 p -79.72 141.92 14.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.463 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -125.3 -7.36 7.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.863 0.364 . . . . 0.0 111.42 -176.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 58.7 m -131.04 127.26 37.9 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -66.46 156.55 34.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.282 0.563 . . . . 0.0 111.719 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.471 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 60.4 t80 -167.35 136.77 2.76 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.973 -176.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.49 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 7.4 t -154.67 136.27 9.27 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.927 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 233' ' ' THR . 1.5 Cg_endo -85.77 -154.06 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.683 2.256 . . . . 0.0 110.017 173.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 45.0 m -68.56 157.15 89.04 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 110.508 -0.182 . . . . 0.0 110.508 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -58.87 -39.73 78.59 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.466 2.111 . . . . 0.0 112.265 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -76.37 23.69 0.15 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -94.18 124.1 37.99 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.064 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 4.1 m -123.34 -16.05 6.99 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 120.864 0.364 . . . . 0.0 111.368 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -88.33 -22.4 23.86 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 10.8 m -89.46 -161.76 0.81 Allowed 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.647 -177.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.5 tp -136.54 105.94 6.09 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -78.27 109.32 12.29 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.238 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.471 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 16.3 pt -106.45 154.71 7.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.346 -176.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -123.7 -172.04 2.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.898 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -91.28 87.3 6.43 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.36 0.6 . . . . 0.0 112.509 -176.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 111.74 52.63 0.54 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.729 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -125.12 179.94 4.84 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 48.7 mm -118.58 123.58 71.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.886 0.374 . . . . 0.0 110.821 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 52.2 mt -115.39 126.08 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 121.056 0.455 . . . . 0.0 110.199 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . 0.515 ' HB3' ' HG2' ' A' ' 264' ' ' MET . 32.9 t70 -76.21 161.04 29.12 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 48.2 mt -128.83 122.8 57.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.966 -177.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 36.5 pt -110.89 -28.07 2.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.895 0.379 . . . . 0.0 110.873 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 53.9 t -145.97 122.63 11.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.096 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -92.74 96.18 10.01 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.504 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 32.1 m -71.74 141.34 84.71 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.26 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 256' ' ' THR . 26.0 Cg_exo -65.28 3.99 0.88 Allowed 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.955 2.437 . . . . 0.0 113.001 178.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 21.6 mmt -121.84 -171.9 2.33 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.629 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -71.96 -29.45 67.01 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.406 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 17.1 ptp -82.47 104.28 12.63 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.079 0.466 . . . . 0.0 111.65 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -97.37 163.09 13.03 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.654 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 2.4 m -112.45 119.3 37.75 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.362 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -154.99 -166.98 16.0 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.019 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . 0.515 ' HG2' ' HB3' ' A' ' 251' ' ' ASP . 20.3 ptt? -143.74 130.68 20.48 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.219 0.533 . . . . 0.0 111.444 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.507 HD22 HD22 ' A' ' 266' ' ' ASN . 6.4 tt -113.8 138.55 50.11 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . 0.507 HD22 HD22 ' A' ' 265' ' ' LEU . 10.7 p30 49.25 33.67 5.4 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.399 0.68 . . . . 0.0 111.082 -175.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.3 m120 71.49 13.43 6.45 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.88 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -102.61 123.22 45.94 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 13.7 p -81.79 134.13 27.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.224 0.535 . . . . 0.0 111.522 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -168.75 -177.07 39.41 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.669 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -97.67 143.26 28.51 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -139.65 145.07 37.99 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.11 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -85.44 118.8 25.19 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.051 0.453 . . . . 0.0 110.747 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.5 ' HA ' HG22 ' A' ' 277' ' ' VAL . 40.3 t80 -52.28 -32.95 39.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.279 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 24.8 pt -54.02 -26.22 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -93.96 -9.84 35.67 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.5 HG22 ' HA ' ' A' ' 274' ' ' PHE . 5.6 m -111.83 178.93 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.232 0.539 . . . . 0.0 112.358 -176.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -141.13 140.19 34.08 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.951 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 12.2 t -83.02 118.15 30.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.498 HD13 ' HB2' ' A' ' 227' ' ' ARG . 41.7 pt . . . . . 0 C--N 1.316 -0.867 0 CA-C-O 121.178 0.513 . . . . 0.0 111.493 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.843 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -91.49 164.26 13.86 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.883 0.373 . . . . 0.0 110.685 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -140.0 148.46 41.91 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.582 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -92.61 138.93 31.08 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.477 HG21 ' HB ' ' A' ' 244' ' ' ILE . 3.0 p -90.11 129.92 40.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.408 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -111.04 3.89 19.01 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 52.5 m -143.15 133.57 24.79 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.61 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -84.91 94.66 8.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.581 0.705 . . . . 0.0 111.705 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.443 ' H ' HG13 ' A' ' 244' ' ' ILE . 89.0 t80 -109.1 104.16 13.3 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.406 HG23 ' HB3' ' A' ' 243' ' ' LYS . 30.7 m -116.97 108.18 44.71 Favored Pre-proline 0 N--CA 1.434 -1.256 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.676 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.18 156.44 25.01 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 123.091 2.528 . . . . 0.0 112.134 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.8 m -62.38 151.72 81.74 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.827 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.18 -25.28 45.45 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.819 2.346 . . . . 0.0 113.029 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -74.73 -3.06 29.27 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.609 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -69.79 151.38 45.83 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.192 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 19.6 p -118.06 98.88 6.54 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 72.8 14.77 4.89 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 171.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 19.0 m -78.17 176.33 9.34 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 172.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 272' ' ' PHE . 22.6 tp -102.55 133.51 47.42 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.246 -0.981 . . . . 0.0 110.967 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.406 ' HB3' HG23 ' A' ' 233' ' ' THR . 88.9 mttt -99.91 108.15 20.31 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.438 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.477 ' HB ' HG21 ' A' ' 228' ' ' VAL . 24.0 pt -106.6 159.7 6.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-O 121.059 0.457 . . . . 0.0 111.508 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -128.31 164.34 22.84 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.864 -178.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -77.52 91.58 3.96 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.351 0.596 . . . . 0.0 112.003 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 105.9 82.01 1.5 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.231 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -161.67 174.44 13.29 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 46.6 mm -107.73 125.74 64.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 118.013 0.369 . . . . 0.0 110.42 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 36.3 mt -117.95 118.96 60.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.804 0.335 . . . . 0.0 111.367 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -79.6 151.51 30.58 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 173.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 54.4 mt -129.12 132.53 67.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 118.178 0.445 . . . . 0.0 110.842 -174.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 29.6 pt -116.13 -2.5 10.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.93 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.502 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 49.0 t -157.49 123.77 4.85 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -121.19 142.46 49.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.012 0.434 . . . . 0.0 111.208 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.7 p -124.51 159.13 59.18 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.92 -65.68 0.11 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.051 1.834 . . . . 0.0 111.661 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 58.7 mtm -138.51 115.73 11.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.311 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 156.78 -130.67 2.74 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.197 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -106.58 127.87 53.68 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.85 0.357 . . . . 0.0 111.417 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.529 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 45.0 m0 -92.81 176.75 6.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.478 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 254' ' ' CYS . 20.0 m -126.11 116.26 21.09 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.895 0.379 . . . . 0.0 109.994 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -138.81 -168.39 11.25 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.842 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -135.39 135.55 40.73 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.91 0.386 . . . . 0.0 110.655 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.9 142.85 12.29 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 62.94 34.47 14.1 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.894 0.477 . . . . 0.0 110.767 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 17.6 m120 69.35 16.58 8.32 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.813 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -130.5 140.99 50.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.788 0.327 . . . . 0.0 111.15 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.7 p -102.42 131.78 49.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -164.07 -175.66 35.16 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 119.883 -1.151 . . . . 0.0 112.827 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.529 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 7.6 p30 -101.68 137.23 40.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.85 0.357 . . . . 0.0 111.044 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' PHE . . . . . 0.445 ' HB3' ' HB3' ' A' ' 242' ' ' LEU . 43.9 p90 -136.78 162.56 32.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.73 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.447 ' HG3' HG12 ' A' ' 275' ' ' ILE . 22.2 tptm -79.5 114.26 18.29 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.493 ' O ' HG22 ' A' ' 277' ' ' VAL . 11.3 p90 -55.59 -31.06 61.9 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -174.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.447 HG12 ' HG3' ' A' ' 273' ' ' LYS . 18.9 pt -54.63 -25.97 15.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . 0.445 ' CD2' ' HB3' ' A' ' 273' ' ' LYS . 54.3 m-85 -84.59 3.76 35.32 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 274' ' ' PHE . 15.1 m -125.65 161.2 30.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.988 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -129.74 131.16 46.2 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.694 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 7.1 m -79.14 103.77 6.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.627 0.727 . . . . 0.0 110.294 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.562 HD13 ' H ' ' A' ' 280' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.315 -0.918 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.267 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.979 0 N-CA-C 112.331 -0.307 . . . . 0.0 112.331 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -159.28 151.95 21.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.802 0.334 . . . . 0.0 110.571 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -137.18 149.09 47.0 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.638 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -97.72 125.53 42.57 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 246' ' ' LYS . 3.7 p -81.82 111.82 18.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.264 0.554 . . . . 0.0 111.834 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -89.72 -17.6 27.99 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.543 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 276' ' ' TYR . 52.1 m -129.59 122.9 30.05 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -77.45 162.04 27.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.854 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -179.94 101.67 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.846 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 9.7 t -103.81 142.23 24.16 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 168.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.82 -70.05 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.735 1.624 . . . . 0.0 110.537 177.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 238' ' ' ASP . 19.3 m -144.2 156.45 57.84 Favored Pre-proline 0 C--N 1.311 -1.095 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 175.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -58.66 -42.63 52.03 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.203 1.935 . . . . 0.0 111.393 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -92.32 25.45 2.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.649 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.454 ' HB2' ' HB2' ' A' ' 235' ' ' SER . 14.6 t70 -130.09 139.67 50.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.166 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 2.8 m -142.63 25.96 1.79 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.953 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -74.81 -17.73 60.57 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.615 0.721 . . . . 0.0 110.71 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.608 ' HA ' ' OD1' ' A' ' 271' ' ' ASN . 30.2 m -117.25 -167.02 1.24 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.499 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 48.0 tp -99.52 131.09 45.75 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -84.17 96.21 8.88 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.433 ' HA ' HD13 ' A' ' 265' ' ' LEU . 43.0 pt -90.31 140.11 16.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-O 121.233 0.539 . . . . 0.0 110.855 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -135.34 102.94 5.32 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.863 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 228' ' ' VAL . 24.8 pttm -28.53 130.73 0.06 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.832 0.853 . . . . 0.0 113.264 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 97.96 12.53 46.16 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.804 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -124.63 172.71 9.04 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 48.6 mm -115.72 121.96 68.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.458 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 250' ' ' ILE . 4.4 mp -102.05 121.94 53.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.062 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . 0.499 ' HB3' ' CG ' ' A' ' 264' ' ' MET . 14.7 t70 -78.64 151.2 32.42 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 47.5 mt -126.87 131.76 70.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 120.949 0.404 . . . . 0.0 112.029 -173.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 7.7 tt -114.42 -32.6 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.008 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.532 ' HB2' ' HB ' ' A' ' 262' ' ' THR . 19.4 m -133.91 120.29 20.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.024 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.42 ' N ' ' HD3' ' A' ' 255' ' ' LYS . 0.0 OUTLIER -103.82 89.03 3.19 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.63 ' HB ' ' O ' ' A' ' 260' ' ' MET . 45.1 m -71.7 121.59 84.87 Favored Pre-proline 0 N--CA 1.441 -0.916 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.63 -68.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.263 2.642 . . . . 0.0 113.462 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 14.8 tpt -99.6 106.36 18.33 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.752 0.311 . . . . 0.0 111.524 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 131.49 -125.92 4.56 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.898 -1.144 . . . . 0.0 114.068 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' MET . . . . . 0.63 ' O ' ' HB ' ' A' ' 256' ' ' THR . 20.8 ptt? -107.54 158.21 17.41 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.438 -0.381 . . . . 0.0 111.289 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -105.9 154.86 19.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.09 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 254' ' ' CYS . 8.5 m -102.68 114.72 29.2 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 121.169 0.509 . . . . 0.0 110.085 176.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -139.16 -167.92 11.1 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.583 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . 0.499 ' CG ' ' HB3' ' A' ' 251' ' ' ASP . 22.9 ptp -140.56 134.39 30.5 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.214 0.531 . . . . 0.0 112.152 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 244' ' ' ILE . 0.8 OUTLIER -149.58 139.63 22.05 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . 0.427 ' H ' HD23 ' A' ' 265' ' ' LEU . 91.1 m-20 63.25 34.1 13.62 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.283 0.563 . . . . 0.0 110.24 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 69.5 12.12 8.15 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.722 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -117.93 133.45 55.91 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.99 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.3 p -91.77 135.48 27.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 174.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -166.77 -158.25 11.11 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.252 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.608 ' OD1' ' HA ' ' A' ' 241' ' ' SER . 20.2 p-10 -110.09 154.77 22.79 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.738 0.304 . . . . 0.0 111.081 -178.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -165.71 154.75 11.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.856 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.415 ' HB3' HG12 ' A' ' 275' ' ' ILE . 68.2 mttm -88.02 109.29 19.72 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.012 0.434 . . . . 0.0 110.264 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -54.5 -13.59 1.0 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.415 HG12 ' HB3' ' A' ' 273' ' ' LYS . 31.3 pt -65.42 -21.23 28.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.651 0.262 . . . . 0.0 111.665 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . 0.412 ' HB3' ' O ' ' A' ' 230' ' ' THR . 61.0 m-85 -91.37 -12.97 33.35 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-O 121.003 0.43 . . . . 0.0 111.265 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 15.3 m -107.3 177.62 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.066 0.46 . . . . 0.0 111.363 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -139.73 137.78 35.41 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 20.0 t -86.53 102.4 11.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.085 0.469 . . . . 0.0 110.564 -175.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 44.4 pt . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.097 -179.73 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.626 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 -131.68 149.81 52.36 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 278' ' ' ASP . . . -125.83 132.04 52.3 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -175.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.565 ' HE ' HD13 ' A' ' 280' ' ' ILE . 29.9 ttm-85 -91.94 116.68 29.12 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 175.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 277' ' ' VAL . 9.1 p -76.35 144.21 12.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -177.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.497 ' NE2' ' HB2' ' A' ' 278' ' ' ASP . 98.9 m-70 -101.22 -32.24 10.62 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.879 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.5 m -130.64 137.49 49.62 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.22 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -60.46 145.92 46.58 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.308 0.575 . . . . 0.0 110.964 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.499 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 63.0 t80 -136.57 112.53 9.63 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.104 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 84.4 m -153.93 98.65 2.6 Favored Pre-proline 0 C--N 1.307 -1.246 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.903 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.2 -69.6 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.124 1.883 . . . . 0.0 110.06 177.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.9 t -143.14 144.69 29.68 Favored Pre-proline 0 N--CA 1.435 -1.182 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.93 -20.65 57.77 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 121.885 1.723 . . . . 0.0 109.773 173.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -94.7 23.31 5.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.303 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -120.32 130.22 54.34 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.692 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 18.2 p -129.61 19.98 5.64 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.119 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -99.65 -21.87 15.66 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.542 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.5 m -102.89 -175.22 2.75 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.863 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 47.0 tp -109.1 117.1 33.29 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? -90.94 113.56 25.82 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.499 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 32.7 pt -130.01 173.32 14.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.189 0.518 . . . . 0.0 110.739 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -120.74 -156.78 0.69 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -105.4 153.93 21.0 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.99 30.69 77.52 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.221 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.424 ' H ' ' CG1' ' A' ' 228' ' ' VAL . 11.3 m-20 -100.95 161.43 13.6 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 177.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 35.6 mm -116.88 91.69 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 49.3 mt -80.3 132.87 30.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.055 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -83.64 154.89 23.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 175.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.467 HG21 ' HG3' ' A' ' 255' ' ' LYS . 28.3 mt -134.27 133.36 55.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.592 -176.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 12.7 tt -110.03 -23.79 4.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.348 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.404 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 48.8 t -148.23 119.44 7.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.263 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.467 ' HG3' HG21 ' A' ' 252' ' ' ILE . 3.9 mppt? -100.54 103.14 14.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.713 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.585 ' HB ' ' O ' ' A' ' 260' ' ' MET . 44.2 m -97.52 102.54 13.17 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.23 33.83 0.25 Allowed 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.2 2.6 . . . . 0.0 113.925 -175.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 48.9 ttm -108.35 -30.44 8.32 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.018 0.437 . . . . 0.0 110.364 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 273' ' ' LYS . . . 168.33 -53.3 0.22 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.85 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' MET . . . . . 0.585 ' O ' ' HB ' ' A' ' 256' ' ' THR . 4.1 mpp? -101.95 135.12 44.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.989 0.423 . . . . 0.0 111.738 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.486 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 38.2 m0 -112.24 149.4 32.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.878 176.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 254' ' ' CYS . 5.9 m -96.77 114.03 25.64 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -139.48 -175.99 14.53 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.895 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 56.0 ttp -133.07 129.32 37.87 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.082 0.468 . . . . 0.0 111.013 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.536 HD13 ' N ' ' A' ' 266' ' ' ASN . 2.0 tm? -156.26 144.53 19.84 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . 0.536 ' N ' HD13 ' A' ' 265' ' ' LEU . 0.0 OUTLIER 54.56 34.88 22.2 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.417 1.087 . . . . 0.0 112.928 179.176 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 266' ' ' ASN . 7.4 m120 75.06 13.97 3.2 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.069 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -130.48 134.54 47.16 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.416 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.3 p -95.97 132.4 40.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -164.59 -156.31 8.88 Favored Glycine 0 C--N 1.311 -0.848 0 C-N-CA 120.151 -1.024 . . . . 0.0 112.085 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 29.2 p30 -117.01 164.61 14.46 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.047 0.451 . . . . 0.0 111.39 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 260' ' ' MET . 50.3 p90 -170.4 154.56 4.78 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 259' ' ' GLY . 97.5 mttt -85.21 112.16 20.48 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 120.987 0.422 . . . . 0.0 110.101 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.464 ' HA ' HG22 ' A' ' 277' ' ' VAL . 33.5 p90 -58.67 -11.68 3.36 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -176.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 32.7 pt -61.26 -23.92 31.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.638 0.256 . . . . 0.0 111.281 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -89.44 -11.99 41.48 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.363 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 274' ' ' PHE . 10.3 m -113.4 -178.96 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.497 ' HB2' ' NE2' ' A' ' 229' ' ' HIS . 27.3 t70 -141.18 141.09 34.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.546 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 57.2 t -83.8 117.72 29.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.885 0.374 . . . . 0.0 110.852 -176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.565 HD13 ' HE ' ' A' ' 227' ' ' ARG . 37.0 pt . . . . . 0 C--N 1.317 -0.814 0 CA-C-O 121.645 0.736 . . . . 0.0 111.472 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.467 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -157.4 151.63 24.83 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 124.18 0.992 . . . . 0.0 108.466 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -144.82 147.03 32.39 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.143 0.497 . . . . 0.0 111.629 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -93.94 125.74 38.74 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.5 p -81.55 137.07 21.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 120.745 0.307 . . . . 0.0 110.483 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -113.4 0.85 14.89 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -175.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 83.1 m -140.15 139.42 35.75 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.621 0.248 . . . . 0.0 111.023 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -77.82 157.97 29.71 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.443 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 68.4 t80 178.52 103.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.047 0.451 . . . . 0.0 112.004 -176.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.449 ' OG1' ' HG2' ' A' ' 243' ' ' LYS . 5.1 t -136.45 116.49 11.0 Favored Pre-proline 0 N--CA 1.435 -1.213 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.983 172.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -53.99 -45.64 39.49 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.692 2.262 . . . . 0.0 111.282 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 238' ' ' ASP . 46.4 m -141.73 127.36 10.85 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.26 176.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.45 -27.91 83.02 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.766 2.311 . . . . 0.0 113.514 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -92.25 -27.07 17.85 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.542 ' HB2' ' HB2' ' A' ' 235' ' ' SER . 25.7 t70 -48.79 162.17 0.11 Allowed 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 2.9 m -143.13 -0.6 1.12 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.768 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -90.06 -48.59 7.1 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.837 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 69.4 m -74.36 -178.16 3.36 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 31.6 tp -107.17 110.97 23.17 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.941 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.449 ' HG2' ' OG1' ' A' ' 233' ' ' THR . 43.7 mtmt -86.56 101.56 13.33 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.776 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.443 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 29.6 pt -100.39 149.8 5.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.241 0.543 . . . . 0.0 111.341 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -108.82 162.25 14.36 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.488 -177.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -81.23 86.47 6.21 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.305 0.574 . . . . 0.0 111.217 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 107.48 72.5 0.79 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.62 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -147.94 -174.06 4.46 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 44.1 mm -117.59 124.94 73.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.99 0.424 . . . . 0.0 111.059 -176.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.481 HG12 HD12 ' A' ' 265' ' ' LEU . 55.0 mt -118.47 126.39 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.279 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . 0.464 ' HB3' ' HB3' ' A' ' 264' ' ' MET . 26.3 t70 -76.39 167.21 22.26 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 73.2 mt -138.28 107.75 4.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 118.375 0.534 . . . . 0.0 109.924 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 50.9 pt -95.5 -8.31 9.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.117 0.484 . . . . 0.0 110.753 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.5 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 52.7 t -164.31 121.6 1.68 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.312 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.442 ' N ' ' HD3' ' A' ' 255' ' ' LYS . 0.1 OUTLIER -86.09 -94.87 0.08 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.371 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 30.1 p 49.11 90.59 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 123.299 0.639 . . . . 0.0 112.107 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -63.12 59.85 0.16 Allowed 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.673 2.915 . . . . 0.0 114.23 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 22.2 ptp -91.96 21.57 4.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.299 0.571 . . . . 0.0 109.942 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 105.09 -59.7 0.43 Allowed Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' MET . . . . . 0.423 ' HB3' ' HB2' ' A' ' 271' ' ' ASN . 3.8 mpp? -108.83 122.21 46.69 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.685 0.279 . . . . 0.0 111.107 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.442 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 19.9 m0 -87.62 168.62 12.87 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 175.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 254' ' ' CYS . 6.4 m -117.76 114.07 22.76 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 121.112 0.482 . . . . 0.0 110.092 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -136.63 -169.87 11.81 Favored Glycine 0 N--CA 1.431 -1.663 0 C-N-CA 120.155 -1.022 . . . . 0.0 112.78 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . 0.464 ' HB3' ' HB3' ' A' ' 251' ' ' ASP . 50.8 ttp -134.67 125.0 26.22 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.942 0.401 . . . . 0.0 111.236 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.481 HD12 HG12 ' A' ' 250' ' ' ILE . 9.3 tt -135.18 129.78 34.3 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 62.13 38.96 13.39 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.861 0.464 . . . . 0.0 110.944 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 63.9 t30 70.74 2.91 4.34 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.827 0.851 . . . . 0.0 111.994 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 264' ' ' MET . 54.6 tttp -108.64 136.11 48.77 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.86 0.362 . . . . 0.0 111.502 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 6.4 p -89.94 135.38 26.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.915 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -160.27 178.58 36.25 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.256 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 17.8 p30 -108.11 145.31 34.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.903 0.383 . . . . 0.0 111.354 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -152.36 160.59 43.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.6 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.42 ' HE3' ' SD ' ' A' ' 260' ' ' MET . 9.1 mptt -78.04 109.09 11.81 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 176.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.508 ' O ' HG22 ' A' ' 277' ' ' VAL . 54.8 p90 -55.05 -26.41 37.27 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 27.4 pt -59.31 -19.77 16.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -89.54 -7.97 53.76 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 274' ' ' PHE . 15.6 m -109.48 172.28 2.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.064 0.459 . . . . 0.0 111.246 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -133.93 129.48 36.36 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.584 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 6.1 m -76.38 107.3 7.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.391 0.615 . . . . 0.0 111.806 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--N 1.319 -0.723 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.029 -179.833 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.482 ' HA3' ' HB ' ' A' ' 252' ' ' ILE . . . . . . . . 0 N--CA 1.435 -1.421 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 -132.66 112.78 12.31 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.969 0.414 . . . . 0.0 110.636 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.498 ' HB2' HD11 ' A' ' 252' ' ' ILE . . . -132.62 148.48 52.36 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.595 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 45.5 ttt85 -107.23 122.31 46.27 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.6 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.46 133.17 30.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.012 0.434 . . . . 0.0 110.26 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -124.0 -24.24 4.44 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.152 0.501 . . . . 0.0 109.998 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.452 ' HB ' ' HA ' ' A' ' 276' ' ' TYR . 20.4 m -107.65 127.2 53.45 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 176.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -69.41 148.48 49.55 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.994 0.426 . . . . 0.0 110.578 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -145.19 103.91 3.9 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 3.8 t -152.61 114.97 2.83 Favored Pre-proline 0 N--CA 1.425 -1.714 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.611 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 233' ' ' THR . 6.8 Cg_exo -76.07 -156.54 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.402 2.068 . . . . 0.0 109.102 172.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.4 t -64.88 129.93 94.62 Favored Pre-proline 0 C--N 1.316 -0.885 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.09 -20.16 70.63 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.531 2.154 . . . . 0.0 111.595 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -65.69 -37.66 87.08 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.29 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -63.33 133.76 54.65 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 171.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.448 ' O ' ' HE2' ' A' ' 268' ' ' LYS . 30.3 m -104.55 -26.58 12.31 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -76.86 -48.31 18.74 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 3.7 m -59.72 131.62 51.46 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.776 0.322 . . . . 0.0 110.425 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 26.0 tp -72.89 107.95 5.57 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.592 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -100.05 108.89 21.18 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.251 0.548 . . . . 0.0 109.587 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 21.2 pt -108.53 178.71 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.663 -175.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -130.69 129.88 43.15 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -60.5 160.77 8.42 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.14 36.0 71.28 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.765 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -135.59 176.02 9.06 Favored 'General case' 0 C--N 1.318 -0.783 0 O-C-N 122.629 -0.336 . . . . 0.0 110.332 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 49.2 mm -108.29 130.68 60.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 34.2 mt -122.85 129.07 75.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 120.664 0.268 . . . . 0.0 110.819 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . 0.415 ' O ' ' HA2' ' A' ' 263' ' ' GLY . 3.4 m-20 -80.0 133.92 36.2 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 226' ' ' ALA . 4.1 mt -99.09 102.44 13.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 48.4 mm -67.69 -60.66 2.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.018 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.401 ' C ' ' HD3' ' A' ' 255' ' ' LYS . 57.7 m -121.62 142.86 49.7 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.401 ' HD3' ' C ' ' A' ' 254' ' ' CYS . 3.2 mppt? -119.27 97.76 5.82 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.852 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.0 m -84.91 126.08 69.05 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -27.53 -77.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 125.112 3.875 . . . . 0.0 115.539 -175.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 46.4 ttm -31.12 -45.67 0.08 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 144.75 4.84 0.59 Allowed Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 119.793 -1.194 . . . . 0.0 112.731 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 72.5 mtm -78.35 106.02 9.99 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.431 0.634 . . . . 0.0 109.299 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -111.37 140.46 45.93 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.22 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . 0.486 HG22 HG22 ' A' ' 269' ' ' VAL . 1.3 m -100.3 114.87 28.7 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 269' ' ' VAL . . . -108.96 173.91 17.87 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.952 -176.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 39.5 ttp -129.93 114.51 15.94 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.802 0.334 . . . . 0.0 110.355 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.64 143.62 11.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.328 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 63.5 38.02 10.11 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.965 0.412 . . . . 0.0 110.944 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 14.6 m120 65.07 16.33 10.5 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.48 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.448 ' HE2' ' O ' ' A' ' 239' ' ' THR . 63.3 tttp -135.59 141.9 45.21 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.824 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 263' ' ' GLY . 4.5 p -101.16 125.03 55.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -149.84 172.41 29.76 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.132 -1.033 . . . . 0.0 112.182 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -88.97 120.12 30.1 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -123.84 -178.82 4.16 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.758 175.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -109.34 143.74 38.45 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.081 0.467 . . . . 0.0 111.348 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -66.98 -14.28 62.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.734 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 36.3 pt -68.98 -21.97 25.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.801 -177.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . 0.452 ' HA ' ' HB ' ' A' ' 230' ' ' THR . 63.2 m-85 -90.04 -3.48 57.94 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.964 0.411 . . . . 0.0 111.186 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 33.8 m -132.16 166.71 28.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.79 140.02 46.67 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.042 174.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 16.3 m -80.79 119.47 30.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.385 0.612 . . . . 0.0 112.449 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 38.3 pt . . . . . 0 C--N 1.321 -0.639 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.927 178.483 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.441 0 N-CA-C 111.619 -0.592 . . . . 0.0 111.619 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -148.23 144.0 27.38 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 120.72 0.295 . . . . 0.0 110.388 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.484 ' HB2' HD11 ' A' ' 252' ' ' ILE . . . -139.24 126.81 21.76 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.016 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 47.9 ttp180 -75.57 112.56 12.04 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.503 HG21 HD12 ' A' ' 244' ' ' ILE . 6.5 p -73.65 149.11 8.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.809 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -109.63 -21.95 12.18 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.814 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.7 m -127.28 140.98 51.84 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.045 -174.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -74.02 173.86 9.43 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.426 ' HB2' HG12 ' A' ' 244' ' ' ILE . 16.6 t80 -141.85 123.34 14.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 38.2 m -134.75 97.19 14.23 Favored Pre-proline 0 C--N 1.309 -1.159 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.577 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -97.13 -165.2 0.09 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 123.255 2.637 . . . . 0.0 111.04 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 19.4 m -72.38 140.46 82.26 Favored Pre-proline 0 C--N 1.313 -0.999 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.77 -11.44 9.42 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.236 2.624 . . . . 0.0 114.007 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -113.62 -9.99 13.16 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.84 0.352 . . . . 0.0 110.93 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -58.45 125.93 25.41 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.938 0.399 . . . . 0.0 110.865 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 20.5 p -118.81 28.28 8.39 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.395 0.617 . . . . 0.0 110.144 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -114.38 -18.47 11.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.047 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 12.8 m -114.27 174.33 6.0 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.255 0.55 . . . . 0.0 111.38 -176.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 58.9 tp -115.41 118.64 33.77 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -78.36 88.13 4.38 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.203 0.525 . . . . 0.0 110.326 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.503 HD12 HG21 ' A' ' 228' ' ' VAL . 16.0 pt -94.91 156.25 3.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.535 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -104.14 172.17 6.94 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.471 ' O ' ' HD2' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -87.29 147.95 25.3 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 55.82 60.58 8.64 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.155 -177.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 227' ' ' ARG . 1.3 t70 -134.48 -169.83 2.42 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 37.6 mm -130.9 104.29 9.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -176.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 39.0 mt -86.99 129.79 37.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.336 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . 0.475 ' HB3' ' HG2' ' A' ' 264' ' ' MET . 13.7 t70 -85.68 94.37 9.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.11 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.484 HD11 ' HB2' ' A' ' 226' ' ' ALA . 5.9 mt -74.12 120.65 23.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.386 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 18.0 pt -109.75 -21.78 5.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.064 0.459 . . . . 0.0 110.795 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.504 ' HB2' ' HB ' ' A' ' 262' ' ' THR . 56.6 m -146.31 142.01 27.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.756 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.85 171.72 7.87 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.064 0.459 . . . . 0.0 110.732 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 27.7 m -145.31 128.8 8.49 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.72 -42.7 29.9 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.932 2.421 . . . . 0.0 112.275 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 15.2 tpt -145.09 115.57 7.62 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.752 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 137.07 -132.76 6.13 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 119.956 -1.116 . . . . 0.0 113.372 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -107.17 143.76 34.89 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.048 0.452 . . . . 0.0 111.743 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -102.67 152.24 21.43 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.96 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . 0.504 ' HB ' ' HB2' ' A' ' 254' ' ' CYS . 2.8 m -96.82 122.36 39.69 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.84 0.353 . . . . 0.0 110.176 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -154.87 166.07 32.33 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.652 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . 0.475 ' HG2' ' HB3' ' A' ' 251' ' ' ASP . 23.0 ptp -113.61 146.61 39.46 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.202 0.525 . . . . 0.0 111.223 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.501 HD13 ' N ' ' A' ' 266' ' ' ASN . 1.4 tm? -147.17 142.24 27.1 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . 0.501 ' N ' HD13 ' A' ' 265' ' ' LEU . 11.1 p30 51.18 34.68 11.67 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.624 0.77 . . . . 0.0 111.907 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 15.8 m120 66.89 20.81 10.51 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.462 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -119.46 136.26 54.39 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.0 p -96.13 143.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.028 0.442 . . . . 0.0 111.081 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -175.41 -150.41 7.92 Favored Glycine 0 N--CA 1.438 -1.167 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.803 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -130.96 165.45 23.11 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.946 0.403 . . . . 0.0 110.018 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -154.73 149.58 26.67 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.458 ' HB3' HG12 ' A' ' 275' ' ' ILE . 13.5 mptt -93.56 113.18 25.24 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.575 ' HA ' HG22 ' A' ' 277' ' ' VAL . 46.1 p90 -51.74 -9.03 0.07 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.458 HG12 ' HB3' ' A' ' 273' ' ' LYS . 45.8 pt -81.04 17.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.117 0.484 . . . . 0.0 109.906 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -137.67 12.54 2.95 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.575 HG22 ' HA ' ' A' ' 274' ' ' PHE . 9.9 m -138.74 178.56 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 121.09 0.471 . . . . 0.0 111.574 -174.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.44 118.13 14.02 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.344 176.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 15.8 m -75.45 104.79 3.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.637 0.732 . . . . 0.0 111.371 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 32.0 pt . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.376 -178.389 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.929 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -136.27 147.84 47.72 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.858 0.361 . . . . 0.0 110.494 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -132.52 147.58 52.36 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.552 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -97.66 116.96 30.89 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.674 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.41 ' HA ' HG12 ' A' ' 277' ' ' VAL . 3.4 p -80.79 113.92 20.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.206 0.527 . . . . 0.0 111.57 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -98.55 -22.81 15.79 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.716 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' A' ' 276' ' ' TYR . 59.6 m -122.45 127.35 49.51 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.512 ' HB3' ' HG3' ' A' ' 246' ' ' LYS . 5.1 p-10 -75.96 164.09 26.52 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.493 0.663 . . . . 0.0 111.721 -176.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -157.57 134.42 10.01 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.587 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 5.5 t -143.56 131.5 10.97 Favored Pre-proline 0 N--CA 1.433 -1.277 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.115 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.446 ' HB3' ' HB3' ' A' ' 241' ' ' SER . 89.6 Cg_endo -78.02 -176.41 3.23 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.343 2.029 . . . . 0.0 111.082 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 20.7 m -63.66 147.84 95.11 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.943 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -59.65 -12.8 18.95 Favored 'Trans proline' 0 N--CA 1.478 0.602 0 C-N-CA 122.852 2.368 . . . . 0.0 112.33 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -106.55 13.91 27.74 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.42 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -115.04 109.02 17.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.684 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 3.2 m -97.86 9.81 41.76 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.284 0.564 . . . . 0.0 110.403 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -91.47 -68.34 0.8 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.738 -176.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 234' ' ' PRO . 10.7 t -55.78 160.21 2.73 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.345 0.593 . . . . 0.0 112.034 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 23.3 tp -94.78 128.76 41.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.863 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -89.73 97.94 11.48 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.444 ' HA ' ' CD2' ' A' ' 265' ' ' LEU . 40.5 pt -96.83 137.32 24.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.311 0.576 . . . . 0.0 112.349 -175.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -115.31 108.1 16.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.571 -177.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.602 ' O ' ' HD2' ' A' ' 246' ' ' LYS . 0.1 OUTLIER -41.18 136.35 1.62 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 177.67 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 108.37 -8.59 35.31 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.57 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -109.87 -176.96 3.14 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 120.855 0.359 . . . . 0.0 110.902 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 30.3 mm -121.17 129.46 75.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 35.5 mt -107.7 133.11 53.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.422 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.58 149.66 26.42 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 9.0 mt -129.19 124.87 61.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.817 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 28.3 pt -106.49 -5.78 10.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.217 0.532 . . . . 0.0 110.631 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.414 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 40.4 t -155.86 110.4 2.88 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.32 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.423 ' N ' ' HD3' ' A' ' 255' ' ' LYS . 0.1 OUTLIER -96.14 90.55 5.55 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.589 ' HB ' ' O ' ' A' ' 260' ' ' MET . 20.5 m -89.28 116.82 67.34 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.358 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.02 12.9 0.41 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.034 2.489 . . . . 0.0 113.642 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 51.3 ttm -86.23 -26.95 24.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.744 0.307 . . . . 0.0 110.67 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 144.26 -34.58 1.62 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.446 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' MET . . . . . 0.589 ' O ' ' HB ' ' A' ' 256' ' ' THR . 1.7 pmm? -103.77 138.57 40.21 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.875 0.369 . . . . 0.0 110.826 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.526 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 32.2 m0 -119.37 135.16 54.86 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 254' ' ' CYS . 44.6 m -90.12 114.34 26.26 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.292 0.568 . . . . 0.0 109.47 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -132.54 -168.92 12.13 Favored Glycine 0 N--CA 1.426 -1.999 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.893 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 28.2 ttt -134.54 120.58 19.84 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.053 0.454 . . . . 0.0 110.773 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.444 ' CD2' ' HA ' ' A' ' 244' ' ' ILE . 39.9 tp -143.82 142.64 30.96 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 7.5 p30 46.76 41.2 9.99 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.374 0.67 . . . . 0.0 112.422 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 66.0 t30 68.28 9.3 7.15 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.943 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -113.88 137.63 51.41 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.793 0.33 . . . . 0.0 110.673 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.7 p -102.32 137.28 30.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -172.35 174.51 45.53 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.116 -179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.526 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 7.9 p30 -110.68 103.11 11.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.609 0.718 . . . . 0.0 112.747 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -94.79 173.83 7.41 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.63 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.455 ' HB2' ' CE2' ' A' ' 276' ' ' TYR . 99.0 mttt -95.42 122.51 38.22 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.144 177.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' PHE . . . . . 0.462 ' HA ' HG22 ' A' ' 277' ' ' VAL . 44.2 p90 -61.4 -9.41 5.42 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.413 HG12 ' HB3' ' A' ' 273' ' ' LYS . 32.8 pt -68.63 -17.7 22.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 120.767 0.318 . . . . 0.0 110.939 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' A' ' 230' ' ' THR . 40.1 m-85 -95.67 -6.74 39.3 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-O 121.091 0.472 . . . . 0.0 110.808 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 274' ' ' PHE . 4.9 m -122.09 -178.98 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.223 0.535 . . . . 0.0 111.488 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.7 138.93 38.19 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.233 177.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 6.9 p -95.81 121.81 46.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-O 121.112 0.482 . . . . 0.0 110.544 -176.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.564 HD13 ' H ' ' A' ' 280' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.318 -0.762 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.978 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.434 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.87 144.31 82.7 Favored 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 122.579 2.186 . . . . 0.0 111.604 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -83.45 96.39 8.56 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.255 0.55 . . . . 0.0 110.822 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 252' ' ' ILE . 52.6 t -88.71 111.42 21.94 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.784 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -95.05 -173.28 37.47 Favored Glycine 0 C--N 1.31 -0.879 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.739 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -119.14 112.49 19.58 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -118.75 117.72 29.67 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.618 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -99.52 113.92 26.61 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 246' ' ' LYS . 2.5 p -77.19 112.73 15.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.401 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -93.56 -25.46 17.55 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.655 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.401 ' O ' ' HB3' ' A' ' 276' ' ' TYR . 85.6 m -117.54 117.79 30.39 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -66.72 149.74 50.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.474 0.654 . . . . 0.0 111.637 -177.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.478 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 53.3 t80 -147.29 129.52 15.64 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.647 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 9.7 t -137.78 129.13 16.08 Favored Pre-proline 0 N--CA 1.418 -2.027 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.81 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -91.17 -162.85 0.11 Allowed 'Trans proline' 0 N--CA 1.439 -1.721 0 C-N-CA 122.627 2.218 . . . . 0.0 109.778 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 17.5 m -69.99 128.17 91.88 Favored Pre-proline 0 N--CA 1.431 -1.406 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.94 -32.54 68.32 Favored 'Trans proline' 0 N--CA 1.477 0.529 0 C-N-CA 122.324 2.016 . . . . 0.0 111.897 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -89.55 23.61 2.56 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.098 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -109.77 114.5 28.14 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 16.7 m -70.83 -41.76 71.07 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.01 -74.16 0.05 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.446 ' HA ' ' ND2' ' A' ' 271' ' ' ASN . 8.9 m -49.56 145.98 4.52 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -176.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 53.9 tp -103.1 129.39 49.92 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.262 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.429 ' C ' ' HD3' ' A' ' 243' ' ' LYS . 1.4 tmtp? -82.44 105.41 13.48 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.478 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 44.0 pt -97.91 132.12 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-O 121.579 0.704 . . . . 0.0 110.545 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.15 108.08 16.16 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.743 -174.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 228' ' ' VAL . 26.0 pttm -38.29 120.24 0.88 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.637 0.732 . . . . 0.0 112.811 178.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 113.55 -6.06 24.56 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.677 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.62 166.03 11.53 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-O 121.087 0.47 . . . . 0.0 111.308 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 48.8 mm -114.95 117.28 55.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.552 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 26.9 mt -99.16 134.9 36.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.361 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . 0.552 ' HB2' ' SG ' ' A' ' 223' ' ' CYS . 5.8 p-10 -91.65 145.94 24.18 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 223' ' ' CYS . 11.4 mt -113.13 134.96 54.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 116.351 -0.386 . . . . 0.0 112.001 -171.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 46.8 mm -111.71 -25.51 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 121.445 0.64 . . . . 0.0 109.868 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 42.4 t -145.77 136.93 24.75 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.777 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.406 ' HG3' HG21 ' A' ' 252' ' ' ILE . 0.0 OUTLIER -129.17 133.5 47.61 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.948 178.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.7 t -147.96 130.64 7.85 Favored Pre-proline 0 C--N 1.307 -1.26 0 CA-C-O 120.882 0.372 . . . . 0.0 110.319 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.3 6.34 4.43 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.386 2.057 . . . . 0.0 111.892 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 25.2 ttt -90.56 -29.13 18.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.42 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -172.85 -145.32 4.96 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 119.925 -1.131 . . . . 0.0 113.121 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -66.95 158.88 29.7 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 122.717 0.407 . . . . 0.0 111.79 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -110.35 154.8 23.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.124 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 7.9 m -92.97 118.96 31.75 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.733 174.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -140.25 -171.0 12.22 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.514 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . 0.536 ' HB2' ' OD2' ' A' ' 251' ' ' ASP . 64.6 mtt -137.51 142.67 41.46 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.161 0.505 . . . . 0.0 110.603 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 35.1 tp -150.01 127.76 11.71 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 61.26 33.73 18.96 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -175.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 68.72 3.74 4.05 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.203 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -93.28 128.89 39.46 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 9.2 p -89.84 139.16 17.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -174.38 -165.03 30.27 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.302 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.446 ' ND2' ' HA ' ' A' ' 241' ' ' SER . 10.6 p30 -107.34 164.71 11.96 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.742 0.306 . . . . 0.0 110.637 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -169.56 146.89 3.44 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -96.23 121.02 37.56 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.762 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.425 ' HA ' HG22 ' A' ' 277' ' ' VAL . 42.0 p90 -55.89 -15.46 3.39 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 41.6 pt -68.44 -16.0 20.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.261 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 230' ' ' THR . 27.2 m-85 -98.81 -5.0 31.98 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.282 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' A' ' 274' ' ' PHE . 9.1 m -115.46 165.63 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.305 0.574 . . . . 0.0 112.09 -176.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -112.64 131.77 55.48 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.074 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 39.5 t -91.43 104.07 15.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.603 HD13 ' H ' ' A' ' 280' ' ' ILE . 0.2 OUTLIER -125.91 176.17 6.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.183 -176.512 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 11.2 t -114.34 -4.36 13.0 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.827 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--O 1.25 1.094 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.125 -179.667 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.138 0 N-CA-C 111.839 -0.504 . . . . 0.0 111.839 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -77.8 -10.85 16.89 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.997 2.464 . . . . 0.0 113.458 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -85.64 -175.47 5.65 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 73.1 m 73.86 22.7 2.41 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.985 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -100.09 22.38 40.43 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.665 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.434 ' HG2' ' HA ' ' A' ' 251' ' ' ASP . 97.4 mtt180 -146.94 127.42 14.08 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -133.88 141.88 47.55 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.981 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.408 ' HG3' HD13 ' A' ' 249' ' ' ILE . 67.7 ttt180 -99.3 135.49 40.63 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 245' ' ' LYS . 1.6 p -86.5 129.02 38.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.267 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -115.38 -3.97 12.39 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 120.861 0.363 . . . . 0.0 111.322 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 17.7 m -128.7 124.85 36.69 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -58.15 166.23 1.67 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.397 0.618 . . . . 0.0 112.171 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.448 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 78.0 t80 -168.93 151.17 4.79 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.468 -175.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 86.1 m -151.71 123.45 3.85 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -51.15 142.48 35.5 Favored 'Trans proline' 0 C--O 1.238 0.52 0 C-N-CA 122.604 2.203 . . . . 0.0 111.222 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.4 m -53.75 148.91 17.91 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.215 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -52.58 -20.25 11.85 Favored 'Trans proline' 0 N--CA 1.482 0.832 0 C-N-CA 123.088 2.525 . . . . 0.0 113.456 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -117.69 17.76 14.3 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.141 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -120.26 131.09 54.78 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.2 0.524 . . . . 0.0 111.556 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 20.2 p -120.38 4.9 10.71 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.348 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -90.7 -28.4 18.36 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.588 -176.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 14.9 m -73.42 166.12 23.79 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.35 0.595 . . . . 0.0 111.546 -176.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 21.7 tp -101.89 147.82 26.07 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.576 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -98.32 100.33 11.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.796 0.332 . . . . 0.0 110.564 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.448 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 27.3 pt -111.32 150.38 13.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.502 ' O ' HG13 ' A' ' 228' ' ' VAL . 38.7 ttmt -137.69 155.91 48.59 Favored 'General case' 0 C--O 1.213 -0.837 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -62.12 95.83 0.07 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -173.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 145.82 -52.23 0.58 Allowed Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.938 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -38.2 151.99 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.408 HD13 ' HG3' ' A' ' 227' ' ' ARG . 34.6 mm -111.47 125.8 68.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.699 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 4.8 mp -114.56 116.83 53.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 120.459 -0.497 . . . . 0.0 111.478 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . 0.434 ' HA ' ' HG2' ' A' ' 225' ' ' ARG . 29.4 t70 -75.44 141.24 43.2 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 173.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 36.0 mt -115.69 123.56 71.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.867 -172.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 12.0 tt -90.67 -17.95 7.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.152 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 48.1 t -155.5 125.48 6.58 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -107.46 86.79 2.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.936 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.65 112.3 33.1 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.362 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.75 35.36 0.29 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.034 2.489 . . . . 0.0 114.079 -175.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 20.3 mmt -112.21 -70.71 0.79 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -156.39 -53.09 0.01 OUTLIER Glycine 0 C--O 1.237 0.304 0 C-N-CA 119.924 -1.131 . . . . 0.0 113.229 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -97.71 118.74 34.92 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.61 0.243 . . . . 0.0 111.017 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.454 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 29.6 m0 -91.03 -179.87 5.57 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 16.9 m -134.04 114.33 13.08 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 269' ' ' VAL . . . -132.41 -168.62 12.07 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.132 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 51.3 ttm -138.66 114.3 9.81 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.912 0.387 . . . . 0.0 110.263 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.512 ' HG ' ' ND2' ' A' ' 266' ' ' ASN . 45.0 tp -135.98 137.04 40.85 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . 0.512 ' ND2' ' HG ' ' A' ' 265' ' ' LEU . 61.5 m-80 60.62 33.83 20.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.198 0.523 . . . . 0.0 110.085 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 20.5 m120 70.8 1.21 3.64 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.114 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -101.82 130.33 48.24 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.665 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 263' ' ' GLY . 3.9 p -95.63 119.45 43.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -151.96 174.23 31.03 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.863 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 9.2 p30 -96.31 136.78 36.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.169 0.509 . . . . 0.0 111.729 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -143.02 152.3 41.76 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.637 178.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.402 ' HB3' HG12 ' A' ' 275' ' ' ILE . 98.5 mttt -78.56 122.51 25.99 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.39 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -58.64 -22.14 55.9 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.478 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.402 HG12 ' HB3' ' A' ' 273' ' ' LYS . 34.0 pt -54.0 -22.05 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -95.72 3.17 54.1 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.412 HG12 ' HB ' ' A' ' 228' ' ' VAL . 21.3 m -125.24 166.53 20.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.473 0.654 . . . . 0.0 112.572 -177.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -128.3 119.98 26.19 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.144 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 23.2 m -70.38 129.89 34.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.036 0.446 . . . . 0.0 111.345 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.509 HD13 ' H ' ' A' ' 280' ' ' ILE . 0.2 OUTLIER -127.93 179.68 3.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.947 -178.284 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 15.9 p -116.21 -46.67 2.79 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.303 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 . . . . . 0 C--O 1.254 1.298 0 CA-C-O 118.716 -0.659 . . . . 0.0 110.356 -179.414 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.359 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -74.63 162.0 38.65 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.828 2.352 . . . . 0.0 111.586 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -77.35 129.97 36.52 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.922 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 60.1 m -87.77 80.29 7.93 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.113 0.483 . . . . 0.0 111.433 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -109.29 -80.98 1.24 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.751 -0.737 . . . . 0.0 111.375 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -133.94 172.79 12.32 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.81 123.12 46.32 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.498 ' HB2' HD13 ' A' ' 280' ' ' ILE . 26.5 ttm180 -94.22 124.61 38.35 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 277' ' ' VAL . 7.6 p -79.72 141.92 14.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.463 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -125.3 -7.36 7.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.863 0.364 . . . . 0.0 111.42 -176.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 58.7 m -131.04 127.26 37.9 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -66.46 156.55 34.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.282 0.563 . . . . 0.0 111.719 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.471 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 60.4 t80 -167.35 136.77 2.76 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.973 -176.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.49 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 7.4 t -154.67 136.27 9.27 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.927 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 233' ' ' THR . 1.5 Cg_endo -85.77 -154.06 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.683 2.256 . . . . 0.0 110.017 173.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 45.0 m -68.56 157.15 89.04 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 110.508 -0.182 . . . . 0.0 110.508 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -58.87 -39.73 78.59 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.466 2.111 . . . . 0.0 112.265 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -76.37 23.69 0.15 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -94.18 124.1 37.99 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.064 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 4.1 m -123.34 -16.05 6.99 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 120.864 0.364 . . . . 0.0 111.368 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -88.33 -22.4 23.86 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 10.8 m -89.46 -161.76 0.81 Allowed 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.647 -177.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.5 tp -136.54 105.94 6.09 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -78.27 109.32 12.29 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.238 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.471 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 16.3 pt -106.45 154.71 7.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.346 -176.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -123.7 -172.04 2.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.898 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -91.28 87.3 6.43 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.36 0.6 . . . . 0.0 112.509 -176.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 111.74 52.63 0.54 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.729 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -125.12 179.94 4.84 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 48.7 mm -118.58 123.58 71.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.886 0.374 . . . . 0.0 110.821 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 52.2 mt -115.39 126.08 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 121.056 0.455 . . . . 0.0 110.199 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . 0.515 ' HB3' ' HG2' ' A' ' 264' ' ' MET . 32.9 t70 -76.21 161.04 29.12 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 48.2 mt -128.83 122.8 57.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.966 -177.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 36.5 pt -110.89 -28.07 2.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.895 0.379 . . . . 0.0 110.873 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 53.9 t -145.97 122.63 11.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.096 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -92.74 96.18 10.01 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.504 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 32.1 m -71.74 141.34 84.71 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.26 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 256' ' ' THR . 26.0 Cg_exo -65.28 3.99 0.88 Allowed 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.955 2.437 . . . . 0.0 113.001 178.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 21.6 mmt -121.84 -171.9 2.33 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.629 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -71.96 -29.45 67.01 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.406 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 17.1 ptp -82.47 104.28 12.63 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.079 0.466 . . . . 0.0 111.65 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -97.37 163.09 13.03 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.654 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 2.4 m -112.45 119.3 37.75 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.362 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -154.99 -166.98 16.0 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.019 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . 0.515 ' HG2' ' HB3' ' A' ' 251' ' ' ASP . 20.3 ptt? -143.74 130.68 20.48 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.219 0.533 . . . . 0.0 111.444 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.507 HD22 HD22 ' A' ' 266' ' ' ASN . 6.4 tt -113.8 138.55 50.11 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . 0.507 HD22 HD22 ' A' ' 265' ' ' LEU . 10.7 p30 49.25 33.67 5.4 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.399 0.68 . . . . 0.0 111.082 -175.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.3 m120 71.49 13.43 6.45 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.88 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -102.61 123.22 45.94 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 13.7 p -81.79 134.13 27.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.224 0.535 . . . . 0.0 111.522 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -168.75 -177.07 39.41 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.669 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -97.67 143.26 28.51 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -139.65 145.07 37.99 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.11 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -85.44 118.8 25.19 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.051 0.453 . . . . 0.0 110.747 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.5 ' HA ' HG22 ' A' ' 277' ' ' VAL . 40.3 t80 -52.28 -32.95 39.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.279 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 24.8 pt -54.02 -26.22 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -93.96 -9.84 35.67 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.5 HG22 ' HA ' ' A' ' 274' ' ' PHE . 5.6 m -111.83 178.93 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.232 0.539 . . . . 0.0 112.358 -176.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -141.13 140.19 34.08 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.951 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 12.2 t -83.02 118.15 30.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.498 HD13 ' HB2' ' A' ' 227' ' ' ARG . 41.7 pt -119.43 166.95 13.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.178 0.513 . . . . 0.0 111.493 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 31.3 t -93.1 144.56 25.15 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.2 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 C--N 1.31 -1.119 0 CA-C-O 118.327 -0.844 . . . . 0.0 109.673 178.388 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.95 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -76.44 -20.68 13.9 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.329 2.019 . . . . 0.0 112.705 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -120.51 161.71 20.81 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.891 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 75.6 m -75.98 -39.05 56.72 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.102 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 87.91 -78.04 1.83 Allowed Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.525 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -91.49 164.26 13.86 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.883 0.373 . . . . 0.0 110.685 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -140.0 148.46 41.91 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.582 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -92.61 138.93 31.08 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.477 HG21 ' HB ' ' A' ' 244' ' ' ILE . 3.0 p -90.11 129.92 40.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.408 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -111.04 3.89 19.01 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 52.5 m -143.15 133.57 24.79 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.61 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -84.91 94.66 8.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.581 0.705 . . . . 0.0 111.705 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.443 ' H ' HG13 ' A' ' 244' ' ' ILE . 89.0 t80 -109.1 104.16 13.3 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.406 HG23 ' HB3' ' A' ' 243' ' ' LYS . 30.7 m -116.97 108.18 44.71 Favored Pre-proline 0 N--CA 1.434 -1.256 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.676 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.18 156.44 25.01 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 123.091 2.528 . . . . 0.0 112.134 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 18.8 m -62.38 151.72 81.74 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.827 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.18 -25.28 45.45 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.819 2.346 . . . . 0.0 113.029 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -74.73 -3.06 29.27 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.609 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -69.79 151.38 45.83 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.192 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 19.6 p -118.06 98.88 6.54 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 72.8 14.77 4.89 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 171.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 19.0 m -78.17 176.33 9.34 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 172.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 272' ' ' PHE . 22.6 tp -102.55 133.51 47.42 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.246 -0.981 . . . . 0.0 110.967 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.406 ' HB3' HG23 ' A' ' 233' ' ' THR . 88.9 mttt -99.91 108.15 20.31 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.438 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.477 ' HB ' HG21 ' A' ' 228' ' ' VAL . 24.0 pt -106.6 159.7 6.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-O 121.059 0.457 . . . . 0.0 111.508 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -128.31 164.34 22.84 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.864 -178.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -77.52 91.58 3.96 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.351 0.596 . . . . 0.0 112.003 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 105.9 82.01 1.5 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.231 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -161.67 174.44 13.29 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 46.6 mm -107.73 125.74 64.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 118.013 0.369 . . . . 0.0 110.42 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 36.3 mt -117.95 118.96 60.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.804 0.335 . . . . 0.0 111.367 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -79.6 151.51 30.58 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 173.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 54.4 mt -129.12 132.53 67.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 118.178 0.445 . . . . 0.0 110.842 -174.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 29.6 pt -116.13 -2.5 10.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.93 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.502 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 49.0 t -157.49 123.77 4.85 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -121.19 142.46 49.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.012 0.434 . . . . 0.0 111.208 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.7 p -124.51 159.13 59.18 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.92 -65.68 0.11 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.051 1.834 . . . . 0.0 111.661 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 58.7 mtm -138.51 115.73 11.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.311 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 156.78 -130.67 2.74 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.197 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -106.58 127.87 53.68 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.85 0.357 . . . . 0.0 111.417 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.529 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 45.0 m0 -92.81 176.75 6.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.478 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 254' ' ' CYS . 20.0 m -126.11 116.26 21.09 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.895 0.379 . . . . 0.0 109.994 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -138.81 -168.39 11.25 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.842 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -135.39 135.55 40.73 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.91 0.386 . . . . 0.0 110.655 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.9 142.85 12.29 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 62.94 34.47 14.1 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.894 0.477 . . . . 0.0 110.767 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 17.6 m120 69.35 16.58 8.32 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.813 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -130.5 140.99 50.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.788 0.327 . . . . 0.0 111.15 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.7 p -102.42 131.78 49.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -164.07 -175.66 35.16 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 119.883 -1.151 . . . . 0.0 112.827 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.529 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 7.6 p30 -101.68 137.23 40.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.85 0.357 . . . . 0.0 111.044 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' PHE . . . . . 0.445 ' HB3' ' HB3' ' A' ' 242' ' ' LEU . 43.9 p90 -136.78 162.56 32.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.73 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.447 ' HG3' HG12 ' A' ' 275' ' ' ILE . 22.2 tptm -79.5 114.26 18.29 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.493 ' O ' HG22 ' A' ' 277' ' ' VAL . 11.3 p90 -55.59 -31.06 61.9 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -174.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.447 HG12 ' HG3' ' A' ' 273' ' ' LYS . 18.9 pt -54.63 -25.97 15.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . 0.445 ' CD2' ' HB3' ' A' ' 273' ' ' LYS . 54.3 m-85 -84.59 3.76 35.32 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 274' ' ' PHE . 15.1 m -125.65 161.2 30.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.988 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -129.74 131.16 46.2 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.694 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 7.1 m -79.14 103.77 6.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.627 0.727 . . . . 0.0 110.294 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.562 HD13 ' H ' ' A' ' 280' ' ' ILE . 0.2 OUTLIER -67.96 148.26 11.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.267 -178.148 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 33.8 m 63.88 28.93 14.66 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.672 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 . . . . . 0 C--O 1.242 0.683 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.406 179.166 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.363 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.97 155.11 66.05 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.499 2.133 . . . . 0.0 111.792 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -140.35 149.16 42.36 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.998 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 47.0 t -104.22 94.96 5.65 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 160.24 57.17 0.01 OUTLIER Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.331 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.554 ' O ' ' HB2' ' A' ' 281' ' ' SER . 28.3 ptt180 -159.28 151.95 21.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.802 0.334 . . . . 0.0 110.571 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -137.18 149.09 47.0 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.638 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -97.72 125.53 42.57 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 246' ' ' LYS . 3.7 p -81.82 111.82 18.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.264 0.554 . . . . 0.0 111.834 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -89.72 -17.6 27.99 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.543 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 276' ' ' TYR . 52.1 m -129.59 122.9 30.05 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -77.45 162.04 27.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.854 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -179.94 101.67 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.846 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 9.7 t -103.81 142.23 24.16 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 168.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.82 -70.05 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.735 1.624 . . . . 0.0 110.537 177.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 238' ' ' ASP . 19.3 m -144.2 156.45 57.84 Favored Pre-proline 0 C--N 1.311 -1.095 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 175.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -58.66 -42.63 52.03 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.203 1.935 . . . . 0.0 111.393 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -92.32 25.45 2.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.649 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.454 ' HB2' ' HB2' ' A' ' 235' ' ' SER . 14.6 t70 -130.09 139.67 50.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.166 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 2.8 m -142.63 25.96 1.79 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.953 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -74.81 -17.73 60.57 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.615 0.721 . . . . 0.0 110.71 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.608 ' HA ' ' OD1' ' A' ' 271' ' ' ASN . 30.2 m -117.25 -167.02 1.24 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.499 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 48.0 tp -99.52 131.09 45.75 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -84.17 96.21 8.88 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.433 ' HA ' HD13 ' A' ' 265' ' ' LEU . 43.0 pt -90.31 140.11 16.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-O 121.233 0.539 . . . . 0.0 110.855 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -135.34 102.94 5.32 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.863 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 228' ' ' VAL . 24.8 pttm -28.53 130.73 0.06 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.832 0.853 . . . . 0.0 113.264 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 97.96 12.53 46.16 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.804 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -124.63 172.71 9.04 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 48.6 mm -115.72 121.96 68.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.458 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 250' ' ' ILE . 4.4 mp -102.05 121.94 53.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.062 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . 0.499 ' HB3' ' CG ' ' A' ' 264' ' ' MET . 14.7 t70 -78.64 151.2 32.42 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 47.5 mt -126.87 131.76 70.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 120.949 0.404 . . . . 0.0 112.029 -173.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 7.7 tt -114.42 -32.6 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.008 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.532 ' HB2' ' HB ' ' A' ' 262' ' ' THR . 19.4 m -133.91 120.29 20.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.024 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.42 ' N ' ' HD3' ' A' ' 255' ' ' LYS . 0.0 OUTLIER -103.82 89.03 3.19 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.63 ' HB ' ' O ' ' A' ' 260' ' ' MET . 45.1 m -71.7 121.59 84.87 Favored Pre-proline 0 N--CA 1.441 -0.916 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.63 -68.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.263 2.642 . . . . 0.0 113.462 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 14.8 tpt -99.6 106.36 18.33 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.752 0.311 . . . . 0.0 111.524 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 131.49 -125.92 4.56 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.898 -1.144 . . . . 0.0 114.068 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' MET . . . . . 0.63 ' O ' ' HB ' ' A' ' 256' ' ' THR . 20.8 ptt? -107.54 158.21 17.41 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.438 -0.381 . . . . 0.0 111.289 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -105.9 154.86 19.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.09 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 254' ' ' CYS . 8.5 m -102.68 114.72 29.2 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 121.169 0.509 . . . . 0.0 110.085 176.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -139.16 -167.92 11.1 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.583 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . 0.499 ' CG ' ' HB3' ' A' ' 251' ' ' ASP . 22.9 ptp -140.56 134.39 30.5 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.214 0.531 . . . . 0.0 112.152 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 244' ' ' ILE . 0.8 OUTLIER -149.58 139.63 22.05 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . 0.427 ' H ' HD23 ' A' ' 265' ' ' LEU . 91.1 m-20 63.25 34.1 13.62 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.283 0.563 . . . . 0.0 110.24 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 69.5 12.12 8.15 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.722 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -117.93 133.45 55.91 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.99 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.3 p -91.77 135.48 27.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 174.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -166.77 -158.25 11.11 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.252 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.608 ' OD1' ' HA ' ' A' ' 241' ' ' SER . 20.2 p-10 -110.09 154.77 22.79 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.738 0.304 . . . . 0.0 111.081 -178.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -165.71 154.75 11.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.856 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.415 ' HB3' HG12 ' A' ' 275' ' ' ILE . 68.2 mttm -88.02 109.29 19.72 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.012 0.434 . . . . 0.0 110.264 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -54.5 -13.59 1.0 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.415 HG12 ' HB3' ' A' ' 273' ' ' LYS . 31.3 pt -65.42 -21.23 28.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.651 0.262 . . . . 0.0 111.665 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . 0.412 ' HB3' ' O ' ' A' ' 230' ' ' THR . 61.0 m-85 -91.37 -12.97 33.35 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-O 121.003 0.43 . . . . 0.0 111.265 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 15.3 m -107.3 177.62 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.066 0.46 . . . . 0.0 111.363 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -139.73 137.78 35.41 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 20.0 t -86.53 102.4 11.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.085 0.469 . . . . 0.0 110.564 -175.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 44.4 pt -105.35 8.09 9.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.097 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.554 ' HB2' ' O ' ' A' ' 225' ' ' ARG . 2.2 t -83.08 6.84 17.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.058 -176.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.207 -179.334 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.422 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.34 154.83 27.5 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.1 2.533 . . . . 0.0 112.051 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -88.98 124.83 34.63 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.156 0.503 . . . . 0.0 111.287 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 5.1 p -83.08 -17.16 44.12 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.492 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 109.98 122.41 4.46 Favored Glycine 0 N--CA 1.432 -1.626 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.471 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 -131.68 149.81 52.36 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 278' ' ' ASP . . . -125.83 132.04 52.3 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -175.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.565 ' HE ' HD13 ' A' ' 280' ' ' ILE . 29.9 ttm-85 -91.94 116.68 29.12 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 175.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 277' ' ' VAL . 9.1 p -76.35 144.21 12.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -177.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.497 ' NE2' ' HB2' ' A' ' 278' ' ' ASP . 98.9 m-70 -101.22 -32.24 10.62 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.879 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.5 m -130.64 137.49 49.62 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.22 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -60.46 145.92 46.58 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.308 0.575 . . . . 0.0 110.964 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.499 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 63.0 t80 -136.57 112.53 9.63 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.104 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 84.4 m -153.93 98.65 2.6 Favored Pre-proline 0 C--N 1.307 -1.246 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.903 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.2 -69.6 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.124 1.883 . . . . 0.0 110.06 177.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.9 t -143.14 144.69 29.68 Favored Pre-proline 0 N--CA 1.435 -1.182 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.93 -20.65 57.77 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 121.885 1.723 . . . . 0.0 109.773 173.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -94.7 23.31 5.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.303 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -120.32 130.22 54.34 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.692 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 18.2 p -129.61 19.98 5.64 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.119 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -99.65 -21.87 15.66 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.542 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.5 m -102.89 -175.22 2.75 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.863 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 47.0 tp -109.1 117.1 33.29 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? -90.94 113.56 25.82 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.499 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 32.7 pt -130.01 173.32 14.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.189 0.518 . . . . 0.0 110.739 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -120.74 -156.78 0.69 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -105.4 153.93 21.0 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.99 30.69 77.52 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.221 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.424 ' H ' ' CG1' ' A' ' 228' ' ' VAL . 11.3 m-20 -100.95 161.43 13.6 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 177.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 35.6 mm -116.88 91.69 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 49.3 mt -80.3 132.87 30.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.055 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -83.64 154.89 23.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 175.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.467 HG21 ' HG3' ' A' ' 255' ' ' LYS . 28.3 mt -134.27 133.36 55.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.592 -176.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 12.7 tt -110.03 -23.79 4.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.348 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.404 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 48.8 t -148.23 119.44 7.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.263 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.467 ' HG3' HG21 ' A' ' 252' ' ' ILE . 3.9 mppt? -100.54 103.14 14.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.713 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.585 ' HB ' ' O ' ' A' ' 260' ' ' MET . 44.2 m -97.52 102.54 13.17 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.23 33.83 0.25 Allowed 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.2 2.6 . . . . 0.0 113.925 -175.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 48.9 ttm -108.35 -30.44 8.32 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.018 0.437 . . . . 0.0 110.364 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 273' ' ' LYS . . . 168.33 -53.3 0.22 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.85 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' MET . . . . . 0.585 ' O ' ' HB ' ' A' ' 256' ' ' THR . 4.1 mpp? -101.95 135.12 44.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.989 0.423 . . . . 0.0 111.738 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.486 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 38.2 m0 -112.24 149.4 32.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.878 176.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 254' ' ' CYS . 5.9 m -96.77 114.03 25.64 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -139.48 -175.99 14.53 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.895 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 56.0 ttp -133.07 129.32 37.87 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.082 0.468 . . . . 0.0 111.013 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.536 HD13 ' N ' ' A' ' 266' ' ' ASN . 2.0 tm? -156.26 144.53 19.84 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . 0.536 ' N ' HD13 ' A' ' 265' ' ' LEU . 0.0 OUTLIER 54.56 34.88 22.2 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.417 1.087 . . . . 0.0 112.928 179.176 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 266' ' ' ASN . 7.4 m120 75.06 13.97 3.2 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.069 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -130.48 134.54 47.16 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.416 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.3 p -95.97 132.4 40.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 174.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -164.59 -156.31 8.88 Favored Glycine 0 C--N 1.311 -0.848 0 C-N-CA 120.151 -1.024 . . . . 0.0 112.085 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 29.2 p30 -117.01 164.61 14.46 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.047 0.451 . . . . 0.0 111.39 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 260' ' ' MET . 50.3 p90 -170.4 154.56 4.78 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 259' ' ' GLY . 97.5 mttt -85.21 112.16 20.48 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 120.987 0.422 . . . . 0.0 110.101 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.464 ' HA ' HG22 ' A' ' 277' ' ' VAL . 33.5 p90 -58.67 -11.68 3.36 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -176.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 32.7 pt -61.26 -23.92 31.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.638 0.256 . . . . 0.0 111.281 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -89.44 -11.99 41.48 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.363 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 274' ' ' PHE . 10.3 m -113.4 -178.96 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.497 ' HB2' ' NE2' ' A' ' 229' ' ' HIS . 27.3 t70 -141.18 141.09 34.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.546 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 57.2 t -83.8 117.72 29.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.885 0.374 . . . . 0.0 110.852 -176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.565 HD13 ' HE ' ' A' ' 227' ' ' ARG . 37.0 pt -134.29 177.57 6.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.645 0.736 . . . . 0.0 111.472 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 24.6 m -142.05 7.12 1.8 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.596 174.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 C--O 1.249 1.072 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.375 -179.908 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 N-CA-C 111.724 -0.551 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.7 21.64 0.63 Allowed 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.302 2.668 . . . . 0.0 113.741 -176.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -87.2 96.72 10.42 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 85.9 m -80.21 46.07 0.79 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.644 -175.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -94.89 36.12 3.94 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 175.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -157.4 151.63 24.83 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 124.18 0.992 . . . . 0.0 108.466 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -144.82 147.03 32.39 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.143 0.497 . . . . 0.0 111.629 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -93.94 125.74 38.74 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.5 p -81.55 137.07 21.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 120.745 0.307 . . . . 0.0 110.483 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -113.4 0.85 14.89 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -175.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 83.1 m -140.15 139.42 35.75 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.621 0.248 . . . . 0.0 111.023 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -77.82 157.97 29.71 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.443 ' HB3' ' CG1' ' A' ' 244' ' ' ILE . 68.4 t80 178.52 103.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.047 0.451 . . . . 0.0 112.004 -176.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.449 ' OG1' ' HG2' ' A' ' 243' ' ' LYS . 5.1 t -136.45 116.49 11.0 Favored Pre-proline 0 N--CA 1.435 -1.213 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.983 172.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -53.99 -45.64 39.49 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.692 2.262 . . . . 0.0 111.282 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 238' ' ' ASP . 46.4 m -141.73 127.36 10.85 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.26 176.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.45 -27.91 83.02 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.766 2.311 . . . . 0.0 113.514 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -92.25 -27.07 17.85 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.542 ' HB2' ' HB2' ' A' ' 235' ' ' SER . 25.7 t70 -48.79 162.17 0.11 Allowed 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 2.9 m -143.13 -0.6 1.12 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.768 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -90.06 -48.59 7.1 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.837 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 69.4 m -74.36 -178.16 3.36 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 31.6 tp -107.17 110.97 23.17 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.941 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.449 ' HG2' ' OG1' ' A' ' 233' ' ' THR . 43.7 mtmt -86.56 101.56 13.33 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.776 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.443 ' CG1' ' HB3' ' A' ' 232' ' ' PHE . 29.6 pt -100.39 149.8 5.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.241 0.543 . . . . 0.0 111.341 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -108.82 162.25 14.36 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.488 -177.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -81.23 86.47 6.21 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.305 0.574 . . . . 0.0 111.217 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 107.48 72.5 0.79 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.62 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -147.94 -174.06 4.46 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 44.1 mm -117.59 124.94 73.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.99 0.424 . . . . 0.0 111.059 -176.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.481 HG12 HD12 ' A' ' 265' ' ' LEU . 55.0 mt -118.47 126.39 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.279 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . 0.464 ' HB3' ' HB3' ' A' ' 264' ' ' MET . 26.3 t70 -76.39 167.21 22.26 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 73.2 mt -138.28 107.75 4.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 118.375 0.534 . . . . 0.0 109.924 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 50.9 pt -95.5 -8.31 9.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.117 0.484 . . . . 0.0 110.753 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.5 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 52.7 t -164.31 121.6 1.68 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.312 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.442 ' N ' ' HD3' ' A' ' 255' ' ' LYS . 0.1 OUTLIER -86.09 -94.87 0.08 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.371 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 30.1 p 49.11 90.59 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.589 0 C-N-CA 123.299 0.639 . . . . 0.0 112.107 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -63.12 59.85 0.16 Allowed 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.673 2.915 . . . . 0.0 114.23 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 22.2 ptp -91.96 21.57 4.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.299 0.571 . . . . 0.0 109.942 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 105.09 -59.7 0.43 Allowed Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' MET . . . . . 0.423 ' HB3' ' HB2' ' A' ' 271' ' ' ASN . 3.8 mpp? -108.83 122.21 46.69 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.685 0.279 . . . . 0.0 111.107 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.442 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 19.9 m0 -87.62 168.62 12.87 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 175.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 254' ' ' CYS . 6.4 m -117.76 114.07 22.76 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 121.112 0.482 . . . . 0.0 110.092 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -136.63 -169.87 11.81 Favored Glycine 0 N--CA 1.431 -1.663 0 C-N-CA 120.155 -1.022 . . . . 0.0 112.78 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . 0.464 ' HB3' ' HB3' ' A' ' 251' ' ' ASP . 50.8 ttp -134.67 125.0 26.22 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.942 0.401 . . . . 0.0 111.236 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.481 HD12 HG12 ' A' ' 250' ' ' ILE . 9.3 tt -135.18 129.78 34.3 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 62.13 38.96 13.39 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.861 0.464 . . . . 0.0 110.944 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 63.9 t30 70.74 2.91 4.34 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.827 0.851 . . . . 0.0 111.994 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 264' ' ' MET . 54.6 tttp -108.64 136.11 48.77 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.86 0.362 . . . . 0.0 111.502 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 6.4 p -89.94 135.38 26.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.915 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -160.27 178.58 36.25 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.256 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 17.8 p30 -108.11 145.31 34.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.903 0.383 . . . . 0.0 111.354 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -152.36 160.59 43.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.6 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.42 ' HE3' ' SD ' ' A' ' 260' ' ' MET . 9.1 mptt -78.04 109.09 11.81 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 176.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.508 ' O ' HG22 ' A' ' 277' ' ' VAL . 54.8 p90 -55.05 -26.41 37.27 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 27.4 pt -59.31 -19.77 16.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -89.54 -7.97 53.76 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 274' ' ' PHE . 15.6 m -109.48 172.28 2.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.064 0.459 . . . . 0.0 111.246 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -133.93 129.48 36.36 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.584 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 6.1 m -76.38 107.3 7.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.391 0.615 . . . . 0.0 111.806 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 2.8 pp -138.02 169.89 17.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.029 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 33.3 m -155.03 145.4 22.04 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.048 0.452 . . . . 0.0 111.843 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 . . . . . 0 C--O 1.249 1.048 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.715 178.37 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.329 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -78.36 161.9 28.4 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.591 2.194 . . . . 0.0 112.165 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -100.03 165.04 11.72 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.989 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 65.9 m -62.57 -36.99 84.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.241 0.543 . . . . 0.0 109.812 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.482 ' HA3' ' HB ' ' A' ' 252' ' ' ILE . . . 161.69 125.81 0.79 Allowed Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.82 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 -132.66 112.78 12.31 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.969 0.414 . . . . 0.0 110.636 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.498 ' HB2' HD11 ' A' ' 252' ' ' ILE . . . -132.62 148.48 52.36 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.595 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 45.5 ttt85 -107.23 122.31 46.27 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.6 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.46 133.17 30.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.012 0.434 . . . . 0.0 110.26 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -124.0 -24.24 4.44 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.152 0.501 . . . . 0.0 109.998 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.452 ' HB ' ' HA ' ' A' ' 276' ' ' TYR . 20.4 m -107.65 127.2 53.45 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 176.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -69.41 148.48 49.55 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.994 0.426 . . . . 0.0 110.578 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -145.19 103.91 3.9 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 3.8 t -152.61 114.97 2.83 Favored Pre-proline 0 N--CA 1.425 -1.714 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.611 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 233' ' ' THR . 6.8 Cg_exo -76.07 -156.54 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.402 2.068 . . . . 0.0 109.102 172.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.4 t -64.88 129.93 94.62 Favored Pre-proline 0 C--N 1.316 -0.885 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.09 -20.16 70.63 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.531 2.154 . . . . 0.0 111.595 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -65.69 -37.66 87.08 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.29 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -63.33 133.76 54.65 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 171.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.448 ' O ' ' HE2' ' A' ' 268' ' ' LYS . 30.3 m -104.55 -26.58 12.31 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -76.86 -48.31 18.74 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 3.7 m -59.72 131.62 51.46 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.776 0.322 . . . . 0.0 110.425 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 26.0 tp -72.89 107.95 5.57 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.592 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -100.05 108.89 21.18 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.251 0.548 . . . . 0.0 109.587 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 21.2 pt -108.53 178.71 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.663 -175.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -130.69 129.88 43.15 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -60.5 160.77 8.42 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.14 36.0 71.28 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.765 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -135.59 176.02 9.06 Favored 'General case' 0 C--N 1.318 -0.783 0 O-C-N 122.629 -0.336 . . . . 0.0 110.332 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 49.2 mm -108.29 130.68 60.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 34.2 mt -122.85 129.07 75.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 120.664 0.268 . . . . 0.0 110.819 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . 0.415 ' O ' ' HA2' ' A' ' 263' ' ' GLY . 3.4 m-20 -80.0 133.92 36.2 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 226' ' ' ALA . 4.1 mt -99.09 102.44 13.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 48.4 mm -67.69 -60.66 2.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.018 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.401 ' C ' ' HD3' ' A' ' 255' ' ' LYS . 57.7 m -121.62 142.86 49.7 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.401 ' HD3' ' C ' ' A' ' 254' ' ' CYS . 3.2 mppt? -119.27 97.76 5.82 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.852 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.0 m -84.91 126.08 69.05 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -27.53 -77.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 125.112 3.875 . . . . 0.0 115.539 -175.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 46.4 ttm -31.12 -45.67 0.08 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 144.75 4.84 0.59 Allowed Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 119.793 -1.194 . . . . 0.0 112.731 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 72.5 mtm -78.35 106.02 9.99 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.431 0.634 . . . . 0.0 109.299 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -111.37 140.46 45.93 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.22 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . 0.486 HG22 HG22 ' A' ' 269' ' ' VAL . 1.3 m -100.3 114.87 28.7 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 269' ' ' VAL . . . -108.96 173.91 17.87 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.952 -176.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 39.5 ttp -129.93 114.51 15.94 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.802 0.334 . . . . 0.0 110.355 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.64 143.62 11.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.328 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 63.5 38.02 10.11 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.965 0.412 . . . . 0.0 110.944 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 14.6 m120 65.07 16.33 10.5 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.48 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.448 ' HE2' ' O ' ' A' ' 239' ' ' THR . 63.3 tttp -135.59 141.9 45.21 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.824 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 263' ' ' GLY . 4.5 p -101.16 125.03 55.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -149.84 172.41 29.76 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.132 -1.033 . . . . 0.0 112.182 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -88.97 120.12 30.1 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -123.84 -178.82 4.16 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.758 175.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -109.34 143.74 38.45 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.081 0.467 . . . . 0.0 111.348 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -66.98 -14.28 62.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.734 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 36.3 pt -68.98 -21.97 25.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.801 -177.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . 0.452 ' HA ' ' HB ' ' A' ' 230' ' ' THR . 63.2 m-85 -90.04 -3.48 57.94 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.964 0.411 . . . . 0.0 111.186 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 33.8 m -132.16 166.71 28.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.79 140.02 46.67 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.042 174.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 16.3 m -80.79 119.47 30.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.385 0.612 . . . . 0.0 112.449 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 38.3 pt -95.92 -8.6 9.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.927 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 3.7 p -68.73 148.38 50.45 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.459 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.679 -0.677 . . . . 0.0 110.339 -178.455 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.869 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -71.64 -171.01 0.58 Allowed 'Trans proline' 0 C--O 1.239 0.54 0 C-N-CA 122.847 2.364 . . . . 0.0 111.731 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -74.32 109.44 7.8 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.096 0.474 . . . . 0.0 110.532 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 79.5 m -85.91 98.46 10.81 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.774 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -94.52 136.12 12.82 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.619 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -148.23 144.0 27.38 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 120.72 0.295 . . . . 0.0 110.388 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.484 ' HB2' HD11 ' A' ' 252' ' ' ILE . . . -139.24 126.81 21.76 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.016 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 47.9 ttp180 -75.57 112.56 12.04 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.503 HG21 HD12 ' A' ' 244' ' ' ILE . 6.5 p -73.65 149.11 8.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.809 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -109.63 -21.95 12.18 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.814 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.7 m -127.28 140.98 51.84 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.045 -174.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -74.02 173.86 9.43 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.426 ' HB2' HG12 ' A' ' 244' ' ' ILE . 16.6 t80 -141.85 123.34 14.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 38.2 m -134.75 97.19 14.23 Favored Pre-proline 0 C--N 1.309 -1.159 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.577 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -97.13 -165.2 0.09 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 123.255 2.637 . . . . 0.0 111.04 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 19.4 m -72.38 140.46 82.26 Favored Pre-proline 0 C--N 1.313 -0.999 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.77 -11.44 9.42 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.236 2.624 . . . . 0.0 114.007 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -113.62 -9.99 13.16 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.84 0.352 . . . . 0.0 110.93 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -58.45 125.93 25.41 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.938 0.399 . . . . 0.0 110.865 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 20.5 p -118.81 28.28 8.39 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.395 0.617 . . . . 0.0 110.144 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -114.38 -18.47 11.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.047 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 12.8 m -114.27 174.33 6.0 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.255 0.55 . . . . 0.0 111.38 -176.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 58.9 tp -115.41 118.64 33.77 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -78.36 88.13 4.38 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.203 0.525 . . . . 0.0 110.326 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.503 HD12 HG21 ' A' ' 228' ' ' VAL . 16.0 pt -94.91 156.25 3.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.535 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -104.14 172.17 6.94 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.471 ' O ' ' HD2' ' A' ' 246' ' ' LYS . 0.0 OUTLIER -87.29 147.95 25.3 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 55.82 60.58 8.64 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.155 -177.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 227' ' ' ARG . 1.3 t70 -134.48 -169.83 2.42 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 37.6 mm -130.9 104.29 9.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -176.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 39.0 mt -86.99 129.79 37.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.336 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . 0.475 ' HB3' ' HG2' ' A' ' 264' ' ' MET . 13.7 t70 -85.68 94.37 9.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.11 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.484 HD11 ' HB2' ' A' ' 226' ' ' ALA . 5.9 mt -74.12 120.65 23.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.386 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 18.0 pt -109.75 -21.78 5.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.064 0.459 . . . . 0.0 110.795 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.504 ' HB2' ' HB ' ' A' ' 262' ' ' THR . 56.6 m -146.31 142.01 27.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.756 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.85 171.72 7.87 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.064 0.459 . . . . 0.0 110.732 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 27.7 m -145.31 128.8 8.49 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.72 -42.7 29.9 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.932 2.421 . . . . 0.0 112.275 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 15.2 tpt -145.09 115.57 7.62 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.752 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 137.07 -132.76 6.13 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 119.956 -1.116 . . . . 0.0 113.372 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -107.17 143.76 34.89 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.048 0.452 . . . . 0.0 111.743 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -102.67 152.24 21.43 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.96 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . 0.504 ' HB ' ' HB2' ' A' ' 254' ' ' CYS . 2.8 m -96.82 122.36 39.69 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.84 0.353 . . . . 0.0 110.176 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -154.87 166.07 32.33 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.652 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . 0.475 ' HG2' ' HB3' ' A' ' 251' ' ' ASP . 23.0 ptp -113.61 146.61 39.46 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.202 0.525 . . . . 0.0 111.223 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.501 HD13 ' N ' ' A' ' 266' ' ' ASN . 1.4 tm? -147.17 142.24 27.1 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . 0.501 ' N ' HD13 ' A' ' 265' ' ' LEU . 11.1 p30 51.18 34.68 11.67 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.624 0.77 . . . . 0.0 111.907 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 15.8 m120 66.89 20.81 10.51 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.462 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -119.46 136.26 54.39 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.0 p -96.13 143.23 12.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.028 0.442 . . . . 0.0 111.081 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -175.41 -150.41 7.92 Favored Glycine 0 N--CA 1.438 -1.167 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.803 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -130.96 165.45 23.11 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.946 0.403 . . . . 0.0 110.018 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -154.73 149.58 26.67 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.458 ' HB3' HG12 ' A' ' 275' ' ' ILE . 13.5 mptt -93.56 113.18 25.24 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.575 ' HA ' HG22 ' A' ' 277' ' ' VAL . 46.1 p90 -51.74 -9.03 0.07 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.458 HG12 ' HB3' ' A' ' 273' ' ' LYS . 45.8 pt -81.04 17.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.117 0.484 . . . . 0.0 109.906 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -137.67 12.54 2.95 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.575 HG22 ' HA ' ' A' ' 274' ' ' PHE . 9.9 m -138.74 178.56 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 121.09 0.471 . . . . 0.0 111.574 -174.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.44 118.13 14.02 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.344 176.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 15.8 m -75.45 104.79 3.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.637 0.732 . . . . 0.0 111.371 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 32.0 pt -81.69 2.17 2.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.376 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 11.3 m -66.86 -43.11 84.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.86 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.581 -0.723 . . . . 0.0 109.952 -179.746 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.418 ' N ' ' HG ' ' A' ' 223' ' ' CYS . . . . . . . . 0 N--CA 1.476 1.307 0 N-CA-C 112.437 -0.265 . . . . 0.0 112.437 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.57 -21.91 39.02 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.999 2.466 . . . . 0.0 112.854 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -84.41 -39.84 18.52 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.126 0.488 . . . . 0.0 109.767 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . 0.418 ' HG ' ' N ' ' A' ' 220' ' ' GLY . 29.7 m -64.59 -44.74 89.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.403 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 119.55 141.12 6.36 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -136.27 147.84 47.72 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.858 0.361 . . . . 0.0 110.494 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -132.52 147.58 52.36 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.552 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -97.66 116.96 30.89 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.674 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.41 ' HA ' HG12 ' A' ' 277' ' ' VAL . 3.4 p -80.79 113.92 20.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.206 0.527 . . . . 0.0 111.57 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -98.55 -22.81 15.79 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.716 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' A' ' 276' ' ' TYR . 59.6 m -122.45 127.35 49.51 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.512 ' HB3' ' HG3' ' A' ' 246' ' ' LYS . 5.1 p-10 -75.96 164.09 26.52 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.493 0.663 . . . . 0.0 111.721 -176.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -157.57 134.42 10.01 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.587 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 5.5 t -143.56 131.5 10.97 Favored Pre-proline 0 N--CA 1.433 -1.277 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.115 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.446 ' HB3' ' HB3' ' A' ' 241' ' ' SER . 89.6 Cg_endo -78.02 -176.41 3.23 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.343 2.029 . . . . 0.0 111.082 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 20.7 m -63.66 147.84 95.11 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.943 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -59.65 -12.8 18.95 Favored 'Trans proline' 0 N--CA 1.478 0.602 0 C-N-CA 122.852 2.368 . . . . 0.0 112.33 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -106.55 13.91 27.74 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.42 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -115.04 109.02 17.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.684 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 3.2 m -97.86 9.81 41.76 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.284 0.564 . . . . 0.0 110.403 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -91.47 -68.34 0.8 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.738 -176.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 234' ' ' PRO . 10.7 t -55.78 160.21 2.73 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.345 0.593 . . . . 0.0 112.034 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 23.3 tp -94.78 128.76 41.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.863 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -89.73 97.94 11.48 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.444 ' HA ' ' CD2' ' A' ' 265' ' ' LEU . 40.5 pt -96.83 137.32 24.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.311 0.576 . . . . 0.0 112.349 -175.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -115.31 108.1 16.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.571 -177.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.602 ' O ' ' HD2' ' A' ' 246' ' ' LYS . 0.1 OUTLIER -41.18 136.35 1.62 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 177.67 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 108.37 -8.59 35.31 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.57 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -109.87 -176.96 3.14 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-O 120.855 0.359 . . . . 0.0 110.902 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 30.3 mm -121.17 129.46 75.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 35.5 mt -107.7 133.11 53.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.422 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.58 149.66 26.42 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 9.0 mt -129.19 124.87 61.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.817 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 28.3 pt -106.49 -5.78 10.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.217 0.532 . . . . 0.0 110.631 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.414 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 40.4 t -155.86 110.4 2.88 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.32 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.423 ' N ' ' HD3' ' A' ' 255' ' ' LYS . 0.1 OUTLIER -96.14 90.55 5.55 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.589 ' HB ' ' O ' ' A' ' 260' ' ' MET . 20.5 m -89.28 116.82 67.34 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.358 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.02 12.9 0.41 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.034 2.489 . . . . 0.0 113.642 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 51.3 ttm -86.23 -26.95 24.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.744 0.307 . . . . 0.0 110.67 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 144.26 -34.58 1.62 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.446 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' MET . . . . . 0.589 ' O ' ' HB ' ' A' ' 256' ' ' THR . 1.7 pmm? -103.77 138.57 40.21 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.875 0.369 . . . . 0.0 110.826 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.526 ' O ' ' HA ' ' A' ' 271' ' ' ASN . 32.2 m0 -119.37 135.16 54.86 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 254' ' ' CYS . 44.6 m -90.12 114.34 26.26 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.292 0.568 . . . . 0.0 109.47 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -132.54 -168.92 12.13 Favored Glycine 0 N--CA 1.426 -1.999 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.893 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 28.2 ttt -134.54 120.58 19.84 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.053 0.454 . . . . 0.0 110.773 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.444 ' CD2' ' HA ' ' A' ' 244' ' ' ILE . 39.9 tp -143.82 142.64 30.96 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 7.5 p30 46.76 41.2 9.99 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.374 0.67 . . . . 0.0 112.422 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 66.0 t30 68.28 9.3 7.15 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.943 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -113.88 137.63 51.41 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.793 0.33 . . . . 0.0 110.673 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 7.7 p -102.32 137.28 30.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -172.35 174.51 45.53 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.116 -179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.526 ' HA ' ' O ' ' A' ' 261' ' ' TRP . 7.9 p30 -110.68 103.11 11.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.609 0.718 . . . . 0.0 112.747 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -94.79 173.83 7.41 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.63 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.455 ' HB2' ' CE2' ' A' ' 276' ' ' TYR . 99.0 mttt -95.42 122.51 38.22 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.144 177.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' PHE . . . . . 0.462 ' HA ' HG22 ' A' ' 277' ' ' VAL . 44.2 p90 -61.4 -9.41 5.42 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.413 HG12 ' HB3' ' A' ' 273' ' ' LYS . 32.8 pt -68.63 -17.7 22.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 120.767 0.318 . . . . 0.0 110.939 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' A' ' 230' ' ' THR . 40.1 m-85 -95.67 -6.74 39.3 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-O 121.091 0.472 . . . . 0.0 110.808 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 274' ' ' PHE . 4.9 m -122.09 -178.98 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.223 0.535 . . . . 0.0 111.488 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.7 138.93 38.19 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.233 177.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 6.9 p -95.81 121.81 46.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-O 121.112 0.482 . . . . 0.0 110.544 -176.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.564 HD13 ' H ' ' A' ' 280' ' ' ILE . 0.2 OUTLIER -102.82 -5.63 9.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.978 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 20.6 m -84.62 104.98 15.08 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.009 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.623 -0.703 . . . . 0.0 109.624 179.549 . . . . . . . . 0 0 . 1 stop_ save_